Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,glutamate receptor activity (GO:0008066),-0.7616574156553233,-2.104393356374987,0.002457002457002457,0.007872256312415133,0.008,10/19,8.98%,GRM3;GRIK1;GRM5;GRM1;GRM7;GRIA4;GRIA2;GRID2;GRM8;GRIK2
prerank,solute:sodium symporter activity (GO:0015370),0.8329318238669009,2.034143584460461,0.0,0.004032434036536296,0.004,3/27,1.07%,SLC4A10;SLC4A4;SLC5A6
prerank,oxidoreduction-driven active transmembrane transporter activity (GO:0015453),-0.5471366699332917,-1.9014032340902018,0.0,0.08610280341704052,0.145,33/57,26.45%,COX4I1;CYB5A;UQCR10;UQCRH;NDUFA8;COX8A;COX6B1;NDUFB3;NDUFS4;COX6A1;NDUFA6;COX5B;NDUFS3;UQCR11;NDUFA12;NDUFC2;NDUFS2;NDUFB7;NDUFA1;NDUFB8;COX10;NDUFA3;NDUFB9;NDUFB4;NDUFS5;NDUFC1;NDUFA4L2;NDUFA10;UQCRFS1;NDUFA9;NDUFA5;COX4I2;NDUFS6
prerank,monocarboxylate:sodium symporter activity (GO:0140161),-0.8166362347932223,-1.8881676238084653,0.0,0.07150632817110412,0.176,3/10,3.21%,SLC6A13;SLC6A12;SLC6A1
prerank,sodium ion transmembrane transporter activity (GO:0015081),0.7682510304639073,1.8853619930689227,0.0015455950540958269,0.10988382749561408,0.168,8/27,8.41%,SLC9A2;SLC9B2;SLC23A1;CNNM4;SLC9C1;SLC9A8;SLC4A8;PKD2L1
prerank,retinoic acid binding (GO:0001972),-0.7634769073333376,-1.8514953726797867,0.0,0.08511877137798864,0.259,2/12,1.91%,NR2F2;CYP26B1
prerank,metalloendopeptidase activity (GO:0004222),0.6367584308702113,1.835072693662857,0.0,0.20330188267537158,0.365,16/76,8.30%,ADAMTSL3;TRABD2B;ADAMTSL1;THSD4;ADAMTS17;MMP28;ADAMTS2;ADAMTSL5;ADAM9;PHEX;ADAMTS5;MMP16;MMP14;IDE;NLN;ADAM10
prerank,carbohydrate:cation symporter activity (GO:0005402),0.8804308630693868,1.834880051928406,0.0,0.15298046626109574,0.366,2/11,0.26%,SLC23A1;SLC23A2
prerank,outward rectifier potassium channel activity (GO:0015271),-0.7834435626786641,-1.8332900478143836,0.002325581395348837,0.08580759380532495,0.315,6/11,12.56%,KCNK2;KCNT2;KCNQ1;KCND3;KCND2;KCNT1
prerank,retinoid binding (GO:0005501),-0.6342966983242773,-1.819620819360002,0.005555555555555556,0.08577479273735655,0.364,6/22,2.28%,ALDH1A2;PTGDS;NR2F2;ABCA4;CYP26B1;RBP4
prerank,sulfate transmembrane transporter activity (GO:0015116),0.822687025203056,1.8104860006133958,0.0033222591362126247,0.18468547887336237,0.505,2/14,0.36%,SLC26A7;SLC26A2
prerank,anion:anion antiporter activity (GO:0015301),0.7985726431136663,1.7991138763326362,0.005050505050505051,0.1814595316441333,0.564,2/17,0.36%,SLC26A7;SLC26A2
prerank,metal ion:proton antiporter activity (GO:0051139),0.8347484879306203,1.7855276917836966,0.001736111111111111,0.1901004617224254,0.636,4/13,6.83%,SLC9A2;SLC9B2;SLC9C1;SLC9A8
prerank,cell adhesion mediator activity (GO:0098631),-0.6134133621651173,-1.7787613141691236,0.0,0.11724038865275395,0.507,11/24,10.98%,BSG;ESAM;LRRC4C;CD47;CNTN4;CNTN2;JAM3;ROBO4;SIRPA;NINJ1;PALLD
prerank,symporter activity (GO:0015293),0.8792014352493347,1.7665566988037664,0.0,0.2202717092457952,0.744,2/10,1.07%,SLC4A4;SLC5A6
prerank,monovalent cation:proton antiporter activity (GO:0005451),0.8411821159353848,1.7663376331489558,0.0017331022530329288,0.19635713516800354,0.745,4/12,6.83%,SLC9A2;SLC9B2;SLC9C1;SLC9A8
prerank,chloride transmembrane transporter activity (GO:0015108),0.7769813848428462,1.7572019640468737,0.008503401360544218,0.20343629714325617,0.799,2/16,0.36%,SLC26A7;SLC26A2
prerank,bicarbonate transmembrane transporter activity (GO:0015106),0.787780801077794,1.754427447667212,0.0016722408026755853,0.19236543278840196,0.813,2/15,0.36%,SLC26A7;SLC26A2
prerank,sodium:proton antiporter activity (GO:0015385),0.8413339318382006,1.7287284856964402,0.0052173913043478265,0.2420300512346056,0.909,4/11,6.83%,SLC9A2;SLC9B2;SLC9C1;SLC9A8
prerank,monocarboxylic acid binding (GO:0033293),-0.6328234564026168,-1.724502775060826,0.018666666666666668,0.1944693317176301,0.738,5/18,14.43%,NR2F2;CYP26B1;PSAP;NAPEPLD;NR1H4
prerank,potassium ion transmembrane transporter activity (GO:0015079),0.7024597213704337,1.723003389145405,0.007288629737609329,0.24194604219217777,0.923,5/31,5.22%,KCNK5;SLC12A7;SLC12A2;SLC12A8;KCNK7
prerank,metal ion transmembrane transporter activity (GO:0046873),0.7060907662736661,1.721551627381297,0.007374631268436578,0.229200670326697,0.926,9/27,7.46%,SLC9B2;SLC23A1;SLC12A2;CNNM2;CNNM4;CLDN16;ITPR2;SLC4A8;ATP2B4
prerank,cadherin binding involved in cell-cell adhesion (GO:0098641),0.757184771294119,1.7030107118661117,0.0048,0.26997145874610506,0.963,6/18,5.13%,STXBP6;BAIAP2L1;ANXA1;ANXA2;TMOD3;PDLIM5
prerank,aldehyde dehydrogenase (NAD+) activity (GO:0004029),-0.668140345518429,-1.6931771281576609,0.007177033492822967,0.24152519714062537,0.849,8/13,16.55%,ALDH1A2;ALDH1A1;ALDH7A1;ALDH9A1;ALDH1L1;ALDH4A1;ADH5;ALDH1A3
prerank,organic anion transmembrane transporter activity (GO:0008514),0.5493272578638329,1.6835825816278658,0.002285714285714286,0.31326971921341357,0.981,20/134,6.88%,SLC26A7;SLC38A2;SLC23A1;SLC23A2;SLC26A2;SLCO3A1;SLC38A1;SLC5A6;SLC6A7;SLCO4A1;SLC16A1;SLCO2A1;ABCG2;SLC7A2;SLC38A6;SFXN1;SLC38A7;SFXN2;ABCC4;SLC4A8
prerank,cation:chloride symporter activity (GO:0015377),0.8389077781898581,1.6759928798388994,0.01206896551724138,0.3218238164159188,0.984,3/10,1.56%,SLC12A7;SLC12A2;SLC12A8
prerank,5'-nucleotidase activity (GO:0008253),0.7965225490573624,1.6756860266066482,0.0034662045060658577,0.30551288429590967,0.984,4/13,8.56%,NT5E;NT5C1A;NT5DC3;ACP3
prerank,MAP kinase kinase kinase activity (GO:0004709),0.8094838301377665,1.665173968869181,0.012389380530973451,0.3239211814875538,0.99,2/11,0.80%,EGFR;MAP3K5
prerank,NADH dehydrogenase (quinone) activity (GO:0050136),-0.5358370275476148,-1.6594631864627034,0.015197568389057751,0.27150338532022644,0.929,22/34,30.60%,NDUFA8;NDUFB3;NDUFS4;NDUFA6;NDUFS3;NDUFA12;NDUFC2;NDUFS2;NDUFB7;NDUFA1;NDUFB8;NDUFA3;NDUFB9;NDUFB4;NDUFS5;NDUFC1;NDUFA10;NDUFA9;NDUFA5;NDUFS6;NDUFS1;NDUFA2
prerank,NADH dehydrogenase (ubiquinone) activity (GO:0008137),-0.5358370275476148,-1.6594631864627034,0.015197568389057751,0.27150338532022644,0.929,22/34,30.60%,NDUFA8;NDUFB3;NDUFS4;NDUFA6;NDUFS3;NDUFA12;NDUFC2;NDUFS2;NDUFB7;NDUFA1;NDUFB8;NDUFA3;NDUFB9;NDUFB4;NDUFS5;NDUFC1;NDUFA10;NDUFA9;NDUFA5;NDUFS6;NDUFS1;NDUFA2
prerank,aldehyde dehydrogenase [NAD(P)+] activity (GO:0004030),-0.6295369363722676,-1.65880659550049,0.00997506234413965,0.25092816995823236,0.929,7/15,16.55%,ALDH1A2;ALDH1A1;ALDH7A1;ALDH9A1;ALDH1L1;ALDH4A1;ALDH1A3
prerank,metallopeptidase activity (GO:0008237),0.5504978231609549,1.6559099899377967,0.0,0.3392285133236159,0.992,29/113,14.54%,ADAMTSL3;TRABD2B;ADAMTSL1;THSD4;ADAMTS17;MMP28;ADAMTS2;ADAMTSL5;BMP1;ADAM9;ADAM12;PHEX;ADAMTS5;MMP16;MMP14;IDE;NLN;ADAM10;ERAP1;LAP3;PMPCB;OMA1;MYSM1;ADAM8;SPG7;PITRM1;METAP1D;COPS5;ADAMTS18
prerank,nucleotidase activity (GO:0008252),0.7673293168120624,1.654685296945305,0.016666666666666666,0.32667516212654163,0.992,4/15,8.56%,NT5E;NT5C1A;NT5DC3;ACP3
prerank,histone acetyltransferase activity (GO:0004402),0.6609618069881982,1.6543031214724715,0.010401188707280832,0.3132009845423362,0.992,17/30,17.41%,KAT6B;NAA40;EP300;TADA3;KAT2A;CREBBP;KAT5;BRCA2;TAF1;USP22;BAZ1A;TAF9;KAT2B;SRCAP;KAT14;EPC1;ATF2
prerank,transmembrane receptor protein serine/threonine kinase binding (GO:0070696),0.7683344432700291,1.652092316114683,0.01870748299319728,0.30646498677675854,0.992,3/13,2.58%,BMP4;BMP5;BMP6
prerank,neutral amino acid transmembrane transporter activity (GO:0015175),0.6495917623479591,1.6453159870784697,0.01884057971014493,0.3128076694800604,0.993,8/32,5.72%,SLC38A2;SLC38A1;SLC6A7;SLC6A19;SLC38A6;SFXN1;SLC38A7;SFXN2
prerank,potassium ion antiporter activity (GO:0022821),0.7517178169141282,1.642715907455627,0.02195945945945946,0.3083602307739306,0.994,4/15,6.83%,SLC9A2;SLC24A3;SLC9C1;SLC9A8
prerank,receptor antagonist activity (GO:0048019),0.726713788260292,1.6379272900650914,0.013513513513513514,0.31053619421749223,0.996,6/17,9.66%,ESR2;LRPAP1;ADH7;IGSF1;IL18BP;AGTR2
prerank,"3',5'-cyclic-AMP phosphodiesterase activity (GO:0004115)",-0.6644904092647952,-1.6340516063693944,0.023529411764705882,0.28642901813633526,0.962,11/12,17.97%,PDE8B;PDE4B;PDE7B;PDE4A;PDE4D;PDE2A;PDE1B;PDE3A;PDE3B;PDE4C;PDE8A
prerank,BMP receptor binding (GO:0070700),0.7683360550992318,1.6287803041454993,0.027874564459930314,0.32636579549410893,0.997,3/12,2.58%,BMP4;BMP5;BMP6
prerank,potassium:proton antiporter activity (GO:0015386),0.8082754790205111,1.6224688206102371,0.01618705035971223,0.33508806766110094,0.999,5/10,13.01%,SLC9A2;SLC9C1;SLC9A8;SLC9A1;SLC9A3
prerank,inorganic cation transmembrane transporter activity (GO:0022890),0.5941277982108132,1.618841344477835,0.013245033112582781,0.33378820361053035,0.999,8/48,6.50%,PIEZO2;SLC12A7;SLC12A2;TRPM6;NALCN;TRPM4;CALHM2;CALHM5
prerank,acetylglucosaminyltransferase activity (GO:0008375),0.5980773091598782,1.6080255242387298,0.02309782608695652,0.3559631145752416,0.999,11/46,9.58%,MGAT4C;EXT1;MGAT3;B3GNT2;LARGE1;GCNT2;HEXA;POMGNT2;B4GAT1;B3GNT6;GCNT4
prerank,sterol transfer activity (GO:0120015),-0.5923263093118438,-1.5948628620985161,0.028132992327365727,0.36359983842967397,0.985,6/17,11.94%,PLTP;ABCA1;GRAMD1B;NPC2;OSBP;STARD5
prerank,cAMP binding (GO:0030552),-0.6868430683473159,-1.5905886855925024,0.02444987775061125,0.350446610174347,0.985,7/11,8.84%,RAPGEF4;PDE4B;RAPGEF2;HCN1;PDE4A;PDE4D;PDE2A
prerank,gated channel activity (GO:0022836),0.7467431935581357,1.5871271507355271,0.04054054054054054,0.4132269298569896,1.0,3/14,2.90%,PIEZO2;TMC6;TMC1
prerank,L-glutamate transmembrane transporter activity (GO:0005313),-0.6243364159887597,-1.5862022738640524,0.019230769230769232,0.34109010553636193,0.988,4/14,6.19%,SLC7A11;SLC1A3;SLC1A1;SLC1A2
prerank,carboxylic acid transmembrane transporter activity (GO:0046943),0.5806694008055251,1.5854919360972706,0.01445466491458607,0.40636223935376314,1.0,9/55,5.58%,SLC38A2;SLC23A1;SLC23A2;SLC38A1;SLC16A9;SLC16A1;SLC7A2;SLC38A6;SLC38A7
prerank,cyclin-dependent protein serine/threonine kinase activity (GO:0004693),-0.5586588644963075,-1.5845896772854013,0.034031413612565446,0.3069633277375762,0.988,6/21,9.56%,CDK8;CDK14;CDK19;CDK6;CDK15;CDK10
prerank,cyclin-dependent protein kinase activity (GO:0097472),-0.5586588644963075,-1.5845896772854013,0.034031413612565446,0.3069633277375762,0.988,6/21,9.56%,CDK8;CDK14;CDK19;CDK6;CDK15;CDK10
prerank,phosphatase activator activity (GO:0019211),-0.6238818231393783,-1.5842207632740415,0.0327455919395466,0.2919985597986613,0.988,5/14,11.18%,CALM1;BMP2;CALM3;FRS2;PPP2R5A
prerank,mechanosensitive ion channel activity (GO:0008381),0.7544448947846096,1.5838122760268707,0.0273972602739726,0.3991804208743923,1.0,3/12,2.90%,PIEZO2;TMC6;TMC1
prerank,delayed rectifier potassium channel activity (GO:0005251),0.6337210522776111,1.5812363048428915,0.02631578947368421,0.39597909233781053,1.0,4/32,4.01%,KCNB2;KCNQ5;KCNS3;KCNB1
prerank,dicarboxylic acid transmembrane transporter activity (GO:0005310),0.6294990688541418,1.5727391036841794,0.04040404040404041,0.41341089804575326,1.0,2/29,0.36%,SLC26A7;SLC26A2
prerank,cytochrome-c oxidase activity (GO:0004129),-0.612512633976895,-1.572064329586966,0.033766233766233764,0.3052959401158494,0.992,8/15,21.48%,COX4I1;CYB5A;COX8A;COX6B1;COX6A1;COX5B;COX10;NDUFA4L2
prerank,solute:anion antiporter activity (GO:0140323),0.7201045239459963,1.570037059520619,0.04861111111111111,0.41091622952870566,1.0,2/14,0.36%,SLC26A7;SLC26A2
prerank,L-amino acid transmembrane transporter activity (GO:0015179),0.5763957772730632,1.5697388805687857,0.02368421052631579,0.40076400164467835,1.0,8/53,5.58%,SLC47A1;SLC38A2;SLC38A1;SLC6A7;SLC7A2;SLC38A6;SFXN1;SLC38A7
prerank,cholesterol transfer activity (GO:0120020),-0.5907335283665334,-1.5623125865209682,0.025380710659898477,0.31399993779460594,0.997,4/16,4.17%,PLTP;ABCA1;GRAMD1B;NPC2
prerank,adenylate cyclase binding (GO:0008179),-0.6764773561673719,-1.546215712679448,0.04470588235294118,0.3411012877186239,0.998,5/10,8.48%,ADCY5;CALM1;ADCY2;CAP2;CALM3
prerank,acetylation-dependent protein binding (GO:0140033),0.67500012338136,1.535231803611923,0.06289308176100629,0.49449014819832915,1.0,8/20,14.38%,MLLT3;ZMYND8;SMARCA4;BRD9;TAF1;BAZ2A;BRD3;CARM1
prerank,lysine-acetylated histone binding (GO:0070577),0.67500012338136,1.535231803611923,0.06289308176100629,0.49449014819832915,1.0,8/20,14.38%,MLLT3;ZMYND8;SMARCA4;BRD9;TAF1;BAZ2A;BRD3;CARM1
prerank,rRNA binding (GO:0019843),-0.4618210481381507,-1.5306869675710335,0.035211267605633804,0.36644497454258484,1.0,17/42,26.04%,RPS14;RPS9;RPS5;RPL5;RPS13;RPL23;RPS3;FASTKD2;EMG1;RPL12;RPL11;MRPS11;RPLP0;MRPL11;RCC1L;MTERF4;MRPS6
prerank,cation transmembrane transporter activity (GO:0008324),0.5740971883662003,1.5289101882117209,0.03099730458221024,0.5046843223852459,1.0,10/48,8.41%,SLC38A2;SLC38A1;SLC6A7;SLC7A2;SLC38A6;SFXN1;SLC38A7;SFXN2;CHRNE;PKD2L1
prerank,calcium activated cation channel activity (GO:0005227),0.6722717507391659,1.5175550842953731,0.06050955414012739,0.5336336335057759,1.0,6/17,11.35%,KCNMB3;KCNMB2;ANO6;TRPM4;PKD2L1;ANO10
prerank,insulin-like growth factor I binding (GO:0031994),-0.6137087743478837,-1.5075401899697123,0.05128205128205128,0.4159585431742267,1.0,6/13,4.91%,IGFBP2;IGF1R;ITGA6;IGFBP3;IGFBP4;INSR
prerank,transmitter-gated ion channel activity (GO:0022824),-0.4974785126014638,-1.5011061445665248,0.0471976401179941,0.4168753330239433,1.0,17/29,25.25%,GRIK1;GABRG3;GRIA4;GRIA2;GRID2;GABRA1;GABRA2;GRIK2;GABRB2;GABRB1;GABRA4;GABRG1;GLRA3;GRIK3;GABRB3;GRID1;GABRA5
prerank,amino acid transmembrane transporter activity (GO:0015171),0.5576771749439795,1.498092442938347,0.037940379403794036,0.5972322839112865,1.0,7/47,5.58%,SLC47A1;SLC38A2;SLC38A1;SLC7A2;SLC6A19;SLC38A6;SLC38A7
prerank,gap junction channel activity (GO:0005243),-0.5258792115430297,-1.4950339779624577,0.05128205128205128,0.4181379218248191,1.0,5/22,7.25%,GJB6;GJB2;GJC1;GJD3;GJA1
prerank,"2 iron, 2 sulfur cluster binding (GO:0051537)",0.7018502731344477,1.4942874790960348,0.08503401360544217,0.5978552346843726,1.0,2/12,6.84%,AOX1;FDX1
prerank,wide pore channel activity (GO:0022829),-0.5193424279647083,-1.4911279561912394,0.060209424083769635,0.4136579127125545,1.0,5/23,7.25%,GJB6;GJB2;GJC1;GJD3;GJA1
prerank,microtubule plus-end binding (GO:0051010),0.6530713537565079,1.488500297203047,0.06528662420382166,0.6073395536392281,1.0,6/20,11.23%,MAPRE2;CLIP4;PAFAH1B1;CLIP1;FBXW11;KIF2C
prerank,cytokine activity (GO:0005125),0.4833340453245219,1.485405079006835,0.011655011655011656,0.6064108718611166,1.0,17/131,7.91%,TNFRSF11B;BMP4;BMP5;WNT9A;TGFB3;WNT11;INHBA;BMP6;GDF6;IL10;GDF5;WNT16;BMP15;TNFSF11;CLCF1;FGF2;FAM3C
prerank,protein phosphatase activator activity (GO:0072542),-0.59402484373358,-1.4849577478215998,0.06716417910447761,0.4147343604589776,1.0,4/13,11.18%,IGFBP3;CALM1;CALM3;PPP2R5A
prerank,transmembrane receptor protein tyrosine phosphatase activity (GO:0005001),-0.5610123398118207,-1.482507138945817,0.04513064133016627,0.39354721348481986,1.0,4/16,3.74%,PTPRG;PTPRM;PTPRB;PTPRT
prerank,transmembrane receptor protein phosphatase activity (GO:0019198),-0.5610123398118207,-1.482507138945817,0.04513064133016627,0.39354721348481986,1.0,4/16,3.74%,PTPRG;PTPRM;PTPRB;PTPRT
prerank,GTPase regulator activity (GO:0030695),-0.3478820503060148,-1.4807646215391126,0.0,0.3852326718043147,1.0,63/212,12.87%,RANBP3L;ASAP1;PLCB1;PREX2;ARHGAP29;ARHGAP28;TBC1D4;CHN2;ERRFI1;ARHGAP24;ARHGAP32;RASGRP3;ALDH1A1;RABGAP1L;RGS3;RGS5;RAPGEF2;CPEB2;CHN1;USP6NL;RGS7;RALGAPA2;RIMS1;RGS12;TNK2;CCDC88A;ARAP3;ARHGAP26;TBC1D12;GPSM1;RALGAPA1;GMIP;IQGAP2;ARL2BP;ARHGAP25;ARHGAP15;ARRB1;OPHN1;GPS2;RHOH;TBC1D9;ACAP2;SIRPA;STARD8;PREX1;SGSM1;TBC1D8;VAV3;LRRK2;SMAP2;RP2;GARNL3;TBC1D2;TBC1D16;SEC23B;ARHGAP39;BNIP2;TBC1D1;IPO5;RABGAP1;RGS16;RANBP3;SH3BP4
prerank,calcium-activated potassium channel activity (GO:0015269),0.7192582084844268,1.4767324907917532,0.08193979933110368,0.6288843864806823,1.0,2/11,0.60%,KCNMB3;KCNMB2
prerank,chemoattractant activity (GO:0042056),0.6107704903196914,1.475692457589946,0.08038585209003216,0.619407606952634,1.0,4/26,7.51%,BMP4;PGF;GDNF;FGF2
prerank,transcription regulatory region nucleic acid binding (GO:0001067),0.468892312252604,1.473757278571925,0.013303769401330377,0.6136230481535467,1.0,56/188,14.70%,BNC2;VSX1;TCF7L2;SIX1;HDAC4;FOXO3;PBX1;GRHL1;CRY2;KLF4;SMAD6;FOXK1;EGR2;DDIT3;NFE2L2;ARID4A;GATA1;CTCFL;ZBED4;FOXC2;NFKB1;HNF4A;HNF1A;TFAP2A;TBL1X;JUN;GLIS2;CREB3L3;ETV5;GATA4;CALCOCO1;NFYA;PER2;ARID4B;FOXA1;FOXK2;GATA3;NKX2-1;GABPB1;GABPB2;RNF10;IRF1;TAF9;REST;RXRA;STAT3;FOXC1;CIITA;XRCC5;CEBPB;HNRNPL;TFE3;KMT2D;CARM1;TFEB;PER3
prerank,calcium-dependent cysteine-type endopeptidase activity (GO:0004198),0.6858736056310953,1.4736136684127852,0.08013937282229965,0.6014498807352147,1.0,4/14,8.13%,CAPN5;CAPN2;CAPN6;CAPN10
prerank,androgen receptor binding (GO:0050681),0.6100683368348895,1.4705940247881548,0.06902086677367576,0.6008729957842734,1.0,6/25,8.85%,FOXP1;DDX5;EP300;TGFB1I1;KDM1A;SMARCA4
prerank,"racemase and epimerase activity, acting on carbohydrates and derivatives (GO:0016857)",0.7132395198911936,1.4566469897033951,0.10052910052910052,0.6400698359660874,1.0,5/10,16.07%,DSE;GLCE;GALE;GNE;FUOM
prerank,potassium channel activity (GO:0005267),0.498818357063356,1.4519816529577454,0.03489771359807461,0.645441472973091,1.0,8/89,5.22%,KCNB2;KCNK5;KCNMB3;KCNMB2;KCNQ5;KCNS3;KCNB1;KCNK7
prerank,proton transmembrane transporter activity (GO:0015078),-0.4542179226551052,-1.451390412603278,0.05357142857142857,0.447427067756407,1.0,14/39,21.48%,SLC33A1;COX4I1;CYB5A;UQCR10;UQCRH;COX8A;COX6B1;COX6A1;COX5B;UQCR11;SLC11A2;COX10;ATP6V1F;NDUFA4L2
prerank,endopeptidase activity (GO:0004175),0.4516881964525042,1.449622511889431,0.009564293304994687,0.6424314131321387,1.0,40/257,13.54%,ADAMTSL3;F3;TRABD2B;ADAMTSL1;THSD4;ADAMTS17;PCSK5;MMP28;ADAMTS2;HTRA3;USP13;ADAMTSL5;ADAM9;USP46;DDI2;USP24;PHEX;ADAMTS5;MMP16;MMP14;USP2;TASP1;IDE;NLN;USP49;USP7;ADAM10;USP10;USP33;PRSS12;PARL;PMPCB;OMA1;USP34;USP25;USP47;SPG7;PITRM1;PREP;NAPSA
prerank,ATPase binding (GO:0051117),0.511215484740903,1.4471985718822664,0.05217391304347826,0.6396261803694749,1.0,9/71,4.72%,EGFR;SLC2A13;PTPN3;ANK2;ATP1B1;EZR;PPP3CA;ATP6V0A4;TOR1AIP1
prerank,I-SMAD binding (GO:0070411),0.6893099064358843,1.4467405937054554,0.09565217391304348,0.6297745502788664,1.0,4/13,7.62%,SMAD9;SMAD6;TGFBR1;TGFB1I1
prerank,protein binding involved in heterotypic cell-cell adhesion (GO:0086080),0.7067880137478607,1.4458892530536176,0.0990990990990991,0.6219489443227344,1.0,5/10,7.87%,CXADR;DSP;DSG2;DSC2;JUP
prerank,phospholipase inhibitor activity (GO:0004859),0.7146735993277299,1.4436505110722588,0.09584086799276673,0.6190493690651028,1.0,3/10,3.90%,ANXA1;ANXA2;ANXA4
prerank,cation channel activity (GO:0005261),0.48494656198810254,1.4415197055159854,0.0392638036809816,0.6162150167987989,1.0,13/94,6.50%,PIEZO2;KCNK5;SLC24A3;PKD1;TRPM6;ANXA2;ANO6;NALCN;PKD2L2;TRPM4;KCNK7;CALHM2;CALHM5
prerank,cAMP-dependent protein kinase regulator activity (GO:0008603),-0.6286460025971775,-1.4402642911605308,0.0738255033557047,0.4625845158124847,1.0,4/10,8.99%,PRKAG2;PRKAR2B;PRKAR1B;PRKAR1A
prerank,inorganic anion transmembrane transporter activity (GO:0015103),0.5858606010180379,1.4398929523465667,0.0847457627118644,0.611921865044383,1.0,6/27,9.87%,SLC26A7;SLC26A2;AQP6;SLC39A14;SLC25A14;SLC26A6
prerank,MHC protein binding (GO:0042287),-0.5118238501007465,-1.4372718265142408,0.06460674157303371,0.45737230332756007,1.0,14/20,41.92%,ATP5F1B;CD81;TAP2;ATP5F1A;CD74;LAG3;ABCB9;LILRB1;TAPBP;TUBB4B;CD8B;COL2A1;KIR3DL2;TAP1
prerank,transmembrane-ephrin receptor activity (GO:0005005),-0.5391990860498643,-1.432921727446811,0.06733167082294264,0.44396245495224507,1.0,6/17,10.39%,EPHA7;EPHB4;EPHB1;EPHA4;EPHA8;EFNB3
prerank,ephrin receptor activity (GO:0005003),-0.5391990860498643,-1.432921727446811,0.06733167082294264,0.44396245495224507,1.0,6/17,10.39%,EPHA7;EPHB4;EPHB1;EPHA4;EPHA8;EFNB3
prerank,UDP-glycosyltransferase activity (GO:0008194),0.5019275653340005,1.4248541376251986,0.05317769130998703,0.655858594234143,1.0,13/70,10.17%,MGAT4C;EXT1;B3GNT2;LARGE1;GCNT2;HEXA;POGLUT3;POMGNT2;B4GAT1;B3GNT6;GXYLT2;GCNT4;B4GALT1
prerank,lysophosphatidic acid acyltransferase activity (GO:0042171),0.6479630783717963,1.424472403870228,0.10961214165261383,0.6465776608419921,1.0,7/15,17.42%,PNPLA3;ABHD4;ABHD5;GPAT3;AGPAT4;LCLAT1;AGPAT5
prerank,poly-purine tract binding (GO:0070717),-0.47290907451367725,-1.4239195375283402,0.06031746031746032,0.4556866204625705,1.0,6/27,8.10%,RBPMS;RBMS1;ATXN1;KHDRBS2;TIA1;ELAVL4
prerank,glucuronosyltransferase activity (GO:0015020),0.6289087923112963,1.4235351399308735,0.09693053311793215,0.6390594957176857,1.0,4/19,12.90%,EXT1;LARGE1;B4GAT1;LARGE2
prerank,secondary active transmembrane transporter activity (GO:0015291),0.5217533131245685,1.4197763227365174,0.06224066390041494,0.6420531082618348,1.0,5/51,2.33%,SLC4A4;SLCO3A1;SLC5A6;SLCO4A1;SLCO2A1
prerank,cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:0097200),-0.611495473303431,-1.4176816418967493,0.08037825059101655,0.4600349782567593,1.0,5/10,20.82%,CASP4;CASP12;CFLAR;CASP3;CASP1
prerank,insulin-like growth factor binding (GO:0005520),-0.5621018101890867,-1.4155034633295498,0.0798004987531172,0.4541434018178204,1.0,6/15,4.91%,IGFBP2;IGF1R;ITGA6;IGFBP3;IGFBP4;INSR
prerank,sequence-specific double-stranded DNA binding (GO:1990837),0.42631944402601546,1.4143280189320966,0.0,0.6518524130233655,1.0,118/597,14.70%,BNC2;FOXP1;KLF12;NR3C2;VSX1;KLF5;TFCP2L1;RARB;SOX9;TCF7L1;TCF7L2;PRRX2;TBX15;NFIB;ZIC4;SIX1;HOXA5;HDAC4;FOXO3;GLI3;PBX1;GRHL1;KLF3;NFAT5;NR2F1;ISL1;CRY2;KLF4;CUX1;SMAD6;FOXK1;MYOG;PITX3;BARHL2;PHOX2A;HOXB6;ELF1;ZBTB7B;ZIC1;ABL1;MEOX2;EGR2;DDIT3;NFE2L2;ARID4A;GATA1;CTCFL;ZBED4;NR4A2;FOXC2;HOXA6;NFKB1;GLIS1;MBNL2;HNF4A;HNF1A;RARG;FOXD2;TFAP2A;HOXB5;LBX1;TBL1X;JUN;FOXE1;NR6A1;KLF10;MCM7;GLIS2;BHLHE40;HES1;NFATC4;CREB3L3;ETV5;GATA4;JDP2;TEAD1;CALCOCO1;NFYA;BCL6;NFKB2;SIX4;E2F3;PER2;BCL11B;ARID4B;FOXA1;FOXK2;GATA3;NKX2-1;GABPB1;GABPB2;MBD4;RNF10;KIF2C;IRF1;HSF5;ZBTB37;TAF9;REST;XPA;KLF16;RXRA;STAT3;FOXC1;RFX5;CIITA;XRCC5;HES7;DDX11;CEBPB;ZNF76;HNRNPL;TFE3;KMT2D;CARM1;TFEB;ZBTB32;PER3
prerank,sequence-specific DNA binding (GO:0043565),0.4241927701165511,1.410340251648506,0.001006036217303823,0.6562010926378873,1.0,88/590,10.39%,FOXP2;FOXP1;KLF12;NR3C2;VSX1;KLF5;SLTM;TFCP2L1;RARB;SOX9;TCF7L1;TCF7L2;PRRX2;TBX15;NFIB;ZIC4;SIX1;HOXA5;FOXD1;HDAC4;FOXO3;GLI3;PBX1;GRHL1;KLF3;NFAT5;NR2F1;ISL1;KLF4;CUX1;FOXK1;MYOG;NOBOX;PITX3;BARHL2;PHOX2A;HOXB6;ELF1;ZBTB7B;ZIC1;MEF2A;ZNF148;ABL1;MEOX2;EGR2;NFE2L2;GATA1;CTCFL;NR4A2;FOXC2;HOXA6;ZNF423;BPTF;GLIS1;MBNL2;HNF4A;SMG6;RARG;FOXD2;TFAP2A;HOXB5;LBX1;JUN;FOXE1;NR6A1;KLF10;KDM1A;GLIS2;BHLHE40;HES1;NFATC4;SMG1;ETV5;GATA4;JDP2;TEAD1;CALCOCO1;CBFB;TELO2;BCL6;NFKB2;SIX4;E2F3;BCL11B;MBD1;FOXA1;FOXK2;GATA3
prerank,"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (GO:0016620)",-0.5284751995583226,-1.4099964025934975,0.07653061224489796,0.4560496484985992,1.0,7/18,16.55%,ALDH1A2;ALDH1A1;FAR2;ALDH9A1;HSD17B12;ALDH18A1;ALDH1A3
prerank,endopeptidase activator activity (GO:0061133),-0.6238764745521097,-1.4072478085597253,0.11333333333333333,0.45279874265251185,1.0,7/10,25.97%,PSME2;APH1B;PSENEN;VSIR;ADRM1;PSME1;APH1A
prerank,double-stranded DNA binding (GO:0003690),0.4244746086094603,1.404673569881751,0.00202020202020202,0.6671998149619014,1.0,71/531,10.12%,EGFR;FOXP1;KLF12;NR3C2;VSX1;KLF5;TFCP2L1;RARB;SOX9;TCF7L1;PRRX2;TBX15;NFIB;ZIC4;SIX1;HOXA5;FOXO3;GLI3;PBX1;GRHL1;KLF3;NFAT5;NR2F1;ISL1;KLF4;CUX1;FOXK1;MYOG;PITX3;BARHL2;PHOX2A;HOXB6;ELF1;ZBTB7B;ZIC1;ABL1;MEOX2;EGR2;HDGFL3;GATA1;NR4A2;FOXC2;HOXA6;GLIS1;MBNL2;HNF4A;RARG;FOXD2;TFAP2A;HOXB5;LBX1;CAMTA2;JUN;FOXE1;NR6A1;KLF10;GLIS2;BHLHE40;HES1;NFATC4;ETV5;GATA4;JDP2;TEAD1;BCL6;NFKB2;SIX4;E2F3;BCL11B;MBD1;FOXA1
prerank,cis-regulatory region sequence-specific DNA binding (GO:0000987),0.42084198615830665,1.4038602033638956,0.0,0.6601756559218901,1.0,134/732,12.82%,FOXP2;ZBTB7C;FOXP1;MKX;KLF12;NR3C2;PBX3;KLF5;TFCP2L1;SMAD9;RARB;SOX9;TCF7L1;ZFHX3;TCF7L2;PRRX2;TBX15;PLAGL1;NFIB;FOXN3;ZIC4;ZFHX4;SIX1;HOXA5;FOXD1;HDAC4;FOXO3;GLI3;ZBTB16;PBX1;ESR2;GRHL1;NFIA;KLF3;NFAT5;NR2F1;ISL1;HOXA3;KLF4;FOXK1;FOXP4;SKIL;MYOG;NOBOX;PITX3;HOXB6;ELF1;ZBTB7B;ZIC1;MEF2A;ZNF148;MEOX2;EGR2;DDIT3;NFE2L2;GATA1;KLF7;CTCFL;NR4A2;E2F5;FOXC2;HOXA6;ATF1;NR4A3;NFKB1;ZNF8;ZNF423;BPTF;FOXO6;GLIS1;HNF4A;HNF1A;RARG;FOXD2;PRRX1;TFAP2A;HOXB5;E2F6;JUN;FOXE1;HIVEP3;NR6A1;KLF10;KLF9;GLIS2;BHLHE40;HES1;NFATC4;CREB3L3;GATA4;HIF3A;JDP2;TEAD1;CALCOCO1;CARF;NFYA;BCL6;TCF3;MXD1;NFKB2;SIX4;E2F3;BCL11B;ZNF585B;ZNF585A;ZKSCAN1;ATOH8;SKI;FOXA1;FOXK2;PRDM15;GATA3;NKX2-1;EBF4;ZNF383;ZFP62;RBMX;IRF1;HSF5;ZBTB11;ZBTB49;ZBTB37;REST;KLF16;NFIL3;RXRA;STAT3;WIZ;FOXC1;EHF;PGBD1;RFX5;HIVEP2;STAT5A
prerank,death receptor binding (GO:0005123),0.651367034622672,1.4027798477011355,0.1040650406504065,0.6548406023082527,1.0,2/15,1.19%,NGF;EDA
prerank,Lys48-specific deubiquitinase activity (GO:1990380),0.646829750899842,1.3991027999082235,0.12560386473429952,0.6581341435138188,1.0,9/14,20.88%,USP13;MINDY3;OTUD7B;USP7;DESI2;USP9X;MINDY2;OTUD5;MINDY4
prerank,glucose transmembrane transporter activity (GO:0005355),-0.5121207148738924,-1.3980851267526873,0.10761154855643044,0.4651191437918607,1.0,12/17,41.41%,SLC2A1;SLC5A3;SLC5A11;MFSD4A;SLC2A8;SLC2A2;SLC2A4;SLC2A3;PPBP;SLC2A10;SLC2A5;SLC2A6
prerank,cysteine-type endopeptidase activity involved in apoptotic process (GO:0097153),-0.5818262209832561,-1.3979230010442747,0.11057692307692307,0.4546914554400473,1.0,4/11,12.16%,CASP4;CASP12;CFLAR;CASP3
prerank,mRNA 5'-UTR binding (GO:0048027),-0.4832026508664254,-1.3970111716231017,0.06914893617021277,0.4468400031876544,1.0,14/24,28.58%,RPS14;RPL41;RPL5;RPS13;RPS7;CCT5;RPL26;MRPS11;MYH10;SHMT2;GNL3;SHMT1;IGF2BP1;RSL1D1
prerank,lipid phosphatase activity (GO:0042577),0.6373752800749037,1.3929274684066275,0.12157534246575342,0.6707521973274214,1.0,2/14,2.52%,PLPPR2;PLPP3
prerank,NAD+ ADP-ribosyltransferase activity (GO:0003950),-0.46985352394997715,-1.390481891272032,0.07816711590296496,0.4522611251482494,1.0,6/25,8.85%,PARP14;ART3;PARP8;PARP11;PARP1;TIPARP
prerank,protein kinase C binding (GO:0005080),0.5242484440236038,1.3897511699546121,0.0898876404494382,0.672266388478465,1.0,11/43,7.70%,GRK5;DSP;HDAC9;ADAM9;ABL1;PDLIM5;PRKCSH;IRS1;ITGAV;CAVIN2;NELL1
prerank,1-acylglycerol-3-phosphate O-acyltransferase activity (GO:0003841),0.6503335893186787,1.3897183218022127,0.140893470790378,0.663027365854652,1.0,6/13,17.42%,PNPLA3;ABHD5;GPAT3;AGPAT4;LCLAT1;AGPAT5
prerank,leucine zipper domain binding (GO:0043522),0.683658579352096,1.3868280274609117,0.13321492007104796,0.6638325484119855,1.0,5/10,15.36%,PAWR;DDIT3;ERC1;MRTFA;AATF
prerank,RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978),0.41537845169885335,1.3847233793878508,0.0,0.6623000443251641,1.0,132/731,12.82%,FOXP2;ZBTB7C;FOXP1;MKX;KLF12;NR3C2;PBX3;KLF5;TFCP2L1;SMAD9;RARB;SOX9;TCF7L1;ZFHX3;TCF7L2;PRRX2;TBX15;PLAGL1;NFIB;ZIC4;ZFHX4;SIX1;HOXA5;FOXD1;HDAC4;FOXO3;GLI3;ZBTB16;PBX1;ESR2;GRHL1;NFIA;KLF3;NFAT5;NR2F1;HOXA3;KLF4;FOXK1;FOXP4;SKIL;MYOG;NOBOX;PITX3;HOXB6;ELF1;ZBTB7B;ZIC1;MEF2A;ZNF148;MEOX2;EGR2;DDIT3;NFE2L2;GATA1;KLF7;CTCFL;NR4A2;E2F5;FOXC2;HOXA6;ATF1;NR4A3;NFKB1;ZNF8;ZNF423;BPTF;FOXO6;GLIS1;HNF4A;HNF1A;RARG;FOXD2;PRRX1;TFAP2A;HOXB5;E2F6;JUN;FOXE1;HIVEP3;NR6A1;KLF10;KLF9;GLIS2;BHLHE40;HES1;NFATC4;CREB3L3;GATA4;HIF3A;JDP2;TEAD1;CALCOCO1;CARF;NFYA;BCL6;TCF3;MXD1;NFKB2;SIX4;E2F3;BCL11B;ZNF585B;ZNF585A;ZKSCAN1;ATOH8;SKI;FOXA1;FOXK2;PRDM15;GATA3;NKX2-1;EBF4;ZNF383;ZFP62;RBMX;IRF1;HSF5;ZBTB11;ZBTB49;ZBTB37;REST;KLF16;NFIL3;RXRA;STAT3;WIZ;FOXC1;EHF;PGBD1;RFX5;HIVEP2;STAT5A
prerank,protein serine/threonine phosphatase inhibitor activity (GO:0004865),-0.5872608415485066,-1.3818827900345136,0.10926365795724466,0.46285872236882125,1.0,3/11,15.23%,PPP1R1A;PPP1R14A;PABIR1
prerank,hexose transmembrane transporter activity (GO:0015149),-0.5654487534238811,-1.3798476414295742,0.11055276381909548,0.45782614038186625,1.0,10/12,41.41%,SLC2A1;SLC5A3;MFSD4A;SLC2A8;SLC2A2;SLC2A4;SLC2A3;PPBP;SLC2A5;SLC2A6
prerank,sulfuric ester hydrolase activity (GO:0008484),0.6583352937886398,1.379754301715804,0.14038128249566725,0.6710776723603704,1.0,5/12,12.70%,SULF1;ARSI;SGSH;SULF2;ARSB
prerank,anion channel activity (GO:0005253),0.4973356535748586,1.3797534530715463,0.08746736292428199,0.6622477029872077,1.0,5/61,4.47%,SLC26A7;CLIC4;LRRC8D;ANO6;GLRB
prerank,Notch binding (GO:0005112),0.5792750459427628,1.377456312528358,0.11563517915309446,0.6616203053128629,1.0,7/22,15.67%,CCN3;SNED1;TCIM;JAG1;AAK1;GALNT11;SNW1
prerank,organic cation transmembrane transporter activity (GO:0015101),-0.5257529840872686,-1.3741587178172658,0.09198113207547169,0.4621875483421854,1.0,11/16,31.25%,SLC22A4;SLC44A1;SLC22A2;SLC44A2;SLC7A8;SLC22A5;SLC25A26;SLC25A42;SLC22A3;SLC29A4;SLC5A7
prerank,acid-thiol ligase activity (GO:0016878),-0.5644965987936412,-1.3706562713229529,0.10050251256281408,0.46183234289951736,1.0,2/13,1.09%,ACSS3;ACSL1
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines (GO:0016814)",-0.6156017032296648,-1.3661698545911947,0.12751677852348994,0.4631051582186012,1.0,5/10,22.32%,APOBEC1;ADARB2;LACC1;GDA;CDA
prerank,CoA-ligase activity (GO:0016405),-0.5418461468096952,-1.3627711064213712,0.09405940594059406,0.4621670476747051,1.0,2/14,1.09%,ACSS3;ACSL1
prerank,tropomyosin binding (GO:0005523),0.6109114702882528,1.3626790831477607,0.14376996805111822,0.7033754010781356,1.0,3/16,3.38%,CALD1;TMOD3;NEBL
prerank,cyclic-nucleotide phosphodiesterase activity (GO:0004112),-0.4756924492749969,-1.3621519689868393,0.08746355685131195,0.45467957312115,1.0,15/23,17.97%,PDE8B;PDE4B;PDE7B;PDE1C;PDE4A;PDE4D;PDE9A;PDE2A;PDE11A;PDE1B;PDE3A;PDE3B;PDE4C;CNP;PDE8A
prerank,chemokine receptor binding (GO:0042379),-0.4300987936408755,-1.3579814731176274,0.07911392405063292,0.45614526670616734,1.0,21/35,46.53%,CXCL12;CX3CR1;CCL19;CCL2;CCL25;CCRL2;CCL5;CXCL5;CCL11;CXCL1;CCL4;PF4;CX3CL1;CCL7;PPBP;CCL8;CCL1;CCL3;XCL1;CXCL13;CXCL2
prerank,ankyrin binding (GO:0030506),0.5943694152231511,1.357971761384908,0.15024232633279483,0.7112396944948955,1.0,1/19,0.12%,CDH1
prerank,"3',5'-cyclic-nucleotide phosphodiesterase activity (GO:0004114)",-0.47835215713912516,-1.3528129788424756,0.12290502793296089,0.46058166272289924,1.0,13/21,15.12%,PDE8B;PDE4B;PDE7B;PDE1C;PDE4A;PDE4D;PDE9A;PDE2A;PDE11A;PDE1B;PDE3A;PDE3B;PDE4C
prerank,GABA-gated chloride ion channel activity (GO:0022851),-0.5575785094986541,-1.3512450221045573,0.14628297362110312,0.45535635319835804,1.0,9/12,25.25%,GABRG3;GABRA1;GABRA2;GABRB2;GABRB1;GABRA4;GABRG1;GABRB3;GABRA5
prerank,acidic amino acid transmembrane transporter activity (GO:0015172),-0.5191640481291581,-1.3507246945982936,0.1024390243902439,0.448542889800689,1.0,4/15,6.19%,SLC1A3;SLC1A5;SLC1A1;SLC1A2
prerank,H4 histone acetyltransferase activity (GO:0010485),0.6403219419333472,1.3499844879665626,0.16470588235294117,0.7307274528458336,1.0,5/10,17.41%,NAA40;EP300;BRCA2;USP22;ATF2
prerank,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization (GO:0086008),0.6252030978346784,1.3477498887292079,0.1371527777777778,0.7293105003302173,1.0,1/14,0.42%,KCNJ2
prerank,transforming growth factor beta binding (GO:0050431),0.557962822582498,1.3449385003326135,0.15347334410339256,0.7306696710166514,1.0,11/23,12.28%,THBS1;CD109;TGFB3;LTBP3;TGFBR1;TGFBR2;ITGAV;TSKU;LTBP4;ACVR1;CD36
prerank,receptor ligand activity (GO:0048018),0.4172413549872812,1.3420340387904446,0.032432432432432434,0.7318746317456855,1.0,31/245,7.91%,TNFRSF11B;BMP4;NGF;BMP5;EDA;WNT9A;OSGIN2;TGFB3;SEMA3D;LRPAP1;SEMA3C;WNT11;INHBA;BMP6;PGF;SEMA3E;GDF6;IL10;GDF5;C1QTNF12;WNT16;PDGFA;ERFE;GDNF;BMP15;TNFSF11;FGF22;JAG1;CLCF1;FGF2;FAM3C
prerank,intracellular ligand-gated ion channel activity (GO:0005217),-0.5687679618365107,-1.3390411478896973,0.12831858407079647,0.4687963161483178,1.0,3/11,14.09%,ITPR1;RYR2;RYR3
prerank,thiol-dependent deubiquitinase (GO:0004843),0.47044409896356776,1.3376470453071119,0.08866995073891626,0.7385834984420141,1.0,37/83,20.84%,USP13;MINDY3;TANK;USP46;USP24;JOSD1;OTUD1;USP2;OTUD7B;USP49;BAP1;USP7;USP32;USP10;UFD1;USP33;USP22;USP34;USP3;USP25;USP21;USP47;MYSM1;COPS5;USP4;STAMBP;USP1;OTUD3;DESI2;ZRANB1;OTUB1;VCPIP1;USP9X;USP48;OTUD5;USP31;USP37
prerank,chloride channel activity (GO:0005254),0.4851583245743037,1.3344507434665243,0.12176165803108809,0.7414815986182728,1.0,4/59,4.47%,SLC26A7;CLIC4;ANO6;GLRB
prerank,"DNA-binding transcription activator activity, RNA polymerase II-specific (GO:0001228)",0.4149782623172944,1.3341878642277691,0.04371002132196162,0.7336568286183058,1.0,55/254,12.75%,KLF5;TFCP2L1;SOX9;PLAGL1;NFIB;SIX1;HOXA5;FOXO3;ZBTB16;GRHL1;NFIA;NFAT5;KLF4;MYOG;ELF1;MEF2A;MEOX2;EGR2;DDIT3;GATA1;KLF7;CTCFL;NR4A2;FOXC2;ATF1;NR4A3;NFKB1;PLSCR1;HNF4A;HNF1A;FOXD2;PRRX1;TFAP2A;JUN;KLF10;GLIS2;CREB3L3;ETV5;GATA4;MDM4;TCF3;NFKB2;E2F3;ZNF585B;ZNF585A;FOXA1;FOXK2;PRDM15;GATA3;ZFP62;IRF1;STAT3;FOXC1;EHF;RFX5
prerank,copper ion binding (GO:0005507),-0.4045335754173179,-1.3339146406170412,0.08414239482200647,0.4725389715805739,1.0,8/42,9.82%,MOXD1;PAM;LOXL3;SNCA;ATOX1;SOD3;COX17;LACC1
prerank,RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977),0.3989436885973868,1.3334438355450602,0.0,0.7278427561406735,1.0,143/831,12.82%,FOXP2;ZBTB7C;FOXP1;MKX;KLF12;NR3C2;PBX3;KLF5;TFCP2L1;SMAD9;RARB;SOX9;TCF7L1;ZFHX3;TCF7L2;PRRX2;TBX15;PLAGL1;NFIB;ZIC4;ZFHX4;SIX1;HOXA5;FOXD1;HDAC4;FOXO3;GLI3;ZBTB16;PBX1;ESR2;GRHL1;NFIA;KLF3;NFAT5;NR2F1;HOXA3;KLF4;CUX1;PURG;FOXK1;FOXP4;SKIL;MYOG;NOBOX;PITX3;BARHL2;LHX2;PHOX2A;HOXB6;ELF1;ZBTB7B;ZIC1;MEF2A;ZNF148;MEOX2;EGR2;DDIT3;NFE2L2;GATA1;KLF7;CTCFL;NR4A2;E2F5;FOXC2;HOXA6;ATF1;NR4A3;NFKB1;ZNF8;ZNF423;BPTF;FOXO6;GLIS1;TWIST2;HNF4A;HNF1A;RARG;FOXD2;PRRX1;TFAP2A;HOXB5;E2F6;JUN;FOXE1;HIVEP3;NR6A1;KLF10;KLF9;GLIS2;BHLHE40;HES1;NFATC4;CREB3L3;ETV5;GATA4;HIF3A;JDP2;TEAD1;CALCOCO1;CARF;NFYA;BCL6;TCF3;MXD1;NFKB2;SIX4;E2F3;BCL11B;ZNF585B;ZNF585A;ZKSCAN1;ATOH8;SKI;FOXA1;FOXK2;PRDM15;GATA3;TCF23;NKX2-1;EBF4;ZNF383;TAF1;ZFP62;RBMX;IRF1;RB1;RBL2;HSF5;ZBTB11;ZBTB49;ZBTB37;REST;KLF16;NFIL3;RXRA;STAT3;WIZ;FOXC1;EHF;PGBD1;RFX5;HIVEP2;STAT5A
prerank,chemokine activity (GO:0008009),-0.43226164833104136,-1.3325273440255145,0.09198813056379822,0.46774878873237796,1.0,19/31,46.53%,CXCL12;CCL19;CCL2;CCL25;CCL5;CXCL5;CCL11;CXCL1;CCL4;PF4;CX3CL1;CCL7;PPBP;CCL8;CCL1;CCL3;XCL1;CXCL13;CXCL2
prerank,tau-protein kinase activity (GO:0050321),0.5650806006772481,1.3306721139951614,0.15930599369085174,0.72943524102958,1.0,5/20,10.41%,MARK1;GSK3B;SIK3;MARK2;MARK3
prerank,poly(A) binding (GO:0008143),-0.47091312451806877,-1.3295987424828983,0.10344827586206896,0.46708720786996455,1.0,7/21,15.13%,RBPMS;RBMS1;KHDRBS2;TIA1;ELAVL4;PABPC4L;PPIE
prerank,fibroblast growth factor binding (GO:0017134),0.5668516792893847,1.3293111179878279,0.16826923076923078,0.7254076982243188,1.0,6/21,13.07%,THBS1;FGFR1;ITGAV;KLB;CEP57;ITGB3
prerank,deubiquitinase activity (GO:0101005),0.46298060028548016,1.3281613152313647,0.09963547995139732,0.7216152720438272,1.0,39/88,20.88%,USP13;MINDY3;TANK;USP46;USP24;JOSD1;OTUD1;USP2;OTUD7B;USP49;BAP1;USP7;USP32;USP10;UFD1;USP33;USP22;USP34;USP3;USP25;USP21;USP47;MYSM1;COPS5;USP4;STAMBP;USP1;OTUD3;DESI2;ZRANB1;OTUB1;VCPIP1;USP9X;USP48;MINDY2;OTUD5;USP31;USP37;MINDY4
prerank,cadherin binding (GO:0045296),0.412030254010599,1.3278183129868966,0.01993704092339979,0.7147821673225135,1.0,72/315,13.30%,CDH1;EGFR;STXBP6;TES;FMNL2;CDH11;BAIAP2L1;NDRG1;ANXA1;CALD1;CTNND2;EZR;AHNAK;PHLDB2;PARVA;ABI1;FLNB;SPTAN1;CTNNA1;ITGB1;ANXA2;TMOD3;ESYT2;PAICS;MPP7;PDXDC1;FXYD5;GIPC1;CAST;PLCB3;STX5;HDLBP;SH3GLB2;PDLIM5;CLINT1;SHTN1;VCL;PKP4;MPRIP;DLG1;ERC1;P2RX4;PFKP;MARK2;JUP;IQGAP1;KTN1;UNC45A;CTNND1;RDX;VAPA;CD46;SERBP1;CDH17;CCS;PAK4;TBC1D10A;TRIM25;PKN2;PAK2;NIBAN2;IST1;ACVR1;BZW1;EHD1;GAPVD1;TXNDC9;SFN;CAPZA1;PLEC;CTTN;ADD1
prerank,phosphatidylinositol-5-phosphate binding (GO:0010314),-0.5226410236486512,-1.3249245856335363,0.15089514066496162,0.46996402284752065,1.0,8/15,22.81%,LANCL2;PLEKHA5;JPH2;PLA2G4E;PHLDA3;SAP30L;RUBCNL;SH3PXD2B
prerank,transition metal ion transmembrane transporter activity (GO:0046915),-0.4171104951442222,-1.3242422180612325,0.08950617283950617,0.46411394977347437,1.0,12/30,16.91%,SLC30A10;SLC39A10;SLC40A1;SLC39A8;SLC39A7;TTYH1;SLC30A4;SLC31A1;SLC30A1;SLC39A3;SLC11A2;ATP7A
prerank,R-SMAD binding (GO:0070412),0.5754726042907544,1.3191103323717814,0.16396103896103897,0.7368177431651457,1.0,8/18,16.20%,DDX5;SMAD6;JUN;PPM1A;LDLRAD4;SMURF1;DROSHA;PAX6
prerank,phosphatase binding (GO:0019902),0.4404126693673217,1.3171361614288732,0.08782201405152225,0.7357674533976819,1.0,29/105,17.26%,EGFR;MET;MAP3K5;WNK1;CRY2;PPP1R3C;SFI1;CNST;VCP;AP3B1;ANAPC5;SHOC2;DLG1;JUP;IQGAP1;CDKN1B;EIF2AK3;PPP1R3F;IKBKE;STAT3;MAPK1;STYXL1;VRK3;PPP6R3;SH3YL1;PPME1;CSRNP2;RCAN3;STAT6
prerank,insulin-like growth factor receptor binding (GO:0005159),-0.5493709945920335,-1.31610809285672,0.15090090090090091,0.4746939317273975,1.0,6/12,6.81%,IGF1;PIK3R1;GNAS;INSR;IGF2;ARRB1
prerank,transcription cis-regulatory region binding (GO:0000976),0.3989277555696101,1.314218219696956,0.020833333333333332,0.7381499198582985,1.0,85/406,14.70%,BNC2;FOXP1;VSX1;SOX9;TCF7L2;PLAGL1;FOXN3;SIX1;HDAC4;FOXO3;GLI3;PBX1;GRHL1;ISL1;CRY2;KLF4;CUX1;SMAD6;PURG;FOXK1;MYOG;BARHL2;LHX2;PHOX2A;ZBTB7B;MEF2A;EGR2;DDIT3;NFE2L2;ARID4A;GATA1;CTCFL;ZBED4;FOXC2;ATF1;NFKB1;TWIST2;HNF4A;HNF1A;TFAP2A;TBL1X;E2F6;JUN;KLF10;GLIS2;CREB3L3;ETV5;GATA4;HIF3A;TEAD1;CALCOCO1;NFYA;TCF3;E2F3;PER2;ARID4B;FOXA1;FOXK2;GATA3;TCF23;NKX2-1;GABPB1;GABPB2;RNF10;IRF1;RB1;RBL2;TAF9;REST;NFIL3;RXRA;STAT3;FOXC1;RFX5;ZBTB4;CIITA;XRCC5;FOXM1;CEBPB;HNRNPL;TFE3;KMT2D;CARM1;TFEB;PER3
prerank,GTPase activator activity (GO:0005096),-0.299167130476078,-1.3139331946507202,0.0,0.4725352602528404,1.0,72/313,10.58%,RANBP3L;ASAP1;PLCB1;PREX2;ARHGAP29;ARHGAP28;TBC1D4;RAPGEF5;DOCK10;CHN2;ERRFI1;DOCK4;DENND2A;ARHGAP24;RAPGEF4;ARHGAP32;RAPGEF3;RASGRP3;ELMO1;ALDH1A1;RABGAP1L;RALGPS1;FGD5;RGS3;RGS5;DOCK11;RAPGEF2;DENND1A;CHN1;USP6NL;SBF2;RGS7;RALGAPA2;CCDC88A;ARAP3;ARHGAP26;RAB3IP;TBC1D12;RALGAPA1;RASGRP2;GMIP;EEF1B2;ARHGEF15;IQGAP2;RASGRF2;RGL1;ARHGAP25;ARHGAP15;EPS8L2;ARRB1;OPHN1;RAPGEF1;DENND5A;TBC1D9;ACAP2;CYTH1;DENND5B;STARD8;PREX1;SGSM1;TBC1D8;SPATA13;VAV3;LRRK2;SMAP2;RASGRF1;RP2;GARNL3;TBC1D2;TBC1D16;RCC1;SEC23B
prerank,cholesterol binding (GO:0015485),-0.3858771464627401,-1.3131130942351201,0.08363636363636363,0.46711243946070946,1.0,11/47,6.04%,OSBPL8;APOD;PROM1;SIDT1;ABCA1;GRAMD1B;PTCH1;NPC2;OSBPL10;NR1H3;CD81
prerank,sodium-independent organic anion transmembrane transporter activity (GO:0015347),0.6349291277495104,1.312960868886185,0.19257950530035337,0.7348155981420852,1.0,3/10,2.33%,SLCO3A1;SLCO4A1;SLCO2A1
prerank,NAD binding (GO:0051287),0.5332397868892355,1.312566474097157,0.15789473684210525,0.7283373955887614,1.0,2/26,1.78%,ME1;BDH2
prerank,ligand-gated channel activity (GO:0022834),-0.4430477263153763,-1.3103732046275516,0.12994350282485875,0.4660286279491663,1.0,10/29,9.58%,GRIK1;GRIN2A;GRIA4;GRIA2;GRIA3;GRIN2B;GRID2;GRIN3A;GRIK2;GABRB1
prerank,GABA receptor binding (GO:0050811),-0.5554814541231577,-1.303905425619486,0.1724137931034483,0.4732900366932418,1.0,5/11,17.12%,PLCL2;GABARAP;TRAK2;JAKMIP1;GABARAPL1
prerank,manganese ion binding (GO:0030145),0.48773093788886895,1.3019481554117414,0.1325811001410437,0.7569335972912667,1.0,11/48,15.15%,ME1;MPPED2;LARGE1;ABL1;DYRK2;B4GALT1;B4GALT7;XPNPEP1;LARGE2;EXD2;XPNPEP3
prerank,ligand-gated ion channel activity (GO:0015276),-0.43978040022652953,-1.3001772549156985,0.12753623188405797,0.47452050871397905,1.0,10/30,9.58%,GRIK1;GRIN2A;GRIA4;GRIA2;GRIA3;GRIN2B;GRID2;GRIN3A;GRIK2;GABRB1
prerank,filamin binding (GO:0031005),0.6264100965225635,1.2974122286750167,0.18055555555555555,0.7640536685299322,1.0,2/11,3.38%,DPYSL3;NEBL
prerank,phosphatidylinositol phospholipase C activity (GO:0004435),0.5498995224526744,1.2956281093724002,0.1723027375201288,0.7624049715896692,1.0,5/23,5.42%,PLCE1;EDNRA;CHRM5;PLCB3;PLCD3
prerank,GABA-A receptor activity (GO:0004890),-0.4827296549558165,-1.2952741898839581,0.13821138211382114,0.479494568362358,1.0,9/18,25.25%,GABRG3;GABRA1;GABRA2;GABRB2;GABRB1;GABRA4;GABRG1;GABRB3;GABRA5
prerank,E-box binding (GO:0070888),-0.41291239345402114,-1.295176862316324,0.11343283582089553,0.4728976827672233,1.0,6/34,10.91%,TCF4;ZEB1;AHR;TAL1;CIART;MITF
prerank,cyclic nucleotide binding (GO:0030551),-0.4702113512413091,-1.2930238738758577,0.15168539325842698,0.471032575763628,1.0,8/21,10.43%,RAPGEF4;PDE4B;RAPGEF2;HCN1;PDE4A;PDE4D;PDE2A;PDE11A
prerank,RNA 7-methylguanosine cap binding (GO:0000340),0.6047654140240973,1.2923526895843442,0.21415929203539824,0.7664144940691797,1.0,1/12,0.73%,CYFIP2
prerank,diacylglycerol kinase activity (GO:0004143),-0.5313783033570817,-1.2909179620934965,0.19463087248322147,0.4692876128461778,1.0,5/11,15.24%,DGKB;DGKI;DGKD;DGKG;DGKE
prerank,O-acyltransferase activity (GO:0008374),0.521268875261788,1.2907952029048106,0.1723625557206538,0.7643159315538784,1.0,9/30,19.03%,SOAT1;MOGAT3;DGAT2L6;GPAT3;LCAT;PLA2G4A;PLA2G15;MBOAT1;MOGAT1
prerank,RNA polymerase II-specific DNA-binding transcription factor binding (GO:0061629),0.40654174546256727,1.28854768588462,0.08370535714285714,0.764274734341459,1.0,42/181,12.66%,ZFPM2;TCF7L2;HDAC4;TACC2;WWP2;ISL1;KLF4;ANXA4;GSK3B;MDFIC;MEF2A;EGR2;NFE2L2;GATA1;DDRGK1;PIAS3;HNF4A;PRRX1;EP300;PIAS2;HCLS1;JUN;TADA3;KDM1A;CREBBP;JUP;BHLHE40;HES1;GATA4;BCL10;SMARCA4;TCERG1;TCF3;BCAS3;TCF23;TAF1;RB1;RBL2;MTDH;RXRA;STAT3;BAZ2A
prerank,sterol binding (GO:0032934),-0.3657723736194843,-1.2866958363719128,0.0967741935483871,0.4720657809259896,1.0,20/56,18.08%,OSBPL8;APOD;PROM1;SIDT1;ABCA1;GRAMD1B;PTCH1;NPC2;OSBPL10;NR1H3;CD81;INSIG2;OSBP;STARD5;OSBPL1A;SYP;STARD3;SCP2;ABCG1;TSPO
prerank,mitogen-activated protein kinase kinase kinase binding (GO:0031435),-0.5533828858745289,-1.2860167030365135,0.16166281755196305,0.467255645786559,1.0,3/11,5.83%,SASH1;ROR2;DAB2IP
prerank,SUMO transferase activity (GO:0019789),0.5716912816808206,1.2800234410844564,0.19824561403508772,0.7859037762906674,1.0,6/16,13.82%,HDAC4;EGR2;PIAS3;PIAS2;RANBP2;NSMCE2
prerank,alkali metal ion binding (GO:0031420),-0.5197920817466262,-1.278623553143726,0.16864608076009502,0.47817396884328256,1.0,1/13,0.02%,ATP1A2
prerank,protein serine/threonine kinase activity (GO:0004674),0.38910721186775576,1.2778780219755022,0.0472193074501574,0.7859562897847019,1.0,96/335,17.53%,STK39;EGFR;MAP3K5;GRK5;STK19;MARK1;PTK2B;CAMK2D;LIMK2;WNK1;CIT;PRKCD;HIPK1;CLK1;ALPK1;MKNK2;NEK7;BCR;GSK3B;STK35;RIPK3;BMPR1A;SGK3;ULK2;SIK3;TLK1;TGFBR1;TRIO;TGFBR2;SIK2;GAK;STK16;PLK3;CHUK;RIPK2;ATM;MARK2;DYRK2;SMG1;IRAK4;EIF2AK4;CDC42BPG;DYRK3;CLK2;CHEK2;CSNK1G3;MARK3;MTOR;PAK4;CSNK1E;PKN2;PAK2;PIM2;TAF1;EIF2AK3;CHEK1;ACVR1;CSNK2A2;CSNK2A1;SQSTM1;IKBKE;NLK;NEK8;CASK;PRKCE;AAK1;CSNK1A1;MAPK1;SRPK1;CPNE3;VRK3;SBK3;CAMK4;ILK;AMHR2;HTATIP2;CDK12;STK11;FAM20A;MAPK15;PRKAA1;ERN2;PRKCA;PRKACA;CSNK1D;WNK3;CDKL2;MAP3K12;PRKDC;MAP4K1;TOP1;TAOK3;MAPK8;VRK2;MAPKAPK2;TLK2
prerank,"oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor (GO:0016628)",0.5646796586592739,1.2772433425384841,0.2003257328990228,0.7806984315402677,1.0,4/17,9.62%,BDH2;PECR;DECR1;LBR
prerank,NAD-retinol dehydrogenase activity (GO:0004745),0.5839899709343067,1.274875972890348,0.22735042735042735,0.7809987808499073,1.0,1/14,2.45%,ADH7
prerank,leak channel activity (GO:0022840),0.5602410918752951,1.2693924667720766,0.2173202614379085,0.7926182491255269,1.0,3/18,5.22%,KCNK5;NALCN;KCNK7
prerank,calcium channel regulator activity (GO:0005246),-0.3934413015513781,-1.269295969700681,0.12944983818770225,0.49252098333545924,1.0,9/37,11.64%,ITPR1;PRKG1;NRXN1;CALM1;SGK1;REM1;CACNG4;CACNG7;SLC30A1
prerank,CCR chemokine receptor binding (GO:0048020),-0.4240505843835246,-1.2681938445650676,0.15229885057471265,0.4889105677663405,1.0,20/28,46.42%,NES;CCL19;CNIH4;CCL2;CCL25;NARS1;CCRL2;CCL5;CCL11;CCL4;CX3CL1;CCL7;CCL8;MSMP;DEFB130A;CCL1;CCL3;XCL1;DEFB1;CXCL13
prerank,MHC class I protein binding (GO:0042288),-0.520070161991857,-1.2676016358557687,0.18734177215189873,0.484042836850551,1.0,9/13,41.92%,ATP5F1B;TAP2;ATP5F1A;ABCB9;LILRB1;TAPBP;TUBB4B;CD8B;TAP1
prerank,histone deacetylase activity (GO:0004407),0.5550928544930744,1.2671053623963642,0.1893687707641196,0.7929146797861394,1.0,4/19,10.68%,HDAC4;HDAC9;HDAC10;HDAC8
prerank,RNA polymerase II CTD heptapeptide repeat kinase activity (GO:0008353),-0.5315449013054633,-1.2670782027933942,0.18099547511312217,0.4790616736953892,1.0,3/12,5.42%,CDK8;CDK19;CDK6
prerank,amino acid:sodium symporter activity (GO:0005283),0.6239814876411364,1.2648630089095922,0.2382608695652174,0.7935386246211336,1.0,2/11,0.55%,SLC38A2;SLC38A1
prerank,small GTPase binding (GO:0031267),0.4040361016672499,1.264241730638246,0.11771177117711772,0.7883683480112769,1.0,40/170,11.88%,PLCE1;STK19;NDRG1;ARHGDIB;AKAP13;CDC42EP5;SGSM2;EXOC4;DOCK7;YBX3;RAPGEF6;MLPH;PDE6D;RAB3GAP2;EXOC5;ANKRD27;MYCBP2;ERC1;RAB11FIP3;OCRL;FGD6;NCKAP1;EXPH5;IQGAP1;SGSM3;SRGAP2;STRN3;UNC13B;PIH1D2;USP33;NOX1;RGP1;HPS4;PAK2;TRIOBP;RANBP2;TRIP11;GGA2;BRK1;EHD1
prerank,ubiquitin-like protein-specific protease activity (GO:0019783),0.5330864425030124,1.2589753073730277,0.2169811320754717,0.7989668627526375,1.0,13/20,25.35%,USP7;USP25;USP21;USP47;COPS5;DESI2;OTUB1;SENP3;USP9X;UFSP2;OTUD5;SENP1;YOD1
prerank,sodium channel activity (GO:0005272),-0.39190366571249896,-1.2579529912820742,0.15605095541401273,0.4918192131181354,1.0,11/37,20.66%,SCN7A;SHROOM2;HCN1;GRIK1;SCN1A;GRIK2;SCN3A;CACNA1I;SCN2A;HCN2;GRIK3
prerank,"DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227)",0.40221088112720854,1.2548996563471924,0.10430839002267574,0.8055957113929354,1.0,35/173,14.58%,FOXP2;FOXP1;KLF12;ZFHX3;PLAGL1;FOXO3;ZBTB16;NR2F1;FOXK1;FOXP4;SKIL;ZNF148;NFKB1;TFAP2A;E2F6;JUN;BHLHE40;HES1;NFATC4;JDP2;BCL6;TCF3;MXD1;SKI;FOXK2;GATA3;ZBTB49;ZBTB37;REST;NFIL3;ZBTB4;CEBPB;THAP1;GTF2IRD1;ZBTB32
prerank,DNA binding (GO:0003677),0.37575539234502403,1.2530861622603993,0.019076305220883535,0.8048006789158758,1.0,165/694,18.68%,FOXP2;EGFR;KLF12;SLTM;RARB;SOX9;TCF7L1;TCF7L2;PLAGL1;NFIB;ZIC4;SIX1;HOXA5;FOXD1;HDAC4;FOXO3;ZBTB16;PBX1;ESR2;GRHL1;NR2F1;CRY2;CUX1;COLEC11;MPG;MYOG;NOBOX;RNF138;MEF2A;RBM6;ZNF148;ABL1;MEOX2;EGR2;HDGFL3;DDIT3;CEBPZ;NFE2L2;ARID4A;IGHMBP2;GATA1;CTCFL;NR4A2;FOXC2;SLPI;NR4A3;ZNF8;ZNF423;BPTF;HNF4A;HNF1A;BCLAF1;RARG;FOXD2;EP300;TFAP2A;CAMTA2;TRIM26;JUN;FOXE1;NR6A1;MCM7;CREBBP;HES1;ETV5;GATA4;TEAD1;TAF6L;CALCOCO1;CBFB;SMARCA4;CARF;SWSAP1;NFYA;BCL6;TCF3;TOP3A;E2F3;ERCC3;RAD52;MBD1;BRCA2;FOXA1;ERCC1;FOXK2;GATA3;QRICH1;NKX2-1;RAD51C;STN1;MBD4;AIFM2;MYRFL;TAF1;IRF1;RPA1;ZBTB49;RAD51AP1;TAF9;XPA;RXRA;STAT3;FOXC1;EHF;RTF1;RFX5;HIVEP2;ZBTB4;SMC1A;CIITA;XRCC5;HES7;TSG101;DDX11;GLYR1;CEBPB;C1D;SOX21;ZNF76;THAP1;KMT2D;TRIM16;RAD23B;ZBTB32;FOXL1;RBBP8;TAF12;XPC;DHX9;SNAPC4;JRK;CENPX;ZNF711;ZBTB18;PAX6;ZNF496;PRKDC;TOP1;CSRNP2;POLG2;MAEL;RORA;NR4A1;ZNF513;WRN;ATAD5;ZBTB7A;HUWE1;YY1;MCM9;POLA1;CLSPN;E2F2;NBN;ATF6;CSRNP1;INO80;ARID1A;SRRT;IKZF3;REXO4;CCDC25;POLR2H;CREM;RC3H2
prerank,protein kinase A catalytic subunit binding (GO:0034236),0.5710107836450795,1.252400258225294,0.22749590834697217,0.8000844339685481,1.0,3/13,3.93%,SOX9;EZR;GSK3B
prerank,estrogen receptor binding (GO:0030331),-0.4017795594039303,-1.2522596581937668,0.16507936507936508,0.4985276389448571,1.0,6/32,7.13%,LEF1;TACC1;NCOA1;PPARGC1B;RERG;WIPI1
prerank,beta-tubulin binding (GO:0048487),-0.4014805918274669,-1.2520764383604917,0.15634218289085547,0.4928320460949156,1.0,13/31,23.38%,GJB6;TTLL7;EML4;PDCD5;ARL8B;GABARAP;CCT5;PACRG;GABARAPL1;TRPV4;CDK5R1;HTT;DLEC1
prerank,WW domain binding (GO:0050699),-0.4262651582385549,-1.2483997346014117,0.17933130699088146,0.49467172045061597,1.0,9/26,23.65%,RAPGEF2;TNK2;NDFIP2;LITAF;TCEAL9;DAZAP2;TCEAL3;TRAF4;TCEAL5
prerank,phospholipase C activity (GO:0004629),0.5170157021026716,1.2467220673270387,0.21451104100946372,0.812263707372645,1.0,5/25,5.42%,PLCE1;EDNRA;CHRM5;PLCB3;PLCD3
prerank,omega peptidase activity (GO:0008242),0.4351837261974198,1.246001765770771,0.15147783251231528,0.807694799400101,1.0,37/89,20.84%,USP13;MINDY3;TANK;USP46;USP24;JOSD1;OTUD1;USP2;OTUD7B;USP49;BAP1;USP7;USP32;USP10;UFD1;USP33;USP22;USP34;USP3;USP25;USP21;USP47;MYSM1;COPS5;USP4;STAMBP;USP1;OTUD3;DESI2;ZRANB1;OTUB1;VCPIP1;USP9X;USP48;OTUD5;USP31;USP37
prerank,ion channel inhibitor activity (GO:0008200),0.48675162186922977,1.2445414304993487,0.20618556701030927,0.805427000925862,1.0,9/35,11.55%,KCNMB2;NEDD4;CAMK2D;WNK1;TNNI3;STX8;MCUB;COMMD1;PHPT1
prerank,"inositol 1,4,5 trisphosphate binding (GO:0070679)",-0.5321665179306635,-1.243551210479629,0.2116788321167883,0.4991385371419404,1.0,5/11,13.51%,ITPR1;TRPC3;RPH3A;TRPC4;TRPC6
prerank,phosphatidate phosphatase activity (GO:0008195),0.5729666549100081,1.2411751326062186,0.22887323943661972,0.8091523145517493,1.0,2/13,2.52%,PLPPR2;PLPP3
prerank,FAD binding (GO:0071949),0.5131062582772522,1.2407980459280952,0.22287390029325513,0.8035471967806246,1.0,2/24,2.73%,MICAL2;CRY2
prerank,nuclear receptor binding (GO:0016922),0.4096976352087674,1.2394136708860495,0.14898688915375446,0.8010682240706637,1.0,31/111,16.82%,FOXP1;TCF7L2;DDX5;TACC2;ISL1;STRN;NR4A2;JMJD1C;NR4A3;EP300;TRIP6;TRIP12;TADA3;TGFB1I1;KDM1A;JUP;SMARCA4;DCAF1;MED14;BCAS3;ZNHIT3;TAF1;RXRA;BAZ2A;BRD8;LCOR;NRIP1;SNW1;PRMT2;MED17;NR4A1
prerank,vinculin binding (GO:0017166),0.5994661468469844,1.23930268073527,0.26545454545454544,0.7949060566651405,1.0,3/11,4.50%,SORBS3;CTNNA1;DMD
prerank,DNA-binding transcription factor binding (GO:0140297),0.3937727617807267,1.2355019725477259,0.11928651059085842,0.8007273677099933,1.0,44/189,12.38%,ZFPM2;TCF7L2;HDAC4;WWP2;HDAC9;ISL1;KLF4;GSK3B;MEF2A;EGR2;DDIT3;TLE6;NFE2L2;GATA1;DDRGK1;ZMYND8;PIAS3;HNF4A;PRRX1;EP300;PIAS2;HCLS1;JUN;TXLNG;KDM1A;CREBBP;BHLHE40;HES1;GATA4;TCERG1;KAT5;TLE4;TCF3;SKI;TCF23;TAF1;RB1;TLE3;RBL2;TLE2;ZBTB49;TAF9;MTDH;STAT3
prerank,acylglycerol O-acyltransferase activity (GO:0016411),0.5321892508480415,1.2347492653622236,0.23809523809523808,0.7967335623814906,1.0,9/20,19.03%,PNPLA3;MOGAT3;ABHD5;GPAT3;AGPAT4;PLA2G15;LCLAT1;AGPAT5;MOGAT1
prerank,NAD+ binding (GO:0070403),-0.4999231337215544,-1.2328493202041884,0.23433874709976799,0.51683678060509,1.0,8/12,35.58%,CRYL1;SIRT5;GLUD1;HADH;SIRT3;UXS1;HPGD;SIRT6
prerank,"N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity (GO:0008532)",0.5816762388598302,1.231178650220107,0.2556131260794473,0.8014218750395937,1.0,3/12,8.63%,B3GNT2;B4GAT1;B3GNT6
prerank,enoyl-CoA hydratase activity (GO:0004300),0.5951827615885452,1.2307610477022677,0.25471698113207547,0.7963815276116993,1.0,3/10,6.64%,EHHADH;AUH;ECHDC1
prerank,ion channel activity (GO:0005216),0.4222581192802868,1.2307582757639335,0.18685567010309279,0.7900690401585043,1.0,13/80,8.55%,PIEZO2;TMEM120A;TRPM6;TMC6;TMC1;P2RX2;NALCN;TRPM4;CALHM2;GRIN2C;CALHM5;PKD2L1;MCUB
prerank,histone methyltransferase activity (H3-K36 specific) (GO:0046975),0.5954806839070095,1.2259224299086744,0.256140350877193,0.7990093410426584,1.0,3/10,11.77%,SMYD2;SETD5;SETD2
prerank,GTPase inhibitor activity (GO:0005095),0.559821427758123,1.2211271294747121,0.2602739726027397,0.8088101823869042,1.0,3/13,7.98%,SLIT2;PDE6D;IQGAP1
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides (GO:0016812)",0.6046252592494596,1.2186391693250405,0.26548672566371684,0.810370760245551,1.0,2/10,10.09%,DPYSL3;CAD
prerank,actinin binding (GO:0042805),0.5204468751513667,1.2160948112543322,0.2581143740340031,0.8126285145321376,1.0,7/21,8.41%,CSRP3;CACNA1C;CSRP2;PDLIM5;NFKB1;MAGI1;PKD2L1
prerank,protein phosphatase 1 binding (GO:0008157),0.5216420285047688,1.2140073521770336,0.24766355140186916,0.812974100995809,1.0,4/21,11.57%,PPP1R3B;PPP1R3C;SHOC2;PPP1R3F
prerank,calcium ion binding (GO:0005509),0.36992787473455896,1.2138748355871163,0.10559006211180125,0.8072581630604604,1.0,27/323,5.12%,CDH1;SLIT3;SLIT2;SMOC2;THBS1;ACER3;CDH11;ANXA3;ANXA1;ESYT3;PPP3CA;DSPP;GLCE;ANXA2;ESYT2;COLEC11;OC90;TGM3;GSN;STIM2;DSG2;ANXA4;SYT8;ITPR2;DSC3;DSC2;TRPM4
prerank,mRNA methyltransferase activity (GO:0008174),0.5800010574706755,1.2123242485020544,0.27854671280276816,0.8063503715691809,1.0,1/12,0.67%,RNMT
prerank,protein-arginine N-methyltransferase activity (GO:0016274),0.5922792608349807,1.2099240752303815,0.2643478260869565,0.808074202049254,1.0,8/11,26.24%,CARM1;PRMT6;PRMT2;PRMT8;FBXO11;NDUFAF7;PRMT3;PRMT9
prerank,ubiquitin-ubiquitin ligase activity (GO:0034450),0.5940299894388219,1.2089242132353368,0.25760286225402507,0.8052098698623561,1.0,4/11,14.50%,UBE4B;UBR5;UBE4A;PPIL2
prerank,hexosyltransferase activity (GO:0016758),0.40812630376148995,1.2084527046977451,0.19583843329253367,0.8007420713177085,1.0,16/101,10.77%,TMTC1;MGAT4C;EXT1;B3GNT2;LARGE1;GCNT2;HEXA;A4GALT;POGLUT3;POMGNT2;B4GAT1;B3GNT6;PIGB;GCNT4;B4GALT1;B4GALT7
prerank,triglyceride lipase activity (GO:0004806),0.5158473026249459,1.206568017887614,0.2714285714285714,0.8003057040395759,1.0,5/20,15.95%,PNPLA3;DAGLB;ABHD5;LCAT;PLA2G15
prerank,metalloendopeptidase inhibitor activity (GO:0008191),-0.47915236351414214,-1.2063599958660525,0.24821002386634844,0.5729354913884456,1.0,6/14,9.45%,TIMP3;COL4A3;SPOCK2;BST2;SPOCK3;SPOCK1
prerank,protein phosphatase binding (GO:0019903),0.4007830266405793,1.2037245492009683,0.19298245614035087,0.8036085844623403,1.0,21/117,12.38%,EGFR;MET;MAP3K5;PPP1R3B;PPP1R3C;STRN;VCP;AP3B1;ANAPC5;SHOC2;ATP2B4;BOD1L1;JUP;IQGAP1;STRN3;CDKN1B;EIF2AK3;PPP1R3F;IKBKE;SLC9A1;STAT3
prerank,MAP kinase tyrosine/serine/threonine phosphatase activity (GO:0017017),0.5975318633599237,1.2031337474713826,0.30700179533213645,0.7939502579186705,1.0,3/10,9.99%,DUSP16;DUSP10;DUSP5
prerank,protein tyrosine/threonine phosphatase activity (GO:0008330),0.5975318633599237,1.2031337474713826,0.30700179533213645,0.7939502579186705,1.0,3/10,9.99%,DUSP16;DUSP10;DUSP5
prerank,RNA cap binding (GO:0000339),0.54191649716991,1.2029801549131791,0.27427597955706984,0.7888270341330667,1.0,1/16,0.73%,CYFIP2
prerank,histone methyltransferase activity (H3-K9 specific) (GO:0046974),-0.5184403262317954,-1.2012519396020267,0.23429951690821257,0.5789162282160111,1.0,2/10,3.90%,MECOM;PRDM16
prerank,voltage-gated potassium channel activity (GO:0005249),0.4163412876597299,1.2003876015389983,0.20148331273176762,0.79135808031455,1.0,5/80,4.01%,KCNB2;KCNJ2;KCNQ5;KCNS3;KCNB1
prerank,transcription corepressor binding (GO:0001222),0.49591254381284894,1.1958176436274583,0.25384615384615383,0.7995075945517156,1.0,13/27,24.46%,ZBTB16;PER2;WIZ;EHMT2;EHMT1;LCOR;PER3;SUZ12;RORA;ZBTB7A;NEK6;EED;EZH2
prerank,transforming growth factor beta-activated receptor activity (GO:0005024),-0.5078989531660062,-1.1949828080728875,0.24113475177304963,0.5876795887769564,1.0,3/12,0.82%,LTBP1;ENG;TGFBR3
prerank,RNA polymerase binding (GO:0070063),0.5209389959286437,1.194061981752218,0.26557377049180325,0.7996050665817122,1.0,6/18,10.79%,NEDD4;STOM;TCERG1;SCAF8;PHRF1;PKN2
prerank,ubiquitin binding (GO:0043130),0.4207548775795178,1.1934351643870298,0.21491782553729458,0.7960441936471258,1.0,19/73,18.14%,NEDD4;USP13;DDI2;RNF185;NPLOC4;UBAP1;RNF168;USP33;CXCR4;SQSTM1;USP25;FAF2;TSG101;RNF31;RAD23B;UBE2N;FAF1;OTUB1;CKS1B
prerank,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential (GO:0099529),-0.43577886444976066,-1.192507256218667,0.21866666666666668,0.5871686007403343,1.0,11/19,25.25%,GRIK1;GABRG3;GRID2;GABRA1;GABRA2;GRIK2;GABRA4;GABRG1;GRIK3;GRID1;GABRA5
prerank,GDP binding (GO:0019003),0.4255894138126855,1.1912561106440271,0.22849807445442877,0.7971376366129611,1.0,18/63,19.30%,MRAS;NRAS;KRAS;RAP1A;ARL3;RAP2C;RAB18;RAB27B;RIT1;RAB42;RAN;RAB5A;RRAS2;RAB17;DIRAS1;RAB22A;RAB7A;MIEF1
prerank,calcium-dependent phospholipid binding (GO:0005544),0.44158175686570317,1.1903059750096283,0.25102880658436216,0.7947872622964924,1.0,7/49,4.30%,ANXA3;ANXA1;ESYT3;ANXA2;ESYT2;ANXA4;SYT8
prerank,endopeptidase regulator activity (GO:0061135),-0.3675957939265495,-1.1902049463078366,0.18471337579617833,0.5860566813913383,1.0,18/40,27.79%,PROS1;ITIH2;CST3;TFPI;SERPIND1;A2M;PSME2;APH1B;PSENEN;VSIR;ADRM1;PSME1;HRG;APH1A;UCHL5;ABCA2;AHSG;PCSK1N
prerank,transmembrane receptor protein tyrosine kinase activity (GO:0004714),0.4298629399408151,1.1894796807508836,0.23418573351278602,0.7917466261331638,1.0,7/60,2.87%,EGFR;CRIM1;MET;NTRK3;FGFR1;DDR2;EFEMP1
prerank,potassium channel regulator activity (GO:0015459),0.44817080324347874,1.1862640170505114,0.25906040268456376,0.7958644559022894,1.0,7/49,6.47%,KCNMB3;KCNMB2;WNK1;KCNS3;ADRB2;SGK3;DLG1
prerank,growth factor activity (GO:0008083),0.41282251432850886,1.185600007458818,0.21508034610630408,0.7925144233706609,1.0,11/74,7.51%,NGF;OSGIN2;INHBA;PGF;IL10;PDGFA;GDNF;FGF22;JAG1;CLCF1;FGF2
prerank,tumor necrosis factor receptor superfamily binding (GO:0032813),0.4775070653197812,1.1825598275344633,0.25806451612903225,0.7963790173547494,1.0,10/28,22.00%,EDA;TNFSF11;TRAF5;TRAP1;CASP8AP2;MYD88;FEM1B;FADD;TRAF3;PIDD1
prerank,myosin binding (GO:0017022),0.4326805408493571,1.1808035097439205,0.23712737127371275,0.7964587805585044,1.0,12/55,11.89%,CALD1;NPHS1;GSN;GIPC1;MLPH;DMD;RAB6A;NCKIPSD;RAB27B;CXCR4;TRIOBP;RHOA
prerank,potassium ion leak channel activity (GO:0022841),0.5419929216020041,1.1806011605993598,0.3050259965337955,0.7917341605624802,1.0,2/15,5.22%,KCNK5;KCNK7
prerank,"4 iron, 4 sulfur cluster binding (GO:0051539)",-0.46543337412991165,-1.1804541718297137,0.2481012658227848,0.603027809777668,1.0,10/14,35.97%,CIAO3;ACO2;EXO5;RSAD1;ACO1;ISCA2;NDUFS1;RSAD2;SDHB;NUBPL
prerank,"hydrolase activity, hydrolyzing O-glycosyl compounds (GO:0004553)",0.47830140989401654,1.1792009312996545,0.271513353115727,0.7906843791186251,1.0,14/29,27.15%,ACER3;HPSE;HYAL3;GANC;MGAM;NEU3;IDUA;GAA;ENGASE;GALC;MOGS;HEXD;HPSE2;NEU1
prerank,SUMO binding (GO:0032183),0.5471895667642266,1.1783187413748795,0.29259259259259257,0.7882367913289998,1.0,8/13,24.46%,HERC2;SERBP1;USP25;RNF111;PML;CASP8AP2;TDG;SIMC1
prerank,sialyltransferase activity (GO:0008373),-0.43092768025130523,-1.1736787528624295,0.26344086021505375,0.6130198723280551,1.0,8/20,8.05%,ST6GALNAC3;ST3GAL1;ST3GAL6;ST8SIA4;ST6GAL1;ST3GAL3;ST8SIA6;ST6GALNAC2
prerank,active ion transmembrane transporter activity (GO:0022853),-0.3588127101762272,-1.1711579538753636,0.2138364779874214,0.6126710447013084,1.0,17/37,16.91%,SLC22A8;SLCO2B1;SLCO1C1;SLC22A6;SLC22A4;COX4I1;CYB5A;UQCR10;UQCRH;COX8A;COX6B1;COX6A1;COX5B;UQCR11;ATP13A3;SLC16A7;COX10
prerank,myosin II binding (GO:0045159),0.5824642040170475,1.1682493759779298,0.32142857142857145,0.812373902511241,1.0,6/10,24.48%,GSN;TRIOBP;MYL3;LLGL1;SHROOM4;STXBP5L
prerank,ionotropic glutamate receptor activity (GO:0004970),-0.449708219033346,-1.1671465002721921,0.2655086848635236,0.6158365616313263,1.0,8/17,8.98%,GRIK1;GRIN2A;GRIA4;GRIA2;GRIA3;GRIN2B;GRIN3A;GRIK2
prerank,syntaxin-1 binding (GO:0017075),-0.40560624280536595,-1.1654625011327786,0.24338624338624337,0.6133316325930589,1.0,10/22,26.21%,UNC13C;DAPK1;LRRK2;CPLX1;SYP;SNAP25;UNC13A;SYT1;STXBP3;VAMP3
prerank,peptide alpha-N-acetyltransferase activity (GO:0004596),0.553432595378917,1.1634577038747673,0.30456852791878175,0.8214222238183794,1.0,1/11,4.18%,NAA40
prerank,GTPase binding (GO:0051020),0.3675055800345463,1.1598991838631436,0.20995670995670995,0.8263809992786518,1.0,42/195,11.88%,PLCE1;STK19;NDRG1;ARHGDIB;AKAP13;CDC42EP5;SGSM2;EXOC4;DOCK7;YBX3;RAPGEF6;MLPH;PDE6D;RAB3GAP2;EXOC5;ANKRD27;BECN1;MYCBP2;ERC1;RAB11FIP3;OCRL;FGD6;NCKAP1;EXPH5;IQGAP1;SGSM3;SRGAP2;STRN3;UNC13B;PIH1D2;USP33;NOX1;RGP1;HPS4;PAK2;GNB3;TRIOBP;RANBP2;TRIP11;GGA2;BRK1;EHD1
prerank,SH3 domain binding (GO:0017124),0.4206811183746637,1.1589416212499248,0.2643229166666667,0.8242586824714279,1.0,9/62,7.25%,AFAP1L1;DPYSL3;ABI1;ADAM9;ABL1;ESPN;ADAM12;PLSCR1;AFAP1
prerank,sodium channel regulator activity (GO:0017080),0.4510755521173473,1.1537479330876261,0.30307262569832405,0.8347453489539237,1.0,8/37,7.87%,PTPN3;NEDD4;CAMK2D;FXYD5;SGK3;ATP2B4;FGF13;FXYD7
prerank,C4-dicarboxylate transmembrane transporter activity (GO:0015556),-0.44138244255917836,-1.153589509783589,0.2916666666666667,0.6355821938901207,1.0,5/16,15.19%,SLC13A3;SLC1A5;SLC1A1;SLC25A18;SLC25A11
prerank,voltage-gated cation channel activity (GO:0022843),0.39563745476775464,1.1533257848497873,0.24572127139364303,0.8308316885713168,1.0,10/97,6.37%,KCNB2;KCNQ5;PTK2B;TMC1;KCNS3;CACNA1C;CACHD1;KCNB1;GRIN2C;ITGAV
prerank,serine-type peptidase activity (GO:0008236),0.38802534518135084,1.1513675426950865,0.24673784104389088,0.8315277248427871,1.0,5/96,6.02%,F3;PCSK5;HTRA3;HTRA1;TMPRSS2
prerank,metalloaminopeptidase activity (GO:0070006),0.5193125082306609,1.1513476103245817,0.3106796116504854,0.8265005443352216,1.0,7/16,17.05%,NPEPPS;MMP16;MMP14;ERAP1;XPNPEP1;XPNPEP3;MMP17
prerank,transforming growth factor beta receptor binding (GO:0005160),0.4946835713354527,1.1494662019938915,0.3066884176182708,0.8270055036700003,1.0,5/18,6.07%,TGFB3;SMAD6;BAMBI;TGFBR1;TGFBR2
prerank,ligand-gated anion channel activity (GO:0099095),-0.43632027394822376,-1.1468752955920138,0.2845953002610966,0.6456366088802015,1.0,11/17,25.25%,GABRG3;GABRA1;GABRA2;GLRA1;GABRB2;GABRB1;GABRA4;GABRG1;GLRA3;GABRB3;GABRA5
prerank,histone acetyltransferase binding (GO:0035035),0.495057502075731,1.1446948750496184,0.2996845425867508,0.8360824292360196,1.0,8/21,17.52%,GLI3;MEF2A;KANSL1L;BCAS3;KANSL1;PAX6;CITED2;ZBTB7A
prerank,voltage-gated sodium channel activity (GO:0005248),-0.40738438601107263,-1.1439310415502135,0.28717948717948716,0.6465793376598822,1.0,10/22,26.19%,SCN7A;HCN1;SCN1A;SCN3A;CACNA1I;SCN2A;HCN2;SCN3B;SCN4B;SCN1B
prerank,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1902282),-0.48452849546790955,-1.142870789613545,0.3161592505854801,0.6429506307684,1.0,4/11,18.42%,KCNQ1;KCND3;KCNJ8;KCNJ3
prerank,core promoter sequence-specific DNA binding (GO:0001046),0.4496512692416953,1.1427143674454137,0.3105590062111801,0.8370640744367175,1.0,7/35,15.21%,FOXP1;TAF1C;KLF10;SMARCA4;TAF1;BAZ2A;RRN3
prerank,voltage-gated ion channel activity (GO:0005244),-0.4532189925414861,-1.1412041303580414,0.3027295285359802,0.6406540590247339,1.0,4/14,10.97%,CACNA1E;HCN1;VDAC3;KCND2
prerank,calcium:sodium antiporter activity (GO:0005432),0.5556257465601517,1.1404145974000335,0.3333333333333333,0.8389273769365199,1.0,1/10,0.72%,SLC24A3
prerank,cell-cell adhesion mediator activity (GO:0098632),0.43498850551944784,1.1399068804147043,0.2956152758132956,0.8354639262989761,1.0,6/42,5.13%,STXBP6;BAIAP2L1;ANXA1;ANXA2;TMOD3;PDLIM5
prerank,damaged DNA binding (GO:0003684),0.4204569957093552,1.1344452581256443,0.30099857346647646,0.8471094046279873,1.0,21/44,27.90%,CRY2;MPG;EP300;CREBBP;ERCC3;ERCC1;RPA1;XPA;RBBP8;XPC;NBN;TDG;UNG;APEX1;ERCC2;ERCC5;HMGB2;CUL4B;XRCC1;NTHL1;POLQ
prerank,phosphatidylcholine transporter activity (GO:0008525),0.5146271770091144,1.1331018395530743,0.32362459546925565,0.8463070934180552,1.0,5/17,8.32%,ATP10A;PITPNA;PITPNC1;ATP8B1;PITPNB
prerank,mannose binding (GO:0005537),0.5295999445055808,1.131655077433174,0.335042735042735,0.8455790150503473,1.0,2/12,9.31%,COLEC11;LMAN2L
prerank,N-methyltransferase activity (GO:0008170),0.4877839457998784,1.1297583606565296,0.3384853168469861,0.8460374830028217,1.0,6/20,20.97%,RNMT;GNMT;TRMT1L;ZCCHC4;NNMT;METTL18
prerank,actin binding (GO:0003779),0.3602719030625859,1.129380022426559,0.2721311475409836,0.8422251280385846,1.0,29/170,10.20%,MICAL2;PHACTR1;COBL;CALD1;SORBS1;EZR;PAWR;PARVA;FLNB;PDLIM7;ITGB1;FXYD5;GSN;GIPC1;MLPH;ABL1;DMD;NCALD;PDLIM5;SYNE2;TNNI3;VCL;MSRB2;SPEF1;RDX;DMTN;SSH3;CXCR4;MRTFA
prerank,phosphatidylinositol-4-phosphate binding (GO:0070273),-0.3987247395936131,-1.129139529253068,0.30144927536231886,0.6650497721354666,1.0,9/24,17.92%,OSBPL8;DAB2IP;LANCL2;CERT1;PLEKHA5;OSBP;JPH2;PLA2G4E;GSDMD
prerank,iron ion binding (GO:0005506),0.4170590789660559,1.1283000901939264,0.3215258855585831,0.8404148729939784,1.0,6/48,7.78%,AOX1;EGLN3;FTO;CDO1;FDX1;SCD
prerank,extracellular ligand-gated ion channel activity (GO:0005230),-0.4974856268773305,-1.1282765415590625,0.3271889400921659,0.6606713931210946,1.0,5/10,17.15%,GABRG3;GABRA1;GABRA2;GABRA4;GABRG1
prerank,calcium channel activity (GO:0005262),0.38542696187791986,1.127317171631236,0.2959697732997481,0.8386137853383492,1.0,20/84,15.73%,SLC24A3;PKD1;ANXA2;TMC1;CACNA1C;CACHD1;STIM2;PKD2L2;TRPM4;ITGAV;P2RX4;PKD2L1;CACNB2;PKD1L2;TRPC5;CACNG5;MCU;TRPM7;TRPC7;TRPM2
prerank,"phosphatidylinositol-4,5-bisphosphate binding (GO:0005546)",0.39994447455236715,1.1250924384566854,0.3083989501312336,0.8399949594574544,1.0,9/72,4.74%,KCNJ2;STXBP6;VILL;MARK1;ANXA2;SNX18;GSN;FZD7;PLEKHA4
prerank,flavin adenine dinucleotide binding (GO:0050660),0.4143627778946156,1.1250246414891123,0.3087431693989071,0.8354371776571378,1.0,3/53,2.73%,MICAL2;AOX1;CRY2
prerank,transmembrane receptor protein serine/threonine kinase activity (GO:0004675),-0.42596248191660396,-1.124980865570714,0.30077120822622105,0.6624541901733803,1.0,3/18,0.82%,LTBP1;ENG;TGFBR3
prerank,CARD domain binding (GO:0050700),0.5258001980403922,1.124155759350386,0.3527397260273973,0.8331280568969598,1.0,5/14,10.95%,CARD14;MAVS;RIPK2;BCL10;CARD19
prerank,protein phosphorylated amino acid binding (GO:0045309),0.42616286484648913,1.1184892849692964,0.3120665742024965,0.8446710290498796,1.0,8/42,8.42%,PTPN3;NEDD4;SHC1;ABL1;NCK2;IRS1;VAV2;BCAR3
prerank,protease binding (GO:0002020),0.378765840543713,1.1141975902856849,0.279322853688029,0.8518796932324352,1.0,14/99,8.66%,F3;FN1;SLC2A13;ITGB1;ANXA2;COL3A1;GSK3B;VCP;SERPINB9;CRADD;ITGAV;RIPK2;TIMP2;BCL10
prerank,calmodulin-dependent protein kinase activity (GO:0004683),0.45106661888350164,1.1139513678848605,0.3456,0.8478248258420277,1.0,4/24,4.99%,PTK2B;CAMK2D;MKNK2;PHKA2
prerank,calcium ion transmembrane transporter activity (GO:0015085),0.3988624457848532,1.1135704915135547,0.3107569721115538,0.844301954515272,1.0,14/55,15.73%,SLC24A3;PKD1;ATP2C2;ANXA2;PKD2L2;ITPR2;ATP2B4;PKD2L1;CACNB2;PKD1L2;TRPC5;MCU;TRPM7;TRPM2
prerank,galactosyltransferase activity (GO:0008378),0.5203746850728403,1.110872581356572,0.35231316725978645,0.847235324477012,1.0,5/11,14.73%,A4GALT;B3GNT6;B4GALT1;B4GALT7;B3GALT6
prerank,3'-5' exonuclease activity (GO:0008408),0.4165550404225247,1.1106198824014966,0.33936022253129344,0.8433539929483636,1.0,18/45,22.42%,REV3L;ERI3;CNOT7;APLF;ANGEL1;EXOSC7;DIS3L2;REXO2;EXD2;PNLDC1;WRN;EXOSC5;REXO4;MRE11;EXOSC4;TATDN1;APEX1;ANGEL2
prerank,aspartic-type endopeptidase activity (GO:0004190),0.524405024430515,1.1050681951027193,0.378839590443686,0.8544836708124103,1.0,5/12,24.23%,DDI2;SPPL2A;NAPSA;BACE2;SPPL3
prerank,serine-type endopeptidase activity (GO:0004252),0.3777753978779015,1.1028331415323762,0.30635118306351183,0.8563990183858382,1.0,2/80,1.12%,F3;PCSK5
prerank,ionotropic glutamate receptor binding (GO:0035255),-0.4710775509428451,-1.100770918087968,0.36423841059602646,0.7170092681472432,1.0,3/10,7.52%,SHANK3;GNAS;IGSF11
prerank,zinc ion transmembrane transporter activity (GO:0005385),-0.386808859833231,-1.0970214802403269,0.3209549071618037,0.719664802960322,1.0,7/20,14.69%,SLC30A10;SLC39A10;SLC39A8;SLC39A7;SLC30A4;SLC30A1;SLC39A3
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines (GO:0016813)",-0.4737270900376813,-1.0967892390905873,0.35,0.7135996114139608,1.0,9/11,50.82%,PADI2;DDAH2;ARG2;ARG1;PADI1;PADI4;AGMAT;PADI3;PADI6
prerank,fatty acid synthase activity (GO:0004312),-0.4731119847197577,-1.096396518899075,0.33860045146726864,0.7081168125506314,1.0,3/10,9.35%,ELOVL7;ELOVL6;ELOVL4
prerank,metal ion binding (GO:0046872),0.3304138187232802,1.0956109978205328,0.26883910386965376,0.8719491689458424,1.0,47/477,9.02%,CDH1;SLIT3;SLIT2;SMOC2;THBS1;ACER3;EYA2;MAP3K5;CDH11;ANXA3;ANXA1;MARK1;ESYT3;PPP3CA;DSPP;GLCE;ANXA2;ESYT2;COLEC11;OC90;TGM3;GSN;STIM2;DSG2;ANXA4;DXO;ABL1;SYT8;GCLC;ITPR2;SIK3;DSC3;DSC2;TRPM4;PLSCR1;SIK2;HACL1;PITPNM3;TRIM26;MARK2;DYRK2;IQGAP1;PKD2L1;CDC42BPG;DYRK3;PLA2G4F;CD320
prerank,nucleoside monophosphate kinase activity (GO:0050145),0.47618412623384004,1.0943877620667863,0.3640856672158155,0.8706625660163901,1.0,9/20,25.71%,MAGI3;DLG1;CASK;AK9;DLG2;CMPK1;AK3;AK6;DTYMK
prerank,GABA receptor activity (GO:0016917),0.4666993054068559,1.0934435236242024,0.36795252225519287,0.8689148601691915,1.0,1/21,0.33%,GPR156
prerank,lipase activator activity (GO:0060229),-0.47030697077663464,-1.093018451061196,0.3442982456140351,0.7103709067100068,1.0,7/10,37.57%,ARHGAP6;SRC;BTK;CCL5;APOH;LCK;CCL8
prerank,sulfotransferase activity (GO:0008146),0.43720302151216206,1.0920651279047553,0.37738619676945667,0.8683952814366086,1.0,5/33,4.37%,UST;HS3ST1;SULT1A1;CHST13;CHST5
prerank,peptidase activator activity involved in apoptotic process (GO:0016505),-0.42831648545531764,-1.0870436873790623,0.37272727272727274,0.7192642258288285,1.0,3/14,5.54%,CTSH;MAL;NOD1
prerank,"oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0016616)",0.37518142674770416,1.0846799600893198,0.36363636363636365,0.8848342560485482,1.0,4/75,2.45%,ME1;BDH2;EHHADH;ADH7
prerank,histone methyltransferase activity (GO:0042054),0.4362364069891704,1.0839722024006555,0.3684210526315789,0.8822839658377774,1.0,13/32,25.29%,SMYD2;SETD2;EHMT2;EHMT1;KMT2C;CARM1;PRMT6;SUZ12;PRMT2;PRMT8;EED;EZH2;KMT5A
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides (GO:0016811)",0.3914032893800011,1.0833650140660738,0.3588709677419355,0.8794467018957813,1.0,7/54,10.68%,ACER3;HDAC4;HDAC9;VNN1;HDAC10;PIGL;HDAC8
prerank,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential (GO:1904315),-0.35910588659892645,-1.08284597569117,0.32628398791540786,0.7240328828427627,1.0,12/28,25.25%,GRIK1;GABRG3;GRID2;GABRA1;GABRA2;GRIK2;CHRNA7;GABRA4;GABRG1;GRIK3;GRID1;GABRA5
prerank,frizzled binding (GO:0005109),0.4242103508772406,1.0798214305920804,0.3905775075987842,0.8847918955760292,1.0,6/34,4.04%,WNT9A;WNT11;LRP6;WNT16;BAMBI;FZD7
prerank,RNA polymerase core enzyme binding (GO:0043175),0.4287483967620988,1.0797927323701197,0.3593984962406015,0.8803372178353632,1.0,16/33,24.06%,SMYD2;ELOF1;SCAF8;CTR9;WDR43;PAF1;RRN3;ELP4;DHX9;ZNF326;UVSSA;URI1;NCOA3;RECQL5;ERCC5;WAC
prerank,clathrin adaptor activity (GO:0035615),0.4889984615339184,1.0766329031738595,0.36904761904761907,0.8845946431221063,1.0,3/15,7.36%,STON1;AP2A2;AP2A1
prerank,glutamate receptor binding (GO:0035254),-0.40187312974779577,-1.0763750620311425,0.35990338164251207,0.7339815192906515,1.0,5/17,11.10%,SHANK3;GNAS;IGSF11;CAMK2A;HIP1
prerank,inward rectifier potassium channel activity (GO:0005242),0.4503831406241238,1.0745873593485147,0.3559322033898305,0.8854877167692482,1.0,1/24,0.42%,KCNJ2
prerank,RNA polymerase II complex binding (GO:0000993),0.4317012967392355,1.073281720286294,0.38244047619047616,0.8847475946501878,1.0,16/32,24.06%,SMYD2;ELOF1;SCAF8;CTR9;WDR43;PAF1;ELP4;DHX9;ZNF326;UVSSA;URI1;NCOA3;RECQL5;PCIF1;ERCC5;WAC
prerank,basal RNA polymerase II transcription machinery binding (GO:0001099),0.42360774715871075,1.0708415756567,0.39280359820089955,0.8869835118808292,1.0,17/33,24.06%,SMYD2;ELOF1;SCAF8;CTR9;WDR43;PAF1;LLPH;ELP4;DHX9;AR;ZNF326;UVSSA;URI1;NCOA3;RECQL5;ERCC5;WAC
prerank,phospholipid transfer activity (GO:0120014),0.46430714978970555,1.070571602084296,0.39176829268292684,0.8833197973309127,1.0,3/21,2.60%,TNFAIP8L3;PITPNA;PITPNC1
prerank,phosphatidylinositol bisphosphate binding (GO:1902936),0.3646164966783762,1.0683983909537371,0.3728395061728395,0.8845224306585879,1.0,15/91,10.75%,KCNJ2;STXBP6;VILL;MARK1;ANXA2;SNX18;GSN;WIPI2;FZD7;PLEKHA4;RLBP1;SDCBP2;PLCD1;COMMD1;PARD3
prerank,NF-kappaB binding (GO:0051059),0.4484150673621776,1.0672782254814577,0.3847328244274809,0.8832278199060447,1.0,5/24,12.18%,ANXA4;GSK3B;EP300;BCL10;MTDH
prerank,calcium channel inhibitor activity (GO:0019855),-0.44753643059845105,-1.062609187522656,0.39955357142857145,0.7631256322850907,1.0,2/11,3.34%,ITPR1;CALM1
prerank,protein serine/threonine/tyrosine kinase activity (GO:0004712),-0.36032666973341126,-1.0598555384724022,0.3888888888888889,0.7630689509200093,1.0,8/28,15.27%,TNK2;MAP2K6;SGK1;LRRK2;PRKAA2;RPS6KA1;RPS6KB1;AKT1
prerank,receptor tyrosine kinase binding (GO:0030971),-0.2992459813971181,-1.0588647054908384,0.31451612903225806,0.7587836525689169,1.0,10/56,8.89%,DOCK4;PIK3R1;GRB14;NRG3;CBLB;SOCS5;ANGPT2;GAS6;FRS2;DUSP3
prerank,cGMP binding (GO:0030553),0.5111535902442064,1.0561583452652024,0.4250871080139373,0.9089265232009424,1.0,3/11,10.41%,PDE5A;PDE10A;CNGB3
prerank,guanyl-nucleotide exchange factor activity (GO:0005085),0.34069700030763944,1.0542378545110205,0.3977401129943503,0.9098969968275515,1.0,22/147,7.94%,DOCK5;PLCE1;ARHGEF28;CYTH3;AKAP13;RASGEF1B;RAP1A;DNMBP;BCR;RAPGEF6;ARHGEF6;RAB3GAP2;ARHGEF10;ARHGEF5;ANKRD27;HERC2;MYCBP2;DENND6A;DENND2C;VAV2;FGD6;SMCR8
prerank,alcohol dehydrogenase (NADP+) activity (GO:0008106),0.5135118156488574,1.0507379437107296,0.4265975820379965,0.9153477734862884,1.0,4/11,20.20%,ALDH3A1;AKR1B10;AKR1B1;RDH13
prerank,ligand-gated calcium channel activity (GO:0099604),-0.3863348490359107,-1.0481755509242596,0.3822784810126582,0.7803202933674709,1.0,6/19,14.09%,ITPR1;GRIN2A;GRIN2B;RYR2;GRIN1;RYR3
prerank,"catalytic activity, acting on a tRNA (GO:0140101)",0.4112921709887931,1.0480601834853445,0.39296187683284456,0.9181421652897982,1.0,17/35,30.35%,FTO;TRMT13;PUS10;DUS1L;QTRT2;QTRT1;TRDMT1;PTRH2;ELAC1;TRMT12;AARS1;DUS2;MTFMT;ELAC2;QRSL1;TRPT1;GATB
prerank,death receptor activity (GO:0005035),-0.4408641331072709,-1.0449239699862807,0.4123006833712984,0.7820424969668521,1.0,4/11,11.37%,TNFRSF19;FAS;TNFRSF1A;TNFRSF11A
prerank,protein phosphatase 2A binding (GO:0051721),-0.3642896436782622,-1.0444909210150777,0.38274932614555257,0.7765358472959154,1.0,14/23,28.48%,MFHAS1;FOXO1;DAB2IP;GRIN3A;SPHK1;MAPT;ENSA;ADCY8;IGBP1;BOD1;SMG7;CTTNBP2NL;SMG5;TP53
prerank,lysine N-methyltransferase activity (GO:0016278),0.44988938476452645,1.043428594749995,0.4173354735152488,0.926627043113194,1.0,7/20,20.93%,SMYD2;SETD2;METTL21C;EHMT2;EHMT1;EEF1AKMT1;METTL21A
prerank,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen (GO:0016709)",0.43574647160634383,1.0433344679824073,0.41013824884792627,0.922414439182153,1.0,2/25,3.70%,MICAL2;FMO1
prerank,"phosphotransferase activity, phosphate group as acceptor (GO:0016776)",0.43152005278744027,1.0414017780925515,0.41252006420545745,0.9233405716243984,1.0,10/24,25.71%,IP6K2;IP6K3;PPIP5K2;AK9;NME6;CMPK1;ITPKA;AK5;AK3;DTYMK
prerank,phospholipase activator activity (GO:0016004),-0.4477787710683828,-1.0413756850991935,0.4245689655172414,0.7780607904710215,1.0,6/10,37.57%,ARHGAP6;SRC;BTK;CCL5;LCK;CCL8
prerank,protein kinase binding (GO:0019901),0.31487164260656286,1.0404020630857236,0.3916581892166836,0.9215119881994572,1.0,101/479,17.48%,SLC12A7;SLC12A2;SOX9;GRK5;TCF7L2;PKD1;ANK2;FOXO3;EZR;CCNA2;DSP;UNC5C;ITGB1;SHC1;WNK1;CIT;HDAC9;PRKCD;CNTLN;ADAM9;GSK3B;RNF138;ABL1;CDC25B;PFKFB2;AP2A2;SPRED2;PDLIM5;ACSL3;DUSP16;NR4A3;DNAJC3;PRKCSH;BECN1;TNNI3;IRS1;PPEF2;ITGAV;DLG1;CAVIN2;HCLS1;PRAM1;MAVS;PTPN2;AP2A1;DUSP10;NELL1;SMCR8;IQGAP1;IRAK4;ADAM10;NSF;BCL10;TELO2;CHEK2;CDKN1B;TCF3;SKI;DUSP5;RHOBTB1;PAK2;CDC42;PPP1R12A;ACVR1;NISCH;SQSTM1;FAM83H;CSK;RHOA;STAT3;NEK9;PRKAR2A;KAT2B;RB1CC1;ZBTB4;FOXM1;TRAP1;MAPK8IP3;ILK;CDKN2D;UFL1;ATF7;RND3;EMP2;PRDX3;DOK7;PRKACA;DIRAS1;MAP3K12;LAX1;PAX6;DUSP22;CDK5RAP1;CCND3;FBXW5;FAF1;SPAG9;VRK2;ATF2;MAPKAPK2;ADIPOR1
prerank,ubiquitin-like protein ligase activity (GO:0061659),0.323653038491406,1.0398029279686147,0.4107929515418502,0.9187547397604937,1.0,42/232,14.70%,WWP1;TRAF3IP2;NEDD4;WWP2;BIRC7;RNF138;RNF115;EGR2;RNF19A;UBR4;RNF185;PIAS3;HERC2;MYCBP2;PIAS2;ARIH1;TRIM44;TRIP12;TRIM26;LRSAM1;RNF135;TRIM7;RNF2;UBE2D3;ASB1;MKRN1;UHRF2;TRIM25;ARIH2;CDC42;FBXO17;RNF10;KCMF1;UBR5;BIRC3;RNF111;BFAR;NSMCE2;SMURF1;PPIL2;TRIM41;UFL1
prerank,ion gated channel activity (GO:0022839),-0.35622366793607585,-1.0388336270833807,0.42058823529411765,0.7781874210004737,1.0,9/24,14.93%,KCNT2;ANO4;ANO3;TTYH2;TTYH3;TMEM63B;TTYH1;KCNT1;ANO2
prerank,ribosomal large subunit binding (GO:0043023),-0.4320787321700566,-1.0387139468246331,0.4337078651685393,0.771973134636209,1.0,2/11,6.00%,CPEB2;CPSF6
prerank,ATP binding (GO:0005524),-0.238519485370407,-1.0369789357185357,0.3191489361702128,0.7702693766842967,1.0,65/266,18.01%,ATP1A2;MYO1B;KSR1;PEAK1;RPS6KA5;PRKAG2;ENPP1;ABCA1;MAP3K20;AKT3;SNRK;HSPA8;DMPK;MAP4K3;ERN1;PRKACB;INSR;MYO18A;CDK6;ABCC6;MYH9;DAPK2;RHOBTB3;MAP4K4;ACLY;SYN1;WNK2;LANCL2;DAPK1;P2RY1;PNPLA8;MTHFS;CDKL5;PEX6;HSPA9;SPHK1;HSP90AB1;ABCB8;TAP2;MLKL;UHMK1;OAS2;STK17B;KCNJ8;ATP5F1D;BRSK2;BLM;PFKM;PDK2;AKT1;P2RX7;ATP5F1A;PNKP;MYH10;ACVR1B;STK3;PIM1;ATP7A;ABCG1;STK26;GUK1;TWF2;PRPS1;PRPS1L1;MYO1F
prerank,hormone receptor binding (GO:0051427),0.4757523643837356,1.0356906052700368,0.43434343434343436,0.92534375157993,1.0,4/14,19.62%,SOCS2;VIP;PTHLH;ADCYAP1
prerank,protein tyrosine phosphatase activity (GO:0004725),0.36484098639617146,1.0332547488843429,0.412303664921466,0.9274692942109456,1.0,12/71,9.90%,EYA2;PTPN3;PTP4A2;PTPRU;CDC25B;EYA4;EYA3;PTPN2;PTPN21;PTPRF;PTPRA;PTPDC1
prerank,MAP kinase phosphatase activity (GO:0033549),0.5002548814235415,1.0320667210118708,0.4584070796460177,0.9262632883971796,1.0,3/12,9.99%,DUSP16;DUSP10;DUSP5
prerank,muscle alpha-actinin binding (GO:0051371),0.46692743338161746,1.0267773236977242,0.43485617597292725,0.9362139613640612,1.0,3/15,8.41%,PDLIM7;PDLIM5;PKD2L1
prerank,protein tyrosine kinase activator activity (GO:0030296),0.45058308150010673,1.0267170295603387,0.4498432601880878,0.9319963166944515,1.0,2/19,1.90%,EFNA5;ABI1
prerank,alpha-actinin binding (GO:0051393),0.4288730135945831,1.0263015743978718,0.4281298299845441,0.928802424528416,1.0,5/24,8.41%,PDLIM7;CACNA1C;PDLIM5;MAGI1;PKD2L1
prerank,"phosphatidylinositol-3,4,5-trisphosphate binding (GO:0005547)",0.4088238595142559,1.0261737882769695,0.4211309523809524,0.9248886892699603,1.0,9/34,10.75%,CYTH3;ARAP1;ARAP2;ZFYVE1;GAB2;IQGAP1;DAPP1;COMMD1;PARD3
prerank,chemorepellent activity (GO:0045499),-0.3629325073240959,-1.0257728508209607,0.41935483870967744,0.7920086722182162,1.0,11/25,16.15%,SEMA6A;EPHA7;SEMA7A;NRG3;SEMA6D;SEMA5B;DPP4;SEMA3G;SEMA6B;SEMA4C;SEMA4A
prerank,NADP binding (GO:0050661),0.4038856200063277,1.02513058363862,0.445440956651719,0.9234780299540286,1.0,7/32,13.14%,ME1;GMDS;DECR1;LBR;NOX1;DUOX1;NNT
prerank,peptidoglycan binding (GO:0042834),-0.4494886810039362,-1.0249472137334021,0.4497716894977169,0.7876816460888788,1.0,3/10,16.11%,PGLYRP1;NOD1;HK1
prerank,acetyltransferase activity (GO:0016407),0.4109835096734022,1.0249114423851158,0.4386503067484663,0.9199310907646787,1.0,8/31,20.78%,KAT6B;EP300;CREBBP;KAT2B;PAFAH1B2;LCAT;SAT1;GNPNAT1
prerank,phosphatidylinositol 3-kinase regulator activity (GO:0035014),-0.38599338833414126,-1.0246556161351463,0.4358974358974359,0.7821864349124975,1.0,8/18,22.48%,PIK3R1;SOCS5;PIK3R6;WDR91;PIK3R5;SOCS7;CCKBR;SOCS1
prerank,Wnt-activated receptor activity (GO:0042813),0.47999113724668463,1.0212889086725967,0.44221105527638194,0.9250102615734612,1.0,8/15,19.38%,PKD1;FZD7;FZD2;LRP5;ROR1;FZD9;FZD3;RYK
prerank,mitogen-activated protein kinase binding (GO:0051019),0.416733100350703,1.0212084503397838,0.44894894894894893,0.9210342719149485,1.0,9/29,20.67%,ABL1;DUSP16;DUSP10;DUSP5;ATF7;DIRAS1;MAPKAPK2;TNIP1;NFATC1
prerank,amyloid-beta binding (GO:0001540),0.3562007728609348,1.0197384662904267,0.44776119402985076,0.9205838954778194,1.0,3/79,3.11%,COL25A1;LRPAP1;ADRB2
prerank,1-phosphatidylinositol-3-kinase regulator activity (GO:0046935),-0.40416728363767485,-1.0191537270175772,0.4250614250614251,0.7900911325392322,1.0,8/15,25.93%,PIK3R1;SOCS5;PIK3R6;PIK3R5;SOCS7;CCKBR;SOCS1;CISH
prerank,phosphate ion binding (GO:0042301),-0.4357675030225985,-1.01774327261371,0.43155452436194897,0.7874364952498817,1.0,6/10,38.90%,PDE2A;RPH3A;RELA;CHST14;ADSS1;PNP
prerank,ubiquitin protein ligase activity (GO:0061630),0.31700330769571194,1.016130836344997,0.4665203073545554,0.9260016714526363,1.0,39/228,14.61%,WWP1;TRAF3IP2;NEDD4;UBE4B;WWP2;BIRC7;RNF138;RNF115;RNF19A;UBR4;RNF185;HERC2;MYCBP2;ARIH1;TRIM44;TRIP12;TRIM26;LRSAM1;RNF135;TRIM7;RNF2;UBE2D3;ASB1;MKRN1;UHRF2;TRIM25;ARIH2;CDC42;FBXO17;RNF10;KCMF1;UBR5;BIRC3;RNF111;BFAR;SMURF1;UBE4A;PPIL2;TRIM41
prerank,BMP binding (GO:0036122),-0.4317660324128319,-1.0132367404967662,0.42788461538461536,0.7927424092872216,1.0,2/11,2.35%,ENG;GREM2
prerank,transcription coactivator binding (GO:0001223),-0.3681392507739598,-1.0122254201299952,0.4765625,0.7889092485583287,1.0,5/20,6.69%,AHR;TEAD2;PPARD;VGLL4;RPL23
prerank,ferrous iron binding (GO:0008198),0.4382163212524117,1.011685639322986,0.4446227929373997,0.9340371763651651,1.0,3/21,6.30%,EGLN3;FTO;CDO1
prerank,low-density lipoprotein particle binding (GO:0030169),0.44469778125892423,1.009527554844377,0.44481605351170567,0.935752189989544,1.0,1/16,0.45%,THBS1
prerank,chloride channel regulator activity (GO:0017081),0.46599465728070455,1.008801183741282,0.4664371772805508,0.9336239456310049,1.0,3/14,6.79%,WNK1;SGK3;STX8
prerank,magnesium ion binding (GO:0000287),0.3314689128761573,1.0074894834893666,0.46635730858468677,0.9329469453324508,1.0,23/135,15.26%,EYA2;MAP3K5;MARK1;DXO;ABL1;GCLC;SIK3;PLSCR1;SIK2;HACL1;MARK2;DYRK2;CDC42BPG;DYRK3;DIS3L2;FOXK2;NLK;SRPK1;EXD2;RAN;CLYBL;STK11;ERN2
prerank,transition metal ion binding (GO:0046914),0.3049207919060056,1.0062258132721311,0.473953013278856,0.9319588978196583,1.0,71/397,15.15%,ME1;AOX1;ACER3;TES;ZFPM2;HDAC4;MPPED2;HHIP;NPEPPS;ADH7;KLF4;LARGE1;SEC24B;EEA1;ABL1;KLF7;ZMYND8;ZNF8;PLSCR1;ZFYVE1;PHEX;MYCBP2;TAB3;CLIP1;MMP16;ARIH1;FDX1;MSRB2;P2RX4;IDE;TK1;HDAC10;CZIB;DYRK2;SCD;RNF2;TIMP2;MDM4;MNAT1;ERAP1;USP33;RBSN;MBD1;SKI;CAD;B4GALT1;CCS;LACTB2;COMMD1;ITGB1BP2;ARIH2;B4GALT7;XPNPEP1;TYW5;ADAM8;RXRA;APIP;RABIF;LARGE2;PITRM1;ABCE1;EXD2;ZMYM2;SCO2;ZDHHC15;THAP1;DUSP12;ZBTB32;FBXL19;NFU1;XPNPEP3
prerank,1-phosphatidylinositol binding (GO:0005545),-0.39272466406534856,-1.0046988863994883,0.4594594594594595,0.8016275885262417,1.0,3/15,6.18%,PICALM;EPB41;SCARB1
prerank,aminopeptidase activity (GO:0004177),0.41868834478021316,1.0032445658501112,0.4779299847792998,0.9356824873735026,1.0,10/26,19.65%,NPEPPS;MMP16;MMP14;ERAP1;LAP3;XPNPEP1;METAP1D;XPNPEP3;MMP17;METAP1
prerank,"phosphotransferase activity, alcohol group as acceptor (GO:0016773)",-0.2674455955847035,-1.002392586659723,0.47641509433962265,0.8011913167188267,1.0,24/74,23.70%,NADK2;DGKB;DGKI;GK;PGM2L1;DGKD;SPHK1;PANK1;PIK3C2A;IDNK;HK2;IPMK;PAPSS1;DGKG;DGKE;HK1;PKM;IPPK;PIK3CD;DCAKD;SPHK2;MVK;XYLB;PIK3CG
prerank,RNA methyltransferase activity (GO:0008173),0.4262688260967548,1.0022711386352599,0.4526143790849673,0.9341369107365738,1.0,7/19,23.16%,TRMT13;MRM2;METTL4;MEPCE;TRDMT1;TRMT12;FTSJ3
prerank,ephrin receptor binding (GO:0046875),-0.35091346327582906,-1.0016723839232757,0.44722222222222224,0.7968180656985305,1.0,7/21,13.11%,EFNB2;LYN;CHN1;SRC;GRB2;EFNB3;EFNB1
prerank,adrenergic receptor binding (GO:0031690),-0.3836479473264921,-1.0016267749107266,0.45979899497487436,0.7908933870234339,1.0,5/16,8.87%,RAPGEF2;GNAS;ADRA2A;PDE4D;APLP1
prerank,phosphotyrosine residue binding (GO:0001784),0.38916173874641513,1.0013325297589546,0.48725212464589235,0.9324786444725286,1.0,7/37,8.42%,PTPN3;SHC1;ABL1;NCK2;IRS1;VAV2;BCAR3
prerank,kinase binding (GO:0019900),0.3044973381697118,1.0012166086020524,0.48360655737704916,0.9288140685894383,1.0,88/434,17.48%,EGFR;SLC12A7;SLC12A2;TCF7L2;PKD1;ANK2;FOXO3;CCNA2;UNC5C;SHC1;WNK1;CIT;TAX1BP1;PRKCD;CNTLN;GSN;GSK3B;RNF138;CDC25B;PFKFB2;AP2A2;SPRED2;ACSL3;TTC28;NR4A3;DNAJC3;PIP5K1A;BECN1;TNNI3;TRIP6;DLG1;HCLS1;PRAM1;MAVS;PTPN2;AP2A1;SMCR8;IQGAP1;IRAK4;ADAM10;NSF;BCAR3;BCL10;TELO2;CHEK2;CDKN1B;SKI;RHOBTB1;PAK2;CDC42;PPP1R12A;RB1;NISCH;SQSTM1;FAM83H;RHOA;ATP1A4;STAT3;NEK9;TRADD;KAT2B;RB1CC1;ZBTB4;MOB1B;FOXM1;TRAP1;CAB39;DLG2;ILK;CDKN2D;UFL1;RND3;EMP2;PRDX3;DOK7;PRKACA;MAP3K12;LAX1;PAX6;CDK5RAP1;CCND3;FLNA;FBXW5;CARD16;FAF1;VRK2;ATF2;ADIPOR1
prerank,mRNA 3'-UTR AU-rich region binding (GO:0035925),-0.3568519476729047,-1.0001516014864886,0.4322916666666667,0.7888681508856449,1.0,4/22,9.92%,CPEB2;HNRNPA0;ELAVL4;EXOSC8
prerank,G protein-coupled receptor binding (GO:0001664),-0.24192838569499442,-0.9997527092986952,0.42105263157894735,0.7839283895584214,1.0,16/132,6.96%,WNT4;WNT5B;ZNRF3;WNT6;WNT5A;GNAS;HSPA8;GRK3;PTCH1;CXCL12;ACE;REEP1;S1PR1;ARRB1;SDCBP;GPRC5B
prerank,protein kinase C activity (GO:0004697),-0.3909107406028248,-0.9981863844812994,0.4795180722891566,0.7820503516287218,1.0,7/14,18.79%,PRKCH;PRKD1;PRKCQ;PRKD3;PKN1;PRKCZ;PRKCI
prerank,phospholipase activity (GO:0004620),0.34809929709983545,0.9971042317039425,0.45849297573435505,0.9350981890302488,1.0,8/67,8.79%,PLCE1;PNPLA3;DDHD1;MGLL;PLCB3;PITPNM3;ABHD6;PLA2G4F
prerank,protein tyrosine kinase binding (GO:1990782),-0.27226527281904284,-0.9956203802839859,0.4383561643835616,0.7828047225954786,1.0,12/71,8.89%,DOCK4;GRB14;NRG3;GRM5;CBLB;SOCS5;ANGPT2;NEDD9;EPHA4;SIRPA;GAS6;DUSP3
prerank,ubiquitin protein ligase binding (GO:0031625),0.3086956972055657,0.9919872842056066,0.49785867237687365,0.9442845159472794,1.0,56/254,17.17%,EGFR;SNCAIP;FHIT;USP13;TANK;SMAD6;MID1;GSK3B;EGR2;UBE2B;VCP;BECN1;HERC2;CLU;VCL;NPLOC4;ARIH1;USP2;JUN;FATE1;USP7;TNFRSF1B;CASC3;BCL10;CHEK2;MOAP1;CXCR4;SKI;WASHC1;RB1;TRIOBP;SQSTM1;USP25;IKBKE;GPI;NLK;TNFRSF14;CUL4A;FAF2;UBE2W;PRKAR2A;XRCC5;TRAF5;TSG101;RNF31;HSPA1L;AMBRA1;EIF4E2;SLC22A18;TCP1;PRKACA;PML;SPOP;UBE2N;FAF1;UBE2G1
prerank,guanyl ribonucleotide binding (GO:0032561),0.31446684075153036,0.9914405387855467,0.5022075055187638,0.941778386550032,1.0,40/196,16.32%,MPPED2;PDE5A;RHOJ;ATL3;MRAS;NRAS;KRAS;PDE10A;GNL1;RAP1A;BMS1;ARF4;RAB6A;ARF3;ARHGEF5;ARL3;RAP2C;ATL2;RAB18;RHOQ;RAB27B;RIT1;EIF2B2;CNGB3;RHOBTB1;CDC42;ARL8A;GTPBP4;RHOA;TUBB2B;LSG1;RAB42;RAN;RAB5A;RRAS2;RND3;RAB17;DIRAS1;RRAGB;GBP6
prerank,ubiquitin-like protein ligase binding (GO:0044389),0.30518480347521365,0.9859560820498355,0.5095137420718816,0.9518968890994463,1.0,57/269,17.17%,EGFR;SNCAIP;FHIT;USP13;TANK;SMAD6;MID1;GSK3B;EGR2;UBE2B;VCP;DDRGK1;BECN1;HERC2;CLU;VCL;NPLOC4;ARIH1;USP2;JUN;FATE1;USP7;TNFRSF1B;CASC3;BCL10;CHEK2;MOAP1;CXCR4;SKI;WASHC1;RB1;TRIOBP;SQSTM1;USP25;IKBKE;GPI;NLK;TNFRSF14;CUL4A;FAF2;UBE2W;PRKAR2A;XRCC5;TRAF5;TSG101;RNF31;HSPA1L;AMBRA1;EIF4E2;SLC22A18;TCP1;PRKACA;PML;SPOP;UBE2N;FAF1;UBE2G1
prerank,MAP kinase activity (GO:0004707),-0.3879770201304088,-0.9859271611341431,0.48586118251928023,0.8010020797882398,1.0,2/14,6.10%,MAPK4;MAPK3
prerank,excitatory extracellular ligand-gated ion channel activity (GO:0005231),0.4226786302938344,0.9856202237112562,0.4843260188087774,0.948812244346814,1.0,5/21,16.23%,P2RX2;GLRB;P2RX4;CHRNA4;CHRNB1
prerank,translation initiation factor activity (GO:0003743),0.3734633669335721,0.9855206743912033,0.484304932735426,0.9450616560544632,1.0,11/36,21.97%,EIF4G3;EIF4G1;EIF2D;EIF2B2;COPS5;EIF4E2;EIF2B3;EIF2S2;EIF4G2;EIF3A;EIF3E
prerank,death domain binding (GO:0070513),0.46985408522434946,0.9849557966251572,0.492091388400703,0.9425520528755096,1.0,3/11,12.87%,DAPL1;CRADD;TRADD
prerank,single-stranded RNA binding (GO:0003727),0.37388150125091696,0.981954113364778,0.49928469241773965,0.9465176805511274,1.0,7/43,15.78%,STRBP;L1TD1;ZFR;LACTB2;DDX11;JMJD6;DHX9
prerank,ubiquitin-protein transferase activity (GO:0004842),0.29911018938671224,0.981663047820718,0.5322245322245323,0.9433146258651839,1.0,76/346,18.88%,WWP1;TRAF3IP2;NEDD4;FBXO10;WWP2;BIRC7;RNF138;KLHL13;RNF115;UBE2B;RNF19A;UBR4;RNF185;FBXW8;BIRC6;HERC2;MYCBP2;FBXW11;ARIH1;TRIM44;TRIP12;TRIM26;RNF141;LRSAM1;RNF135;TRIM45;TRIM7;RNF2;UBE2D3;FBXO4;RNF168;ASB1;FBXL6;MKRN1;UHRF2;UBE2Z;TRIM25;ARIH2;RNF214;CDC42;TAF1;FBXO17;RNF10;KCMF1;UBR5;FBXW2;ERCC8;BIRC3;RNF111;CUL4A;UBE2W;BFAR;TRAF5;RNF31;SMURF1;PPIL2;TRIM41;FBXL14;RNF146;FBXO25;PML;UBE3D;UBE2S;UBE2N;COP1;RNF122;UBE2G1;RNF114;HUWE1;RNF144A;DTX3;TRIM47;RC3H2;PEX12;MEX3C;SEL1L2
prerank,heparan sulfate sulfotransferase activity (GO:0034483),0.4420326286160357,0.9809015751374384,0.48355263157894735,0.9412497571455772,1.0,3/15,4.66%,HS3ST4;HS3ST1;HS6ST2
prerank,anion transmembrane transporter activity (GO:0008509),-0.40514388059493134,-0.9784395543552852,0.4861111111111111,0.8130315149323017,1.0,3/12,5.63%,SLCO2B1;SLC22A6;SLC39A8
prerank,inhibitory extracellular ligand-gated ion channel activity (GO:0005237),-0.40709950374367226,-0.9775053839082728,0.46384039900249374,0.8093628124365871,1.0,7/13,18.47%,GABRG3;GABRA1;GABRA2;GLRA1;GABRA4;GABRG1;GLRA3
prerank,"acyltransferase activity, transferring groups other than amino-acyl groups (GO:0016747)",0.3403365691771664,0.9758007309538872,0.5132743362831859,0.9502372964806275,1.0,19/69,19.83%,SOAT1;MOGAT3;KAT6B;DGAT2L6;EP300;CREBBP;CERS6;CERS5;ZDHHC5;KAT2B;ZDHHC15;PLA2G4A;PLA2G15;CERS3;MCAT;ZDHHC7;NMT1;MOGAT1;LIPT1
prerank,transmembrane receptor protein kinase activity (GO:0019199),0.34972176429253,0.9722821850009654,0.518918918918919,0.9549955922528388,1.0,7/60,6.07%,EGFR;MET;NTRK3;FGFR1;DDR2;EPHB6;TGFBR2
prerank,metalloexopeptidase activity (GO:0008235),0.3601627194648661,0.9695490306415735,0.5048143053645117,0.9577604557063455,1.0,16/51,17.05%,NPEPPS;CPA5;CPQ;CPA4;CPA3;MMP16;MMP14;CPB1;ERAP1;LAP3;XPNPEP1;METAP1D;CPE;XPNPEP3;AGTPBP1;MMP17
prerank,voltage-gated calcium channel activity (GO:0005245),-0.30086432501124,-0.9691266210422654,0.4886731391585761,0.8239721990998226,1.0,10/37,14.71%,CACNA2D3;CACNA1D;CACNA1E;CACNG4;CACNG7;CACNA1B;CACNA2D1;CACNB4;CACNA1I;CACNB1
prerank,ATP hydrolysis activity (GO:0140603),-0.2959477576054696,-0.9686047014119782,0.4828767123287671,0.8195521305669626,1.0,8/41,9.97%,ABCA4;MYO18A;RHOBTB3;ATP2B1;KIF26A;RNF213;RUVBL1;SMCHD1
prerank,carboxy-lyase activity (GO:0016831),0.4067280836621341,0.9682164213635237,0.503125,0.957299023991523,1.0,8/23,22.46%,ECHDC1;MVD;ACOD1;CSAD;PPCDC;AZIN1;UMPS;PCK2
prerank,snoRNA binding (GO:0030515),0.39030168050162733,0.9672379967685111,0.5,0.9558616596667343,1.0,12/30,26.03%,BMS1;NUDT4;UTP6;WDR3;XRCC5;NUDT7;PRKDC;NOP58;NOP56;TSR1;DDX21;HEATR1
prerank,microtubule binding (GO:0008017),0.3063347303829445,0.9671255417467919,0.5756613756613757,0.9522819700479304,1.0,37/222,13.30%,RP1;MAPRE2;NDRG1;CLIP4;EZR;KIF13A;FMN1;MTUS1;MID1;GAS2L2;CAPN6;HDGFL3;NDEL1;DYNC1I1;MAP7D3;PAFAH1B1;CLIP1;KIF1B;ARL3;FBXW11;KIF1C;FGF13;SPEF1;CEP295NL;VAPA;RMDN1;KIF27;TUBGCP4;KIF2C;TOGARAM1;CEP44;TUBGCP5;KIF7;CEP57;KIF9;MAP1B;CCDC66
prerank,chloride channel inhibitor activity (GO:0019869),0.47892170808417345,0.9668248345787278,0.5,0.9490777072732193,1.0,2/10,6.79%,WNK1;STX8
prerank,lipase activity (GO:0016298),0.3625333100322572,0.9664428342284066,0.5041322314049587,0.9462082368521045,1.0,11/43,15.95%,PNPLA3;DDHD1;MGLL;DAGLB;PITPNM3;ABHD6;LDAH;ABHD5;ABHD15;LCAT;PLA2G15
prerank,lipoprotein particle binding (GO:0071813),0.40865327618749236,0.9638427785201343,0.4890282131661442,0.9485821019280622,1.0,1/20,0.45%,THBS1
prerank,nucleotide diphosphatase activity (GO:0004551),0.4442650784604127,0.9594108567461969,0.519327731092437,0.9553880202631139,1.0,2/14,4.90%,FHIT;NUDT4
prerank,glycerophospholipid flippase activity (GO:0140333),0.46550169354434245,0.9564056486723621,0.5212569316081331,0.9587746950847175,1.0,2/11,4.95%,ATP10A;ATP8B1
prerank,cysteine-type endopeptidase activity (GO:0004197),0.33792577687820974,0.9546922237015368,0.5329949238578681,0.9590037413224884,1.0,15/78,12.09%,CAPN5;USP13;USP46;CAPN2;CAPN6;USP24;USP2;USP49;CAPN10;USP7;USP10;USP33;USP34;USP25;USP47
prerank,phosphatidylglycerol binding (GO:1901611),0.45307522373521425,0.9545891397190962,0.5314569536423841,0.9555372255522776,1.0,2/13,2.60%,PITPNA;PITPNC1
prerank,monocarboxylic acid transmembrane transporter activity (GO:0008028),0.39571478571161045,0.9538886950461012,0.5353846153846153,0.9535686620095598,1.0,4/26,2.82%,SLC5A6;SLC16A9;SLC16A1;ABCG2
prerank,intracellular calcium activated chloride channel activity (GO:0005229),-0.36540789177732846,-0.9535705458037042,0.5303430079155673,0.8446779633676967,1.0,6/16,14.93%,ANO4;ANO3;TTYH2;TTYH3;TTYH1;ANO2
prerank,intracellular chloride channel activity (GO:0061778),-0.36540789177732846,-0.9535705458037042,0.5303430079155673,0.8446779633676967,1.0,6/16,14.93%,ANO4;ANO3;TTYH2;TTYH3;TTYH1;ANO2
prerank,ligand-gated cation channel activity (GO:0099094),0.32932291625408844,0.9518724654434346,0.5329113924050632,0.9546826655472904,1.0,7/75,8.29%,KCNJ2;PTK2B;P2RX2;TRPM4;GRIN2C;P2RX4;KCNJ15
prerank,sequence-specific mRNA binding (GO:1990825),0.4593952136210449,0.9501864314641831,0.518796992481203,0.9549667891525779,1.0,5/10,32.69%,ETF1;DHX9;FMR1;DHFR;SSB
prerank,3'-5'-exoribonuclease activity (GO:0000175),0.370608727333379,0.9481641030650304,0.532069970845481,0.9559776671905832,1.0,16/34,27.49%,ERI3;PAN3;CNOT7;ANGEL1;EXOSC7;DIS3L2;REXO2;EXD2;PNLDC1;EXOSC5;EXOSC4;ANGEL2;ERI2;TOE1;NOCT;PNPT1
prerank,C2H2 zinc finger domain binding (GO:0070742),-0.3955351575272842,-0.9474954841695277,0.535796766743649,0.8538254663290115,1.0,3/11,8.46%,LEF1;MBD2;GATA2
prerank,amino acid binding (GO:0016597),-0.30969908352955394,-0.9462231625960115,0.5362776025236593,0.8510655580784866,1.0,11/31,18.47%,NOS3;GRM7;GRIN2B;GRIN3A;GLRA1;ASS1;AGXT;GRIN1;NOS1;DDAH2;GLRA3
prerank,phosphatidylinositol binding (GO:0035091),0.32726002588781883,0.9461935310177053,0.547945205479452,0.9567181500764923,1.0,25/91,19.17%,TNFAIP8L3;ESYT3;PITPNA;PITPNC1;ESYT2;EEA1;SNX24;ITPR2;ZFYVE1;SNX31;PITPNB;PIGU;BCAS3;PHF12;PARD3;SNX4;SNX12;SNX17;SH3YL1;SNX2;PITPNM2;FCHO2;GRAMD2A;GPAA1;SNX13
prerank,solute:proton symporter activity (GO:0015295),0.43242379321066526,0.9461421108692166,0.5384615384615384,0.9531704431286683,1.0,1/16,1.17%,SLC2A13
prerank,CoA hydrolase activity (GO:0016289),0.4255876572644178,0.9460144239628476,0.5262267343485617,0.9498452036632075,1.0,7/16,25.37%,ACOT8;NUDT7;HIBCH;ACOT13;ACOT12;ACOT9;ACOT1
prerank,single-stranded DNA binding (GO:0003697),0.31950324385031537,0.945206762921132,0.5561035758323057,0.9480344066124936,1.0,31/93,24.03%,CRY2;RNF138;IGHMBP2;MCM7;SWSAP1;TOP3A;RAD52;BRCA2;ERCC1;STN1;RPA1;RAD51AP1;RTF1;DDX11;RAD23B;RBBP8;XPC;DHX9;TOP1;MCM9;POLA1;REXO4;POLR2H;LONP1;PMS2;SHOC1;MCM6;MCMDC2;FUBP1;ERCC5;HMGB2
prerank,Hsp70 protein binding (GO:0030544),-0.3119814576815425,-0.9443560660502248,0.5401234567901234,0.849927343976443,1.0,6/31,8.93%,ERN1;SNCA;SACS;GPR37;RPS3;DNAJC10
prerank,deoxyribonuclease activity (GO:0004536),0.42467225052718705,0.9431704856419139,0.5292096219931272,0.9490409588649241,1.0,6/14,23.94%,APLF;DFFB;MBD4;MRE11;APEX1;ERCC5
prerank,protein tyrosine kinase activity (GO:0004713),0.3127596179128092,0.9429135343540762,0.5676646706586826,0.9461022560591019,1.0,9/108,4.13%,EGFR;MET;NTRK3;PTK2B;FGFR1;DDR2;HIPK1;CLK1;ABL1
prerank,dipeptidyl-peptidase activity (GO:0008239),-0.42347863269791397,-0.9428935209597155,0.5597014925373134,0.8475862903988662,1.0,4/10,19.65%,DPP4;PRCP;DPP10;DPP6
prerank,ubiquitin-like protein conjugating enzyme activity (GO:0061650),0.36650771796067805,0.9411764445923428,0.5152838427947598,0.9462967323436847,1.0,10/34,17.17%,UBE2B;BIRC6;UBE2F;UBE2D3;UBE2Z;TAF1;UBE2W;UBE2S;UBE2N;UBE2G1
prerank,ubiquitin conjugating enzyme activity (GO:0061631),0.37432672474815126,0.9410262049282716,0.5208955223880597,0.9431494574764758,1.0,14/31,26.51%,UBE2B;BIRC6;UBE2D3;UBE2Z;TAF1;UBE2W;UBE2S;UBE2N;UBE2G1;UBE2Q2;UBE2L6;UBE2H;UBE2K;UBE2R2
prerank,aminoacyl-tRNA ligase activity (GO:0004812),0.36185702015978055,0.9408517615533761,0.5466847090663058,0.9400967871126422,1.0,6/37,13.56%,WARS2;EARS2;YARS1;CARS2;NARS2;FARSA
prerank,basic amino acid transmembrane transporter activity (GO:0015174),0.4389188788887043,0.9385032262546964,0.5089430894308943,0.9421035379323255,1.0,2/13,5.58%,SLC7A2;SLC38A7
prerank,zinc ion binding (GO:0008270),0.28884368854587017,0.9380152063497499,0.5895833333333333,0.939780327968854,1.0,50/293,14.58%,ACER3;TES;ZFPM2;HDAC4;HHIP;NPEPPS;ADH7;KLF4;SEC24B;EEA1;KLF7;ZMYND8;ZNF8;PLSCR1;ZFYVE1;PHEX;MYCBP2;TAB3;CLIP1;MMP16;ARIH1;MSRB2;P2RX4;IDE;TK1;HDAC10;CZIB;RNF2;TIMP2;MDM4;MNAT1;ERAP1;USP33;RBSN;MBD1;SKI;CAD;LACTB2;ITGB1BP2;ARIH2;ADAM8;RXRA;APIP;RABIF;PITRM1;ZMYM2;ZDHHC15;THAP1;DUSP12;ZBTB32
prerank,GTPase activity (GO:0003924),0.2986264480947624,0.9368395903100049,0.5806805708013172,0.9389530066637332,1.0,40/192,16.80%,ARHGDIB;RHOJ;ATL3;MRAS;NRAS;KRAS;GNL1;RAP1A;BMS1;RAB43;RAB6A;RAP2C;ATL2;RAB18;RHOQ;RAB27B;GNA13;RIT1;GFM2;SAR1B;RHOBTB1;CDC42;GNG8;GNB3;ARL8A;GTPBP4;RHOA;LSG1;RAB42;RAN;RAB5A;RRAS2;RND3;RAB17;DIRAS1;NKIRAS2;RRAGB;GBP6;GSPT1;RAB22A
prerank,methylated histone binding (GO:0035064),0.33673113991059206,0.9359806818829987,0.5498687664041995,0.9375187572637189,1.0,25/62,28.83%,TDRD3;SGF29;ZMYND8;BPTF;MBTD1;TAF1;CBX2;MORC3;GLYR1;SUZ12;LRWD1;ATRX;CBX5;SPIN4;MPHOSPH8;FMR1;ING3;JMJD7;ING1;WDR5;PHF19;KDM5A;NCAPD3;PYGO1;CHD5
prerank,neurexin family protein binding (GO:0042043),0.4541593910802334,0.932255836279788,0.5372881355932203,0.9425005130213777,1.0,4/10,18.22%,SYTL5;SYTL4;CPE;SYTL3
prerank,m7G(5')pppN diphosphatase activity (GO:0050072),0.45103136789642134,0.9317414103458169,0.5171171171171172,0.94023531260092,1.0,2/11,13.69%,NUDT4;NUDT7
prerank,"steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0033764)",-0.342799592908807,-0.931516036320452,0.5495978552278821,0.8694122530977324,1.0,15/18,50.66%,HSD17B7;HSD11B1;HSD17B10;HSD17B14;HSD17B1;SRD5A2;HSD3B2;HSD17B8;AKR1C1;DHRS9;RDH16;DHRS11;HSD17B6;HSD17B3;RDH5
prerank,methylation-dependent protein binding (GO:0140034),0.3389444069006013,0.9293441078854073,0.5640686922060766,0.9421942839317787,1.0,23/57,28.27%,TDRD3;SGF29;ZMYND8;BPTF;MBTD1;CBX2;MORC3;GLYR1;SUZ12;LRWD1;ATRX;CBX5;SPIN4;MPHOSPH8;FMR1;ING3;JMJD7;ING1;WDR5;PHF19;KDM5A;NCAPD3;PYGO1
prerank,aspartic-type peptidase activity (GO:0070001),0.45760704128758456,0.928036090995696,0.5407801418439716,0.9417989891469881,1.0,3/10,19.93%,DDI2;NAPSA;BACE2
prerank,DNA polymerase activity (GO:0034061),0.4001967142588079,0.9279650001390144,0.5644171779141104,0.9385091328182097,1.0,9/22,27.90%,REV3L;REV1;POLD3;POLB;POLA1;CHRAC1;TERT;POLK;POLQ
prerank,protein kinase inhibitor activity (GO:0004860),0.35696892004121566,0.9222168996859519,0.5697674418604651,0.9473907478885939,1.0,6/42,8.98%,PARVA;CIT;SPRED2;DNAJC3;SMCR8;CDKN1B
prerank,2-oxoglutarate-dependent dioxygenase activity (GO:0016706),0.36326208643957436,0.9207351955653167,0.5757142857142857,0.9470243342556145,1.0,9/32,19.50%,EGLN3;FTO;RIOX2;TYW5;JMJD4;KDM2A;TMLHE;RIOX1;ALKBH5
prerank,N-acetyltransferase activity (GO:0008080),0.39772538781953254,0.9203998664885574,0.5553772070626003,0.9442640286054265,1.0,5/19,20.78%,ATAT1;EP300;KAT2B;SAT1;GNPNAT1
prerank,nucleobase-containing compound kinase activity (GO:0019205),0.40835164835164817,0.9157357241216834,0.5485519591141397,0.9508036176396797,1.0,17/17,59.21%,AK9;NME6;CMPK1;AK5;AK3;DTYMK;AK4;AK8;NOL9;CLP1;CMPK2;NME4;AK1;NME1;NME2;NME3;AK7
prerank,Hsp90 protein binding (GO:0051879),0.35764256641384073,0.9120736580430511,0.5832083958020989,0.9551739068523344,1.0,7/33,13.00%,SLC12A2;PPEF2;UNC45A;TELO2;HDAC8;CSNK2A1;PPP5C
prerank,ADP binding (GO:0043531),0.3752981314681565,0.9087775677444478,0.5671875,0.9586330992738251,1.0,2/25,4.47%,ME1;GCLC
prerank,AMP binding (GO:0016208),0.4431972742888178,0.9086673850744293,0.5698729582577132,0.9554710960659192,1.0,2/11,7.17%,MPPED2;PFKP
prerank,telomeric DNA binding (GO:0042162),0.3646513552700225,0.9085257723361876,0.5870503597122302,0.9524017018670989,1.0,10/32,19.49%,SMG6;KDM1A;SMG1;TELO2;STN1;RPA1;XRCC5;WRN;ACD;UPF3A
prerank,alanine transmembrane transporter activity (GO:0022858),-0.38022205675595316,-0.9074920284694209,0.5827338129496403,0.9210209673432064,1.0,5/12,23.33%,SLC38A5;SLC6A6;SLC3A2;SLC7A8;SLC36A2
prerank,histone demethylase activity (H3-K9 specific) (GO:0032454),0.43323883811470104,0.9073739633866194,0.5837837837837838,0.9517633223918451,1.0,4/12,12.60%,JMJD1C;KDM1A;KDM4D;KDM3B
prerank,DNA-directed DNA polymerase activity (GO:0003887),0.39349307960875846,0.9062836456206115,0.5879629629629629,0.9506953293881815,1.0,5/21,17.81%,REV3L;REV1;POLD3;POLB;POLA1
prerank,"phosphatidylinositol-3,4-bisphosphate binding (GO:0043325)",-0.30952733649494124,-0.9061114555348094,0.6022408963585434,0.9182724579888505,1.0,9/25,19.41%,ADAP2;ARAP3;PLEKHA2;PLEK;HIP1;HIP1R;AKT1;PLA2G4E;PHLDA3
prerank,"oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor (GO:0016646)",-0.3600920065370859,-0.9059036058639618,0.5724137931034483,0.9127385919841586,1.0,5/14,20.27%,BLVRB;QDPR;ALDH1L1;ALDH4A1;PYCR2
prerank,low-density lipoprotein particle receptor binding (GO:0050750),-0.3172370794803854,-0.905859950087219,0.6067415730337079,0.9067919978813118,1.0,3/22,1.90%,APOE;HSPG2;PICALM
prerank,hydro-lyase activity (GO:0016836),0.34801565054622685,0.9042461540958525,0.5918958031837916,0.9517311744467908,1.0,6/41,8.51%,GMDS;EHHADH;AUH;ECHDC1;TGDS;CYP2S1
prerank,non-membrane spanning protein tyrosine kinase activity (GO:0004715),-0.2849465466404541,-0.904209496551871,0.6292517006802721,0.904672749314236,1.0,12/35,19.46%,LYN;PEAK1;TNK2;PTK2;TEC;SRC;BMX;ABL2;FES;SYK;HCK;TXK
prerank,protein heterodimerization activity (GO:0046982),0.28692810923047385,0.9038973168391093,0.6419068736141907,0.9492141147832138,1.0,31/178,14.65%,KCNB2;EXT1;ATP1B1;ADRA1B;AGTR1;ITGB1;BMP6;KCNB1;MEF2A;DDIT3;NR4A2;PDGFA;HEXA;PAFAH1B1;CHUK;TLR6;BHLHE40;CREB3L3;SDCBP2;TCF3;VAPA;MICU1;TAF1;TLR4;ATP1A1;SMC1A;ADD1;TUBB2B;PAFAH1B2;RAN;FXR2
prerank,nucleoside diphosphate kinase activity (GO:0004550),0.4082747363134104,0.9037790798910831,0.5472636815920398,0.9462120323894055,1.0,14/14,59.21%,AK9;NME6;CMPK1;AK5;DTYMK;AK4;AK8;CMPK2;NME4;AK1;NME1;NME2;NME3;AK7
prerank,poly(U) RNA binding (GO:0008266),-0.3296219974646985,-0.9000810569786944,0.5988538681948424,0.908152945131494,1.0,2/20,1.39%,RBMS1;ATXN1
prerank,semaphorin receptor binding (GO:0030215),0.3863793984924179,0.9000700843239963,0.5983870967741935,0.9507291823470593,1.0,3/23,2.85%,SEMA3D;SEMA3C;SEMA3E
prerank,growth factor receptor binding (GO:0070851),0.30654495820732963,0.8983490456864199,0.6227106227106227,0.951028235528155,1.0,18/95,13.07%,PDGFC;SHC1;PGF;EFEMP1;IL10;ITGA5;ARF4;PDGFA;PLSCR1;TRIP6;FGF22;FGF2;ERAP1;AGR2;KLB;SNX4;PIBF1;ITGB3
prerank,myosin V binding (GO:0031489),0.3977992362557956,0.8982778201925256,0.5465313028764806,0.947958034755741,1.0,2/15,9.35%,RAB6A;RAB27B
prerank,heme binding (GO:0020037),-0.2534768541910276,-0.8981389952780837,0.6622807017543859,0.9066109376568089,1.0,9/65,9.23%,FLVCR2;NOS3;CYP26B1;CYP27A1;GUCY1B1;CYB5A;BACH1;SRC;CAT
prerank,four-way junction DNA binding (GO:0000400),0.38955417563384204,0.895177397164316,0.6018957345971564,0.9509778038605031,1.0,7/17,24.03%,ABL1;RAD51C;FANCM;WRN;YY1;XRCC2;HMGB2
prerank,carboxylic acid binding (GO:0031406),-0.27872712810555456,-0.8951269525690042,0.6348122866894198,0.908015564035133,1.0,19/38,28.22%,NOS3;GRM7;GRIN2B;GRIN3A;GLRA1;PSAP;MAG;GRIN1;NOS1;GLRA3;UBR1;SHMT2;RTN4R;GLUD1;GLDC;PHYH;SHMT1;HIF1AN;SESN1
prerank,nuclease activity (GO:0004518),0.3244900456272158,0.8925494425618542,0.6086369770580297,0.9531870300182089,1.0,27/52,30.03%,N4BP2;PLSCR1;STK31;RNASE6;DFFB;DIS3L2;DDX1;ERN2;WRN;REXO4;RNASE7;MRE11;REXO1;N4BP1;RNASEH1;RNASEH2A;APEX1;ERCC5;EXO1;NTHL1;ZC3H12A;RNASE12;ANG;DNASE1L1;PARN;DNA2;EXOG
prerank,protein homodimerization activity (GO:0042803),0.2682365776813375,0.8923775665681591,0.7903225806451613,0.9502933164199976,1.0,82/589,13.89%,FOXP2;SLIT2;AOX1;MAP3K5;ABCD3;EXT1;PDGFC;ZBTB16;NECTIN3;CAMK2D;GRHL1;FGFR1;GLCE;MYOM3;ABCG2;LRP6;ADRB2;MID1;ZBTB7B;PON3;NFS1;EEA1;MGLL;BMPR1A;DDIT3;PDCD6IP;RABEP1;PDGFA;NAGA;GDNF;CPQ;NR4A3;HNF4A;CEP131;RAB11FIP3;CHUK;RIPK2;IDE;NR6A1;CARNMT1;MVD;JUP;BHLHE40;HES1;CREB3L3;SDCBP2;SPPL2A;ADAM10;MKLN1;PRPS2;SRGAP2;MMACHC;ACP3;GALE;FBXO4;CHEK2;TCF3;KYAT1;HPS4;COMMD1;NOG;XPNPEP1;ACVR1;GLB1;NPR3;TGFB2;TYW5;XPA;PNPO;CEP57;STAT3;BNIP3;INHBB;ST3GAL2;ZBTB4;S100A10;CCDC66;ADD1;EXD2;TSG101;CEBPB;TPD52
prerank,acetylcholine receptor activity (GO:0015464),0.38582611626523416,0.8923702373948083,0.6022187004754358,0.9471213272459228,1.0,5/22,16.23%,CHRM5;CHRNG;CHRNE;CHRNA4;CHRNB1
prerank,steroid hydroxylase activity (GO:0008395),-0.3424395358131552,-0.891482365057577,0.6066838046272494,0.9107373214425104,1.0,2/16,2.17%,CYP7B1;CYP27A1
prerank,UDP-galactosyltransferase activity (GO:0035250),0.4272237487465957,0.8908986166009168,0.5650557620817844,0.9469510501133953,1.0,7/10,32.32%,B4GALT1;B4GALT7;B3GALT6;A3GALT2;B3GALT1;B4GALT6;B3GALT5
prerank,"phosphatidylinositol-3,5-bisphosphate binding (GO:0080025)",-0.3050428601032655,-0.8906457901709658,0.617816091954023,0.9069349972074399,1.0,11/23,22.94%,CLVS2;WIPI1;PLEKHA5;CLVS1;HIP1;JPH2;HIP1R;PLA2G4E;PHLDA3;SH3PXD2B;SNX14
prerank,cytokine receptor binding (GO:0005126),-0.23815453833457179,-0.8890525400383337,0.75,0.9048205543485887,1.0,9/83,6.86%,IL34;TGFBR3;OSMR;IL13RA1;CXCL12;CSF1;IL6ST;IL6R;SDCBP
prerank,pre-mRNA binding (GO:0036002),0.36027485707888757,0.8887196071840147,0.5951293759512938,0.9482201429681157,1.0,5/28,13.98%,DDX5;CELF1;U2AF1L4;SRSF6;HNRNPL
prerank,lipoprotein particle receptor binding (GO:0070325),-0.29306076313110263,-0.8872567058952171,0.6461538461538462,0.9032368584454872,1.0,3/27,1.90%,APOE;HSPG2;PICALM
prerank,PDZ domain binding (GO:0030165),0.317358789752436,0.8854723772547497,0.6336898395721925,0.9515472582960135,1.0,11/61,10.66%,CRIM1;CXADR;CIT;FZD7;ERC1;ATP2B4;KIDINS220;NSF;FZD2;SLC26A6;TBC1D10A
prerank,RNA polymerase II core promoter sequence-specific DNA binding (GO:0000979),-0.3714301658985044,-0.8853420526728716,0.6118721461187214,0.9015322597778392,1.0,6/12,32.43%,TBPL1;RUVBL2;RELA;STAT1;GTF2A1;TBP
prerank,GTP binding (GO:0005525),0.28226749579341176,0.8852219383701684,0.6759465478841871,0.948900493814501,1.0,35/172,16.80%,RHOJ;ATL3;MRAS;NRAS;KRAS;GNL1;RAP1A;BMS1;ARF4;RAB6A;ARF3;ARHGEF5;ARL3;RAP2C;ATL2;RHOQ;RAB27B;RIT1;EIF2B2;RHOBTB1;CDC42;ARL8A;GTPBP4;RHOA;TUBB2B;LSG1;RAB42;RAN;RAB5A;RRAS2;RND3;DIRAS1;RRAGB;GBP6;RAB22A
prerank,kinase inhibitor activity (GO:0019210),0.3527374534941828,0.8840769031529401,0.6023738872403561,0.9481010996596774,1.0,5/33,8.98%,PARVA;LRP6;DNAJC3;SMCR8;CDKN1B
prerank,platelet-derived growth factor binding (GO:0048407),0.42685904233565375,0.8819500378794971,0.6102003642987249,0.9492966525239003,1.0,3/11,5.02%,COL6A1;COL3A1;PDGFA
prerank,thioesterase binding (GO:0031996),-0.37297303541971205,-0.8783758898376165,0.6255813953488372,0.9107763205891396,1.0,5/11,23.41%,ADRA2A;RAC1;TRAF2;ARF6;TRAF4
prerank,nucleoside-triphosphatase activity (GO:0017111),0.27394348700756704,0.8779924836763288,0.7147435897435898,0.9543151780319198,1.0,48/248,16.33%,ARHGDIB;RHOJ;ATL3;MRAS;NRAS;KRAS;GNL1;RAP1A;BMS1;RAB43;DYNC1I1;VCP;RAB6A;CLU;TDRD9;RAP2C;ATL2;RAB18;KIF1C;KLC1;RHOQ;SWSAP1;RAB27B;GNA13;RIT1;GFM2;SAR1B;RHOBTB1;CDC42;GNG8;GNB3;ARL8A;GTPBP4;RHOA;CHD1L;LSG1;RAB42;RAN;RAB5A;RRAS2;RND3;RAB17;DIRAS1;DHX9;NKIRAS2;RRAGB;GBP6;GSPT1
prerank,"intramolecular oxidoreductase activity, transposing C=C bonds (GO:0016863)",0.4054077525001972,0.8772927536039856,0.6196943972835314,0.9526065351034148,1.0,2/13,11.47%,EHHADH;EBP
prerank,histone demethylase activity (GO:0032452),0.35736073939575685,0.8766795386141336,0.6038034865293186,0.950718566417018,1.0,10/27,18.95%,JMJD1C;RIOX2;KDM1A;KDM4D;KDM3B;FBXL19;JMJD6;KDM6B;KDM2A;RIOX1
prerank,serine-type endopeptidase inhibitor activity (GO:0004867),0.3387933704536899,0.8763943643238921,0.6195190947666195,0.9482013336708243,1.0,5/38,6.41%,ANXA2;SLPI;SERPINB9;SERPINB7;SERPINE2
prerank,DNA replication origin binding (GO:0003688),0.36541745404611276,0.8734554886457336,0.6047619047619047,0.9507572486743074,1.0,10/23,27.65%,MCM7;DDX11;ORC5;DHX9;MCM9;POLA1;MCM6;MCMDC2;ORC2;MCM2
prerank,histone demethylase activity (H3-K36 specific) (GO:0051864),-0.3860726631282098,-0.8733791681339921,0.6412037037037037,0.9159527181660745,1.0,2/10,4.79%,KDM7A;KDM2B
prerank,kinase activity (GO:0016301),0.28741596821186094,0.8729885744228894,0.681924882629108,0.9485878315770386,1.0,16/109,11.62%,STK39;IP6K2;GSK3B;ABL1;PAPSS2;TRRAP;SHPK;RFK;ETNK1;IP6K3;PPIP5K2;MTOR;PKN2;TAF1;CSNK2A1;DGKA
prerank,protein serine/threonine kinase activator activity (GO:0043539),-0.27495303986893743,-0.8722827445277685,0.6535947712418301,0.9125277109459075,1.0,11/34,20.52%,CALM1;RICTOR;IGF2;CALM3;ETAA1;ALS2;INCENP;STK3;PARP16;CCNK;CDK5R1
prerank,poly-pyrimidine tract binding (GO:0008187),-0.31020914792526905,-0.8709103765541365,0.6346749226006192,0.9098062041546804,1.0,2/23,1.39%,RBMS1;ATXN1
prerank,phosphatidylinositol phosphate binding (GO:1901981),0.29824655167451397,0.8706410070375753,0.6719706242350061,0.950062852950589,1.0,17/100,10.75%,CYTH3;ARAP1;ARAP2;WIPI2;SNX24;PLEKHA4;GOLPH3;ZFYVE1;RLBP1;GAB2;IQGAP1;ARFIP1;OSBPL5;DAPP1;ZFYVE26;COMMD1;PARD3
prerank,phosphoric diester hydrolase activity (GO:0008081),0.3411958480634161,0.8685063736821266,0.6334310850439883,0.9514928767717432,1.0,4/35,5.19%,PLCE1;MPPED2;PLCB3;APEX2
prerank,TBP-class protein binding (GO:0017025),-0.3121410528591286,-0.8671655728609684,0.6323907455012854,0.9121739885857045,1.0,7/21,22.02%,AHR;RUVBL1;DRAP1;RUVBL2;HHEX;PSMC5;THRA
prerank,G protein-coupled chemoattractant receptor activity (GO:0001637),-0.3379521239554058,-0.8667594318832915,0.6291866028708134,0.9074425274135893,1.0,3/15,19.33%,CCR9;CX3CR1;CCR5
prerank,pyrophosphate hydrolysis-driven proton transmembrane transporter activity (GO:0009678),0.36862047200792275,0.8666663838789793,0.621875,0.9522084091834959,1.0,5/22,14.09%,ATP2C2;ATP6V0A4;ATP6V0A1;ATP6V0E1;ATP6V0D1
prerank,vascular endothelial growth factor receptor binding (GO:0005172),0.41409337054407325,0.866583555016387,0.6109154929577465,0.9493621094521146,1.0,2/12,4.00%,PGF;ITGA5
prerank,gamma-tubulin binding (GO:0043015),0.37102125541796377,0.8651692574040462,0.6046875,0.9489597425759282,1.0,4/21,12.19%,NDRG1;BRCA2;TUBGCP4;TUBGCP5
prerank,LRR domain binding (GO:0030275),0.40068904020754326,0.8648145397014018,0.6241610738255033,0.9465468955240733,1.0,7/14,17.73%,PAWR;DDIT3;ERC1;MRTFA;ZXDC;AATF;LRRFIP2
prerank,phosphatidylinositol phosphate kinase activity (GO:0016307),-0.3446448562859905,-0.8618588443583458,0.6180904522613065,0.9122972748717217,1.0,7/13,29.09%,PIP5K1B;PIK3C2A;PIK3CD;PIK3CG;PIK3CB;PIP4K2B;PIK3C2G
prerank,RNA binding (GO:0003723),0.25714286312512413,0.860818860912555,0.94,0.9508784752843049,1.0,332/1321,22.45%,MSI2;STRBP;RNMT;SLTM;TES;SAMD4A;SPATS2L;MBNL1;FNDC3A;DDX5;EIF4G3;EZR;AHNAK;RBM47;RBFOX2;DSP;FLNB;GPATCH8;RPSA;CTNNA1;ANXA2;GOLGB1;ZCCHC24;LARP1B;PURG;EIF4G1;HOXB6;YBX3;BMS1;DUSP14;DIAPH1;DXO;RBM6;POLR1G;CAST;L1TD1;CEBPZ;TDRD3;IGHMBP2;HDLBP;ZBED4;VCP;NUDT4;TCF20;SLPI;SYNCRIP;PRRC2C;RPP38;ERI3;LUC7L2;NUFIP2;FAM120C;LARP4B;MBNL2;MOV10;SMG6;BCLAF1;TDRD9;SREK1;PNISR;TRIP6;MRPL32;MRPL14;SON;PABPC4;R3HDM2;CCDC9;HNRNPH1;UTP6;ZCCHC8;CELF1;DDX19B;JUN;PDAP1;MRPL21;RBM34;KIF1C;MARK2;YARS1;DDX42;RBM28;KDM1A;ZC3H12D;FUS;SMG1;KTN1;NOL11;ANKHD1;FDPS;EIF2AK4;ZFR;ALG13;CASC3;SRRM2;USP10;TCERG1;PCBP4;SCAF8;NIP7;WDR3;RDX;NOC3L;DHX57;MRPS31;SNTB2;LBR;PUS10;SEC63;EXOSC7;MKRN1;PRPF3;SERBP1;PPIG;SRSF5;BRIX1;SRSF6;CS;LACTB2;ZC3H7A;CSNK1E;TRIM25;RPF1;PKN2;RBM25;SF3B2;SF3B1;ANXA11;WDR43;NXF1;SRSF12;ELP5;SRRM1;RBMX;EBNA1BP2;NANOS2;ETF1;BZW1;GTPBP4;DDX55;RBM26;TYW5;IMMT;FNDC3B;RAD51AP1;THOC2;PRPF38B;ERH;MTDH;PRPF40B;STAT3;SCAF4;RBM8A;RTF1;BAZ2A;RBMS3;PLEC;SMC1A;SRPK1;LSM2;RBM39;XRCC5;ADD1;SRSF11;CPNE3;EWSR1;DUSP11;KMT2C;FARSA;DDX11;NUDT7;DDX17;NCOA5;TRMT1L;ZC3H14;LSM14B;C1D;LRP1;TRAP1;SNRPD3;HNRNPL;MRPS28;MRPS35;PNLDC1;SECISBP2L;PUM2;DDX1;RAN;FXR2;THOC5;SNRNP70;PUM1;TAF15;WDR75;MATR3;EIF4E2;NOSIP;MTO1;UTP11;MRPL20;AATF;SEPSECS;LLPH;RBM27;ARCN1;DROSHA;TCP1;SNW1;JMJD6;DHX9;MRM1;PRRC2A;MEX3B;GSPT1;PRR3;PRKDC;SCAF11;TOP1;FLNA;MCAT;RCAN3;PDCD11;UBE2N;DNAJC21;DALRD3;ARHGEF1;GPKOW;ZNF346;ZC3H4;EDC3;FAM50A;MRPS27;MYEF2;HUWE1;YTHDF3;TRMT10B;MTIF2;YY1;MRPS30;NELFE;NOP58;TRA2B;TNRC6A;NOL3;EIF2S2;USO1;SRRT;ZFP36L1;REXO4;PWP2;ATXN2;PINX1;MRPS23;YTHDF2;NYNRIN;RC3H2;ZC3H11A;FASTKD1;RBM4B;PTPN1;MEX3C;DDX43;LONP1;CPSF7;PABPC1;CWC22;PHF5A;CHTOP;HMGN2;ZNF326;GRSF1;ALKBH5;ZC3H15;SUGP2;LRPPRC;CHD2;EIF4G2;DDX47;RAE1;DHX32;LUC7L;FAM32A;UTP4;PPIL4;SYNE1;NOP2;ZCCHC7;MRPL9;RTCA;KCTD12;PUM3;PRPF6;HNRNPM;MEPCE;TRUB2;HTATSF1;DDX56;NVL;N4BP1;DDX52;SUMO1;DCAF13;NUP98;ZCRB1;EIF3A;UTP14A;PSIP1;MRPS24;PHF6;EIF4ENIF1;NCBP3;NUDT21;HNRNPUL1;ALKBH8;HNRNPA3;RBM5;ZC3H18;CPSF4;RNASEH1;RRBP1;PUS7;EIF3E;CSDE1;RPN1;SNRPD2;SNRPD1;DDX18;SAFB2;RBM33;DCP1A;APEX1;FMR1;SRPRA
prerank,cysteine-type endopeptidase activator activity involved in apoptotic process (GO:0008656),-0.34780380534236544,-0.8597420228246068,0.6391304347826087,0.9114873338770542,1.0,2/12,5.54%,CTSH;NOD1
prerank,platelet-derived growth factor receptor binding (GO:0005161),0.40281770031520847,0.857158049913076,0.6236933797909407,0.9549387106586128,1.0,3/13,5.02%,PDGFC;ITGA5;PDGFA
prerank,chemokine binding (GO:0019956),0.3465364343400045,0.856184519383714,0.640117994100295,0.9538349808084673,1.0,9/30,22.76%,ITGB1;ITGAV;FGF2;CXCR4;ITGB3;PDPN;CCR1;CXCR6;PLP2
prerank,tubulin binding (GO:0015631),0.2656621396172489,0.8551881787999799,0.780564263322884,0.9527255479135209,1.0,44/295,12.46%,RP1;MAPRE2;NDRG1;EZR;KIF13A;UNC5C;TBCE;FMN1;MTUS1;MID1;GAS2L2;CAPN6;HDGFL3;NDEL1;DYNC1I1;NCALD;MAP7D3;PAFAH1B1;CLIP1;KIF1B;ARL3;TTLL2;KIF1C;FGF13;SPEF1;CEP295NL;VAPA;BRCA2;BCAS3;RMDN1;KIF27;TUBGCP4;WASHC1;KIF2C;ARL8A;BEX4;TOGARAM1;SETD2;CEP44;TTLL6;TUBGCP5;KIF7;CEP57;KIF9
prerank,phosphatidylinositol 3-kinase activity (GO:0035004),-0.35503170380700294,-0.8534551992037122,0.65311004784689,0.919045405508153,1.0,7/12,29.09%,PIK3R6;PIK3C2A;IPMK;PIK3CD;PIK3CG;PIK3CB;PIK3C2G
prerank,general transcription initiation factor binding (GO:0140296),-0.2930018144592194,-0.853032858880263,0.6908077994428969,0.9144419837989413,1.0,8/25,22.02%,AHR;RUVBL1;DRAP1;RUVBL2;HHEX;RELA;PSMC5;THRA
prerank,cytokine receptor activity (GO:0004896),0.2900153926173519,0.8527214837068605,0.6847414880201765,0.954239084656888,1.0,4/83,2.21%,F3;IL17RE;CD44;IL22RA1
prerank,dynactin binding (GO:0034452),0.4141256032237218,0.8521129597196838,0.6174377224199288,0.9524997409997901,1.0,2/12,5.93%,GSK3B;PAFAH1B1
prerank,histone methyltransferase activity (H3-K4 specific) (GO:0042800),0.38792764297476473,0.8504811689440934,0.6481178396072013,0.9525657876834549,1.0,8/15,29.95%,KMT2C;KMT2D;ASH2L;SETD1B;KMT2A;WDR5;SETD4;SETD1A
prerank,high voltage-gated calcium channel activity (GO:0008331),-0.37116582220762206,-0.8491638961364552,0.6650717703349283,0.9167116611244288,1.0,4/10,14.71%,CACNA1D;CACNA1B;CACNB4;CACNB1
prerank,DNA-(apurinic or apyrimidinic site) endonuclease activity (GO:0003906),0.40742920628986845,0.8475404709161469,0.616871704745167,0.9552481527708679,1.0,2/11,8.42%,APEX2;APLF
prerank,exonuclease activity (GO:0004527),0.31645248392182995,0.8447387707862285,0.6708333333333333,0.9574208132948128,1.0,15/46,22.37%,REV3L;DXO;APEX2;CNOT7;APLF;EXOSC7;REXO2;EXD2;WRN;EXOSC5;REXO4;MRE11;REXO1;EXOSC4;APEX1
prerank,cysteine-type peptidase activity (GO:0008234),0.29729833188125193,0.8427682051398531,0.6878109452736318,0.9581483831415277,1.0,14/73,12.09%,USP13;USP46;CAPN2;USP24;USP2;OTUD7B;USP49;USP7;USP10;USP33;USP34;USP25;USP21;USP47
prerank,nucleosomal DNA binding (GO:0031492),-0.2966849824887201,-0.8400240477616906,0.7142857142857143,0.9292447754672222,1.0,6/21,20.27%,MBD2;ACTB;RCC1;HDAC2;SMARCE1;H1-0
prerank,cysteine-type endopeptidase inhibitor activity (GO:0004869),0.33662056814934727,0.8390647595606043,0.6686390532544378,0.9617879270247792,1.0,9/30,17.90%,BIRC7;CAST;BIRC6;SERPINB9;UBE2Z;BIRC3;PRDX3;CARD16;NOL3
prerank,"exoribonuclease activity, producing 5'-phosphomonoesters (GO:0016896)",0.32946081350027173,0.8382271035479495,0.671071953010279,0.9603678095231607,1.0,15/33,27.49%,ERI3;CNOT7;ANGEL1;EXOSC7;DIS3L2;REXO2;EXD2;PNLDC1;EXOSC5;EXOSC4;ANGEL2;ERI2;TOE1;NOCT;PNPT1
prerank,actin monomer binding (GO:0003785),-0.29160541118885003,-0.8380667560502847,0.6965317919075145,0.9278064842688232,1.0,6/22,13.76%,MTSS1;NOS3;TMSB4X;TMSB10;ABL2;PFN1
prerank,phosphatidic acid binding (GO:0070300),0.3653813111576803,0.8368356008515468,0.6507936507936508,0.9600869998479062,1.0,3/19,3.85%,MARK1;PITPNC1;RAPGEF6
prerank,tumor necrosis factor receptor binding (GO:0005164),0.3874237290468909,0.8365644407761451,0.6598639455782312,0.9577336324200714,1.0,3/12,13.94%,TNFSF11;TRAF5;TRAP1
prerank,phosphatase activity (GO:0016791),0.29482334094402496,0.8362137008034418,0.7120622568093385,0.9554279868304726,1.0,14/73,14.82%,PLPPR2;PLPP3;DUSP16;NANP;OCRL;DUSP10;ACP3;DUSP5;PLPP1;PPP5C;LPIN2;DUSP11;DUSP12;ARMT1
prerank,MHC class II protein complex binding (GO:0023026),0.40327738942660235,0.8329010329386515,0.6514886164623468,0.9583194873742203,1.0,1/11,1.47%,ATP1B1
prerank,endopeptidase inhibitor activity (GO:0004866),0.28596375297545823,0.8305322661321201,0.7367088607594937,0.9597132459898781,1.0,12/82,11.05%,NGF;ANXA2;BIRC7;CAST;BIRC6;SLPI;SERPINB9;SERPINB7;SERPINE2;TIMP2;UBE2Z;SERPING1
prerank,neuropeptide receptor activity (GO:0008188),-0.2723705389994049,-0.8294132547350095,0.7071651090342679,0.9395031835247377,1.0,15/29,40.72%,GPR37;SORCS2;NPY1R;NMUR2;GRPR;KISS1R;SORCS1;NPY5R;GPR143;NPY2R;SSTR1;NMUR1;NTSR1;NPFFR1;GAL
prerank,double-stranded RNA binding (GO:0003725),0.2915437942723679,0.8280055314685527,0.7197452229299363,0.9613582315952188,1.0,2/70,0.90%,STRBP;MBNL1
prerank,P-type ion transporter activity (GO:0015662),0.39738749689951347,0.8277375200375982,0.6585365853658537,0.9590121200996786,1.0,2/12,7.46%,ATP2C2;ATP2B4
prerank,pentosyltransferase activity (GO:0016763),-0.2563578808669206,-0.8271754412737955,0.7629179331306991,0.9382354115980618,1.0,7/36,9.82%,PARP14;ART3;PARP8;PARP11;PARP1;TIPARP;LACC1
prerank,N-acyltransferase activity (GO:0016410),-0.26043640714217525,-0.825283042792219,0.7579617834394905,0.936653954098218,1.0,7/32,18.60%,CERS4;TGM2;NMT2;CERS1;PLA2G4E;CERS2;SMARCE1
prerank,endodeoxyribonuclease activity (GO:0004520),0.35416865698105204,0.8251717508734698,0.6858054226475279,0.9608054176013127,1.0,10/20,30.03%,APLF;ERCC1;MBD4;RBBP8;MRE11;APEX1;ERCC5;EXO1;DNA2;EXOG
prerank,quaternary ammonium group transmembrane transporter activity (GO:0015651),-0.34707644125827375,-0.8251065713343382,0.7049891540130152,0.9317235494254364,1.0,3/11,24.70%,SLC22A4;SLC22A5;SLC22A3
prerank,signal sequence binding (GO:0005048),-0.2616065340513234,-0.8231978848571159,0.745928338762215,0.9299982350751259,1.0,5/35,14.03%,CEMIP;PEX5L;CAT;IPO5;KPNA2
prerank,hexosaminidase activity (GO:0015929),0.391184229663351,0.8181900696645952,0.6828859060402684,0.970075596418553,1.0,4/12,10.89%,NAGA;HEXA;SPAM1;HYAL3
prerank,MAP-kinase scaffold activity (GO:0005078),-0.35258242101624193,-0.8161434571749234,0.7029478458049887,0.9380832096728298,1.0,2/11,1.64%,KSR1;SH3RF1
prerank,protein-lysine N-methyltransferase activity (GO:0016279),0.3211343322117458,0.8143130250775277,0.7112375533428165,0.9739670354534299,1.0,10/34,25.29%,SMYD2;SETD2;METTL21C;EHMT2;EHMT1;EEF1AKMT1;CAMKMT;METTL21A;EZH2;KMT5A
prerank,adenyl-nucleotide exchange factor activity (GO:0000774),-0.3493772232121063,-0.8138432677289769,0.705607476635514,0.9320135102182749,1.0,4/11,29.48%,PFN1;GRPEL1;HSPBP1;HSPH1
prerank,adenyl nucleotide binding (GO:0030554),-0.3493772232121063,-0.8138432677289769,0.705607476635514,0.9320135102182749,1.0,4/11,29.48%,PFN1;GRPEL1;HSPBP1;HSPH1
prerank,voltage-gated chloride channel activity (GO:0005247),0.39886902458628215,0.8113002512373224,0.6756756756756757,0.9762951025537899,1.0,1/10,2.81%,ANO6
prerank,glycine binding (GO:0016594),-0.3467333830378108,-0.8111348466187872,0.7136150234741784,0.9315933480965143,1.0,5/11,18.47%,GRIN2B;GRIN3A;GLRA1;GRIN1;GLRA3
prerank,DNA secondary structure binding (GO:0000217),0.3234754072860441,0.8100438924227928,0.7090103397341211,0.9756147998646615,1.0,13/31,24.03%,ABL1;RAD51C;RAD51AP1;FANCM;RBBP8;XPC;WRN;YY1;CLSPN;KMT2A;XRCC2;ERCC5;HMGB2
prerank,phospholipase binding (GO:0043274),-0.32767117667748985,-0.8095629519216199,0.7125307125307125,0.9295840488910909,1.0,4/13,16.35%,ARHGAP6;SRC;BLNK;SYK
prerank,carboxypeptidase activity (GO:0004180),0.31078568319068145,0.8088391356296062,0.7124463519313304,0.9748586663122825,1.0,6/35,7.58%,CPA5;CPVL;CPA4;CPA3;SCPEP1;CPB1
prerank,transferrin receptor binding (GO:1990459),0.3882354762659165,0.8076170425645505,0.6822916666666666,0.9741187453363401,1.0,4/10,20.05%,CHUK;SNX4;SNX2;HFE
prerank,channel activity (GO:0015267),0.3080729788812257,0.8069600596351819,0.7063037249283668,0.9725131675768649,1.0,4/41,8.55%,TMEM120A;AQP6;CHRNG;MCUB
prerank,histone deacetylase binding (GO:0042826),0.27148255752883715,0.8059801884569827,0.773067331670823,0.9713740900585054,1.0,17/88,19.09%,HDAC4;GLI3;HDAC9;MEF2A;CAMTA2;HDAC10;KAT2A;HES1;PKN2;BEX4;KAT2B;LCOR;MAPK8;BRMS1L;IKZF3;MIER2;RBBP4
prerank,adenyl ribonucleotide binding (GO:0032559),0.2466603747742824,0.8059496473468897,0.8450261780104712,0.9686081878979164,1.0,31/291,8.75%,ME1;MAP3K5;ABCD3;MARK1;MPPED2;WNK1;PDE10A;MKNK2;EIF4G1;SMC4;P2RX2;ABL1;BMPR1A;GCLC;IGHMBP2;SIK3;TLK1;TGFBR1;N4BP2;SIK2;HACL1;P2RX4;PFKP;IDE;MARK2;DYRK2;PPIP5K2;CARS2;PRPS2;CDC42BPG;DYRK3
prerank,protein kinase regulator activity (GO:0019887),0.27374353114303834,0.8032777016994785,0.7539975399753998,0.970167500446375,1.0,21/95,17.92%,PARVA;CCNA2;WNT11;WNK1;DNAJC3;FGF13;KIDINS220;MARK2;SMCR8;CCNL2;CDKN1B;PRKAR2A;CAB39;STK11;ELP4;CCND3;TAOK3;FAF1;GMFG;GPRC5A;CCNYL1
prerank,5'-3' RNA polymerase activity (GO:0034062),0.3267080934005852,0.800906914520772,0.7272727272727273,0.9714098731473835,1.0,9/27,26.41%,POLR1A;CRCP;POLR1H;POLR3B;POLR1F;TERT;POLR3K;POLR1D;POLR1C
prerank,ATPase activator activity (GO:0001671),0.3529731446204119,0.798597834454798,0.7244094488188977,0.972552406142374,1.0,4/20,12.29%,ATP1B1;TOR1AIP1;DNAJB6;DNAJC19
prerank,nucleoside-diphosphatase activity (GO:0017110),-0.33226551876855737,-0.7964667134840321,0.7303102625298329,0.9468356279757302,1.0,2/12,7.42%,ENTPD1;ENTPD5
prerank,nuclear receptor coactivator activity (GO:0030374),-0.22889580673947119,-0.7959700654915225,0.8549618320610687,0.9425175260925358,1.0,11/52,17.39%,TACC1;NCOA1;PPARGC1B;ETS1;PPARGC1A;WDR77;ELK1;RBM14;CNOT9;MED30;PKN1
prerank,mannosyltransferase activity (GO:0000030),0.34474781083954287,0.7945395515460375,0.7149837133550488,0.9762880984274238,1.0,1/21,0.65%,TMTC1
prerank,thyroid hormone receptor binding (GO:0046966),0.3242553321978583,0.7938196818383508,0.7125193199381762,0.9746277853907184,1.0,7/28,16.53%,JMJD1C;TRIP6;TRIP12;ZNHIT3;BRD8;PRMT2;MED17
prerank,purine ribonucleoside triphosphate binding (GO:0035639),0.2381305037453956,0.789644153585663,0.9080694586312564,0.9787871992487472,1.0,76/431,16.56%,MAP3K5;ABCD3;MARK1;RHOJ;ATL3;MRAS;NRAS;KRAS;WNK1;MKNK2;EIF4G1;GNL1;SMC4;RAP1A;P2RX2;BMS1;ABL1;BMPR1A;ARF4;IGHMBP2;SIK3;RAB6A;ARF3;TLK1;TGFBR1;ARHGEF5;N4BP2;SIK2;HACL1;ARL3;RAP2C;ATL2;P2RX4;PFKP;IDE;MARK2;DYRK2;PPIP5K2;CARS2;PRPS2;RHOQ;CDC42BPG;DYRK3;RAB27B;RIT1;CAD;EIF2B2;RHOBTB1;CDC42;ACVR1;ARL8A;GTPBP4;RHOA;ATP1A3;ATP1A1;NLK;PPP5C;SRPK1;ABCE1;TUBB2B;LSG1;RAB42;HSPA1L;RAN;RAB5A;STK11;RRAS2;RND3;ERN2;DIRAS1;WNK3;DHX9;RRAGB;GBP6;MAP4K1;TOP1
prerank,methyl-CpG binding (GO:0008327),-0.2737465998476176,-0.7886604645053111,0.7871720116618076,0.9496645885329188,1.0,7/22,19.73%,MBD2;CXXC4;CXXC5;WDR77;ZBTB33;PRMT1;TET3
prerank,tRNA (guanine) methyltransferase activity (GO:0016423),0.3771115272660018,0.7882535526827092,0.7305699481865285,0.9782604782187465,1.0,3/13,17.66%,METTL1;TRMT1L;TRMT10B
prerank,transmembrane receptor protein tyrosine kinase adaptor activity (GO:0005068),0.39040532204948863,0.7871266379760254,0.7133105802047781,0.9773512041953375,1.0,4/12,12.87%,SHC1;IRS1;GAB2;TRADD
prerank,ribosome binding (GO:0043022),0.29636248315152053,0.7865872778972421,0.75,0.9755300872569729,1.0,17/46,30.77%,RPSA;IGHMBP2;SERBP1;ETF1;MRPS27;YTHDF3;NCLN;EIF6;FMR1;SEC61A2;CCDC47;YTHDF1;ZC3H12A;SEC61A1;NAA15;EIF3C;MTIF3
prerank,bHLH transcription factor binding (GO:0043425),0.34610935294739964,0.7856820532213422,0.7136075949367089,0.9741309927628369,1.0,5/19,9.43%,ISL1;KDM1A;CREBBP;BHLHE40;TCF3
prerank,cyclin-dependent protein serine/threonine kinase inhibitor activity (GO:0004861),0.38086122999808636,0.7853262613100995,0.6920415224913494,0.972011994623029,1.0,5/10,25.02%,CDKN1B;KAT2B;CDKN2D;HEXIM2;CDKN1A
prerank,kinase activator activity (GO:0019209),0.3163221046924671,0.7847344445942543,0.7511591962905718,0.9702465514576885,1.0,8/30,14.93%,WNT11;WNK1;FGF13;MARK2;BCL10;MOB1B;CAB39;STK11
prerank,single-stranded telomeric DNA binding (GO:0043047),0.3805413240459202,0.7799884115763096,0.7245080500894454,0.9754322768994602,1.0,2/11,11.37%,STN1;RPA1
prerank,epidermal growth factor receptor binding (GO:0005154),0.3227922173422072,0.777604510915672,0.7581395348837209,0.9764275057913147,1.0,9/25,18.48%,SHC1;EFEMP1;ARF4;PLSCR1;AGR2;SNX4;SNX2;AREG;ATXN2
prerank,lysophospholipase activity (GO:0004622),-0.2734039891037997,-0.7759217183559491,0.7837837837837838,0.9653040250320636,1.0,3/20,9.89%,ENPP2;ABHD12;ASPG
prerank,mRNA binding (GO:0003729),0.24173252673743495,0.7751078597718132,0.893048128342246,0.9777140375836817,1.0,72/249,23.54%,SAMD4A;DDX5;EIF4G3;RBM47;RBFOX2;EIF4G1;YBX3;DXO;HDLBP;SLPI;SYNCRIP;LUC7L2;AUH;LARP4B;PABPC4;CELF1;ZC3H12D;SRRM2;PCBP4;SCAF8;SERBP1;SRSF5;SRSF6;RBM25;SF3B1;RBMX;NANOS2;ETF1;THOC2;RBM8A;RBMS3;LSM14B;HNRNPL;SECISBP2L;PUM2;FXR2;THOC5;SNRNP70;PUM1;DHX9;EDC3;MYEF2;YTHDF3;TRA2B;EIF2S2;ZFP36L1;YTHDF2;NYNRIN;RC3H2;ZC3H11A;RBM4B;PABPC1;GRSF1;EIF4G2;LUC7L;PUM3;HNRNPM;N4BP1;NUP98;EIF3A;EIF4ENIF1;NCBP3;NUDT21;RBM5;DCP1A;FMR1;ANGEL2;LARP1;FUBP1;AQR;FYTTD1;MRPS7
prerank,titin binding (GO:0031432),0.36548631069374865,0.7748436343939954,0.7254237288135593,0.975391059568936,1.0,1/13,2.02%,CAMK2D
prerank,syntaxin binding (GO:0019905),-0.2174036409484149,-0.7698012648611212,0.9259259259259259,0.9696256017394229,1.0,23/61,27.34%,UNC13C;ABCA1;SYT12;DAPK1;SYT9;LRRK2;CPLX1;SYP;STXBP4;SCFD1;BLOC1S6;SNAP25;STX7;UNC13A;TMED10;SYT1;BAIAP3;SYT5;STXBP3;VAMP3;SNAP29;SYT17;SYT2
prerank,signaling receptor complex adaptor activity (GO:0030159),0.29629780096117675,0.7665935357236033,0.7787234042553192,0.9855096125826293,1.0,5/38,7.52%,SORBS1;SHC1;NCK2;IRS1;GAB2
prerank,pseudouridine synthase activity (GO:0009982),0.3633639584763586,0.7660355697574567,0.7529610829103215,0.9836945093990943,1.0,7/13,30.30%,RPUSD1;PUS10;TRUB2;PUS7;RPUSD3;RPUSD4;PUS3
prerank,Lys63-specific deubiquitinase activity (GO:0061578),-0.3286935242922189,-0.764543635819195,0.7760180995475113,0.9727881782267249,1.0,3/10,15.94%,STAMBPL1;ATXN3;TNFAIP3
prerank,phospholipase A2 activity (GO:0004623),0.3103042424669802,0.7645038572465215,0.7514970059880239,0.9835095536996542,1.0,4/26,15.95%,PNPLA3;PLA2G4F;PLA2G4A;PLA2G15
prerank,ubiquitin-like protein conjugating enzyme binding (GO:0044390),0.300833416675917,0.7631263290859809,0.7701674277016742,0.9829085583468431,1.0,9/33,18.00%,RNF19A;RNF185;ARIH1;DCUN1D4;TCERG1;ARIH2;ZMYM2;UBE3D;RNF144A
prerank,"phosphotransferase activity, for other substituted phosphate groups (GO:0016780)",0.3688597487010361,0.7625804314466393,0.7178217821782178,0.9811374749224869,1.0,2/11,9.82%,SGMS2;PIGN
prerank,protein serine/threonine phosphatase activity (GO:0004722),0.2767851233124489,0.7620274093957335,0.8092715231788079,0.9793540680615522,1.0,6/60,6.30%,PPP3CA;PPTC7;PPP1R3C;PPM1H;PHLPP2;PPEF2
prerank,exoribonuclease activity (GO:0004532),0.3523491903430407,0.7597526750289004,0.7341337907375644,0.9802102019139072,1.0,6/12,27.35%,CNOT7;EXOSC7;EXOSC5;EXOSC4;EXOSC1;ZC3H12A
prerank,polynucleotide adenylyltransferase activity (GO:0004652),-0.3114084665586735,-0.7594211786651035,0.7543424317617866,0.9748975426893838,1.0,5/12,28.50%,TENT5A;TENT4B;PAPOLG;PAPOLB;PAPOLA
prerank,"proton-transporting ATPase activity, rotational mechanism (GO:0046961)",0.3426111372362564,0.7587635683228284,0.7177280550774526,0.9763939603602346,1.0,4/16,14.09%,ATP6V0A4;ATP6V0A1;ATP6V0E1;ATP6V0D1
prerank,"ATPase activity, coupled to transmembrane movement of ions, rotational mechanism (GO:0044769)",0.3426111372362564,0.7587635683228284,0.7177280550774526,0.9763939603602346,1.0,4/16,14.09%,ATP6V0A4;ATP6V0A1;ATP6V0E1;ATP6V0D1
prerank,peptide N-acetyltransferase activity (GO:0034212),0.36793873964348495,0.7583765463480237,0.7413793103448276,0.9742784526954777,1.0,10/10,63.23%,NAA50;NAA15;NAA16;NAA20;NAA10;NAA80;NAA60;NAA25;NAA11;NAA30
prerank,transcription coregulator binding (GO:0001221),0.278768268777977,0.7570033445335321,0.8108843537414966,0.9737921702868568,1.0,13/50,17.97%,ZBTB16;CIT;PER2;ZBTB49;WIZ;EHMT2;EHMT1;LCOR;PER3;SUZ12;RORA;ZBTB7A;AR
prerank,vitamin D receptor binding (GO:0042809),0.353015218743712,0.7563612949036375,0.7538461538461538,0.9721814678152556,1.0,4/14,16.53%,MED14;RXRA;SNW1;MED17
prerank,"endodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016888)",-0.30709856518728695,-0.7469294762174477,0.8112745098039216,0.9880501698780203,1.0,1/13,5.01%,FAN1
prerank,cAMP response element binding (GO:0035497),0.37093464689872296,0.746866771959355,0.7559322033898305,0.9836767029127071,1.0,4/10,17.41%,NR4A3;JUN;ATF7;ATF2
prerank,ribosomal small subunit binding (GO:0043024),-0.27899581895214026,-0.7460000751828294,0.7989690721649485,0.984205391846336,1.0,4/17,16.86%,CPEB2;EIF4H;EIF1B;PIM1
prerank,adenylyltransferase activity (GO:0070566),0.324416159751058,0.7447563543763971,0.7774244833068362,0.9841262797741139,1.0,2/21,4.13%,NMNAT2;ABL1
prerank,carboxylic ester hydrolase activity (GO:0052689),0.2553778795226071,0.7445287143409256,0.8721071863580999,0.9818842821983285,1.0,15/85,15.95%,PNPLA3;PON3;MGLL;DAGLB;ABHD6;PLA2G4F;GDPD3;ABHD4;APMAP;ABHD5;ABHD15;PAFAH1B2;LCAT;PLA2G4A;PLA2G15
prerank,retinoic acid receptor binding (GO:0042974),0.33615638286332916,0.744131476636482,0.7674418604651163,0.9797825318469197,1.0,5/17,15.93%,NR4A2;RARG;NRIP1;SNW1;PRMT2
prerank,"DNA binding, bending (GO:0008301)",0.33833272137798986,0.7436117910599482,0.7631578947368421,0.977881255582419,1.0,1/14,1.50%,FOXD1
prerank,U6 snRNA binding (GO:0017070),-0.28823039147250373,-0.7411961058989595,0.8088235294117647,0.9860001031299954,1.0,4/14,25.34%,METTL16;PRPF8;LARP7;SART3
prerank,peptide hormone receptor binding (GO:0051428),0.3517516545710323,0.7409549380946681,0.75,0.9790675363036628,1.0,3/11,19.62%,VIP;PTHLH;ADCYAP1
prerank,DNA-directed 5'-3' RNA polymerase activity (GO:0003899),0.3025143938919708,0.7394365444830715,0.8023255813953488,0.9785709298164457,1.0,5/27,15.20%,POLR1A;CRCP;POLR1H;POLR3B;POLR1F
prerank,hyaluronic acid binding (GO:0005540),0.358869595865387,0.7354021431435489,0.7478559176672385,0.981551067910508,1.0,1/10,1.61%,CD44
prerank,intracellular cyclic nucleotide activated cation channel activity (GO:0005221),-0.3104853064710069,-0.7351336129055266,0.7962962962962963,0.9890077087467899,1.0,1/11,3.12%,HCN1
prerank,ribonuclease activity (GO:0004540),0.2647178688651228,0.7328339280786895,0.8381962864721485,0.9825732789393586,1.0,22/56,28.08%,SMG6;CNOT7;ZC3H12D;RNASE6;EXOSC7;DIS3L2;LACTB2;ERN2;EXOSC5;PIWIL4;NYNRIN;RNASE7;N4BP1;RNASEH1;EXOSC4;RNASEH2A;EXOSC1;ELAC2;AGO3;ZC3H12A;RNASE12;ANG
prerank,calcium-release channel activity (GO:0015278),-0.27397750085386674,-0.7322863713277519,0.85,0.9876066860508964,1.0,1/17,0.30%,ITPR1
prerank,peptidase activator activity (GO:0016504),0.3047433801735233,0.7300435855720103,0.772093023255814,0.983898112092259,1.0,2/22,4.82%,TANK;VCP
prerank,microtubule motor activity (GO:0003777),0.27219681067443596,0.7293529511227628,0.828042328042328,0.9822389746314513,1.0,10/51,14.10%,KIF13A;DYNC1I1;KIF1B;DNAH8;KIF1C;KIF27;KIF2C;KIF7;KIF9;APPBP2
prerank,translation elongation factor activity (GO:0003746),-0.28909525051484075,-0.7225656063855008,0.8426150121065376,0.9950811703736316,1.0,5/14,24.55%,EEF1A1;EEF1B2;EIF5A2;EEF2;EEF1A2
prerank,cysteine-type endopeptidase inhibitor activity involved in apoptotic process (GO:0043027),-0.2742481577400673,-0.7218182335767487,0.8236914600550964,0.9909649920543026,1.0,4/18,11.29%,TNFAIP8;SNCA;GAS6;RPS6KA1
prerank,protein kinase activator activity (GO:0030295),0.25997744984590143,0.7214810272488298,0.8701986754966887,0.9901694145988076,1.0,13/60,15.69%,ABI1;WNT11;WNK1;FGF13;MARK2;IQGAP1;MLST8;PAK2;CAB39L;CAB39;STK11;FAM20A;MAP2K2
prerank,acylglycerol lipase activity (GO:0047372),0.34404334041288814,0.7149343729490418,0.7915936952714536,0.9960764990263521,1.0,4/11,18.08%,MGLL;ABHD6;ABHD15;ABHD2
prerank,protein tyrosine/serine/threonine phosphatase activity (GO:0008138),0.3092955203753406,0.7145939306616234,0.8006482982171799,0.9939090272651081,1.0,5/22,16.06%,DUSP16;DUSP10;DUSP5;DUSP12;CDKN3
prerank,peptidase inhibitor activity (GO:0030414),0.27934795816384067,0.7134290875804518,0.8248175182481752,0.992877756349167,1.0,4/33,7.84%,GPC3;CAST;SLPI;TIMP2
prerank,water transmembrane transporter activity (GO:0005372),-0.30232169109467344,-0.7133731893179948,0.8167053364269141,0.9965574317901752,1.0,2/11,6.29%,AQP4;AQP11
prerank,tau protein binding (GO:0048156),0.2688316246720115,0.7101003734896596,0.8380681818181818,0.9947620854270293,1.0,11/40,20.02%,MARK1;GSK3B;CLU;EP300;MARK2;MARK3;PPP5C;PRKAA1;PPP2CB;MAP1A;DCTN1
prerank,pyrophosphatase activity (GO:0016462),-0.20818273661340403,-0.7094752035920668,0.9343065693430657,0.9961503936128157,1.0,13/50,21.70%,ENTPD1;ENPP1;ENTPD5;ENPP3;BNIP2;PPA1;LHPP;CILP;DCP2;PLPP5;CILP2;PRUNE2;ENTPD3
prerank,disordered domain specific binding (GO:0097718),0.30014375524715375,0.7094446465595542,0.8360128617363344,0.993017900220421,1.0,3/23,11.30%,FN1;DFFB;RB1
prerank,protein kinase A regulatory subunit binding (GO:0034237),0.30615405992111505,0.7089374033391606,0.825944170771757,0.9911124700235578,1.0,2/21,7.45%,EZR;PRRC1
prerank,nuclear import signal receptor activity (GO:0061608),0.3168484971672336,0.7086210638487098,0.7833333333333333,0.9890470288542227,1.0,3/15,15.05%,KPNA1;TNPO2;KPNA4
prerank,glutathione transferase activity (GO:0004364),-0.2454962490170373,-0.7083000551860361,0.8839285714285714,0.9924721944515207,1.0,17/23,48.49%,MGST3;HPGDS;GSTZ1;GSTK1;GSTA3;GSTA4;GSTT1;ALOX5AP;MGST1;LTC4S;GSTP1;GSTA2;GSTT4;GSTM2;GSTT2;GSTO1;GSTM1
prerank,postsynaptic neurotransmitter receptor activity (GO:0098960),-0.24835979557444,-0.7077007350020942,0.9088607594936708,0.9881727679290901,1.0,5/21,17.91%,GRM5;GRM1;CHRFAM7A;CHRNA7;ANXA9
prerank,"endoribonuclease activity, producing 5'-phosphomonoesters (GO:0016891)",0.2874951738529052,0.7062601478556046,0.8195956454121306,0.989631650123151,1.0,15/28,31.33%,RPP38;DROSHA;EDC3;RNASEH1;ELAC1;RNASEH2A;APEX1;POP4;POP1;EXO1;ELAC2;AGO3;NUDT16L1;NUDT16;RPP14
prerank,3'-5' DNA helicase activity (GO:0043138),0.31561278292295813,0.7055106750952073,0.806873977086743,0.9880205398315065,1.0,7/16,21.94%,MCM7;ERCC3;FANCM;DHX9;WRN;RECQL5;MCM6
prerank,C-C chemokine receptor activity (GO:0016493),-0.25345486166264763,-0.7033683211336889,0.8664772727272727,0.9883220309462805,1.0,1/21,1.69%,CCR9
prerank,Tat protein binding (GO:0030957),0.3440806473376073,0.7008741442260402,0.7845303867403315,0.9911518687930949,1.0,2/10,8.85%,MDFIC;SMARCA4
prerank,GDP-dissociation inhibitor activity (GO:0005092),0.32439367305503164,0.6966301382182256,0.7947368421052632,0.9937658744359393,1.0,1/13,1.79%,ARHGDIB
prerank,G protein-coupled peptide receptor activity (GO:0008528),0.2469535552818328,0.692775637557759,0.9010416666666666,0.9958029831006641,1.0,8/73,13.03%,EDNRA;NLRP6;BDKRB1;FPR3;MAS1;NPR3;GALR1;CRHR2
prerank,exopeptidase activity (GO:0008238),-0.1996462431075861,-0.6859928401891467,0.952755905511811,1.0,1.0,14/50,21.30%,CTSH;ACE;ENPEP;CTSZ;CTSA;DPP4;TRHDE;ACE2;PRCP;DPP10;LNPEP;DPP6;CPM;ZMPSTE24
prerank,CXCR chemokine receptor binding (GO:0045236),-0.28627695792171726,-0.6836174176848661,0.8551401869158879,0.9994693416742861,1.0,1/11,3.83%,CXCL12
prerank,K63-linked polyubiquitin modification-dependent protein binding (GO:0070530),0.29260740616675096,0.6815393913133715,0.8509615384615384,1.0,1.0,10/22,26.55%,TAB3;OTUD7B;RNF168;SQSTM1;IKBKE;ZRANB1;MINDY2;WDR81;UIMC1;ZBTB1
prerank,retinoid X receptor binding (GO:0046965),0.34307909892157695,0.6810582572805416,0.842756183745583,1.0,1.0,2/11,6.12%,NR4A2;RARG
prerank,purinergic nucleotide receptor activity (GO:0001614),0.31138874691277096,0.6798902515906391,0.831081081081081,1.0,1.0,2/15,7.14%,P2RX2;P2RX4
prerank,O-methyltransferase activity (GO:0008171),-0.2872882990358602,-0.6784984619440879,0.8732057416267942,0.9995138246760041,1.0,2/10,20.46%,COMT;CMTR2
prerank,phosphatase inhibitor activity (GO:0019212),0.3036039422537138,0.677658834254282,0.8557692307692307,1.0,1.0,11/20,31.02%,CABIN1;BOD1L1;STYXL1;PPME1;URI1;SAG;PPP1R1B;LGALS3;STYX;ARPP19;MGAT5
prerank,G protein-coupled receptor activity (GO:0004930),0.21092793711825233,0.6771335698646604,0.9840255591054313,1.0,1.0,22/239,13.62%,GPR156;GPR4;ADRA1B;ADGRL2;AGTR1;ADRB2;LPAR4;PDGFRL;ADGRG6;SSTR3;BDKRB1;AGTR2;CXCR4;FPR3;MAS1;DRD3;NPR3;CMKLR1;GALR1;CRHR2;OPRL1;ADGRD1
prerank,nuclear export signal receptor activity (GO:0005049),0.3279217109396724,0.6765820344633551,0.8297872340425532,0.9993081971362237,1.0,4/11,26.23%,XPO1;RAN;EIF4ENIF1;XPO5
prerank,C-C chemokine binding (GO:0019957),-0.24464103692637273,-0.6738370902032425,0.9166666666666666,0.9993629729936421,1.0,1/22,1.69%,CCR9
prerank,ubiquitin-dependent protein binding (GO:0140036),-0.2841737646185901,-0.6695346595539426,0.8637413394919169,0.9983478128507908,1.0,3/10,19.75%,FAN1;ANKRD13A;DNAJB2
prerank,"oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor (GO:0050664)",-0.26369562194107904,-0.6689251664361092,0.8753117206982544,0.9940795240822109,1.0,2/14,6.82%,CYBA;MICAL1
prerank,protein serine/threonine kinase inhibitor activity (GO:0030291),0.26806992954609105,0.6686714641566188,0.8759571209800919,1.0,1.0,7/29,14.68%,CIT;SPRED2;CDKN1B;SFN;PRKAR2A;KAT2B;CDKN2D
prerank,metallocarboxypeptidase activity (GO:0004181),0.274952525385582,0.6684207962438001,0.8609794628751974,1.0,1.0,4/26,7.58%,CPA5;CPA4;CPA3;CPB1
prerank,histone methyltransferase binding (GO:1990226),0.3222621151395572,0.6628760232980021,0.8511796733212341,1.0,1.0,4/11,22.72%,WIZ;LCOR;CBX1;NOP56
prerank,G protein-coupled amine receptor activity (GO:0008227),0.28210883235954665,0.6599147643906536,0.8837579617834395,1.0,1.0,3/22,12.74%,CHRM5;HTR1B;HTR2B
prerank,G protein-coupled serotonin receptor activity (GO:0004993),0.28210883235954665,0.6599147643906536,0.8837579617834395,1.0,1.0,3/22,12.74%,CHRM5;HTR1B;HTR2B
prerank,serotonin receptor activity (GO:0099589),0.28210883235954665,0.6599147643906536,0.8837579617834395,1.0,1.0,3/22,12.74%,CHRM5;HTR1B;HTR2B
prerank,phosphoric ester hydrolase activity (GO:0042578),0.24572340600581002,0.6598983114613979,0.90625,1.0,1.0,11/49,14.82%,MPPED2;DUSP16;DUSP10;ACP3;PLCXD3;DUSP5;GDPD3;PPP5C;DUSP11;DUSP12;ARMT1
prerank,cyclin-dependent protein serine/threonine kinase regulator activity (GO:0016538),0.2501883861179038,0.6586214961312762,0.8946648426812586,0.9988074204074648,1.0,13/42,26.25%,CCNA2;CCNL2;CDKN1B;KAT2B;CDKN2D;CCND3;CCNYL1;CKS1B;CCNT1;CCNE2;HEXIM2;CDKN1A;CCNF
prerank,FMN binding (GO:0010181),-0.2760558837550587,-0.6579668111529816,0.8963963963963963,0.9983426764198177,1.0,1/11,1.83%,NOS3
prerank,protein phosphatase inhibitor activity (GO:0004864),-0.2195288523700842,-0.657833970790298,0.9403409090909091,0.9937231223559191,1.0,5/26,15.23%,PPP1R1A;SET;PPP1R14A;ENSA;PABIR1
prerank,endonuclease activity (GO:0004519),0.2448465363856186,0.6577962214301639,0.9090909090909091,0.997249320873062,1.0,11/49,19.95%,N4BP2;SMG6;ZC3H12D;APLF;LACTB2;MBD4;ERN2;PIWIL4;REXO4;NYNRIN;MRE11
prerank,voltage-gated anion channel activity (GO:0008308),0.3005305651891437,0.6544320475383388,0.8625429553264605,0.9982153764766397,1.0,1/15,2.81%,ANO6
prerank,tRNA binding (GO:0000049),0.24977022507164612,0.6542430308090728,0.9124820659971306,0.9960087719797571,1.0,19/43,30.76%,IGHMBP2;EIF2AK4;ELP5;TYW5;SEPSECS;DALRD3;MRPS27;TRMT10B;ALKBH8;AARS1;XPOT;TERT;FARS2;KARS1;TRNAU1AP;THG1L;RPUSD4;NEMF;PTCD1
prerank,cardiolipin binding (GO:1901612),-0.2806240958521462,-0.6515286518655864,0.8869778869778869,0.9943133171957592,1.0,2/10,17.92%,GSDME;GSDMD
prerank,ubiquitin conjugating enzyme binding (GO:0031624),0.2664351335687474,0.6496275834882946,0.8767550702028081,0.9980808659396032,1.0,10/27,24.42%,RNF19A;ARIH1;DCUN1D4;ARIH2;ZMYM2;UBE3D;RNF144A;RNF14;ANKIB1;RNF217
prerank,protein-cysteine S-palmitoyltransferase activity (GO:0019706),0.27172837964334734,0.6447842451075546,0.8810641627543035,1.0,1.0,6/24,18.50%,ZDHHC11;ZDHHC23;ZDHHC15;GLUL;GOLGA7;ZDHHC7
prerank,"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen (GO:0016702)",0.29230445482284234,0.6441773062601589,0.8872549019607843,0.9984045581612583,1.0,4/16,24.90%,CDO1;ADI1;ALOXE3;HAAO
prerank,Toll-like receptor binding (GO:0035325),-0.2727188804317384,-0.6439630780838718,0.8978102189781022,0.9955817108717495,1.0,2/11,6.39%,DAB2IP;UNC93B1
prerank,poly(A)-specific ribonuclease activity (GO:0004535),0.3079214487789421,0.6413881251620224,0.8479020979020979,0.9986086540683345,1.0,3/12,14.27%,PAN3;CNOT7;PNLDC1
prerank,polyubiquitin modification-dependent protein binding (GO:0031593),0.2385739292365664,0.6398656948762778,0.9172320217096337,0.9975438206767764,1.0,10/49,18.18%,VCP;TAB3;OTUD7B;UFD1;RNF168;SQSTM1;IKBKE;RAD23B;ZRANB1;TNIP1
prerank,phosphatidylinositol-3-phosphate binding (GO:0032266),0.2532187323626861,0.6385041271168306,0.8888888888888888,0.9963400424191113,1.0,9/38,16.78%,WIPI2;PLEKHA4;ZFYVE1;ZFYVE26;PARD3;SNX12;PLA2G4A;SNX20;ATG2A
prerank,methyltransferase activity (GO:0008168),0.24447421665989535,0.638259133685692,0.9165562913907285,0.9942296565950216,1.0,13/46,23.16%,CARNMT1;MRM2;METTL4;EHMT1;ARMT1;EEF1AKMT1;NSUN4;NNMT;PRMT8;MEPCE;GAMT;NDUFAF7;FTSJ3
prerank,palmitoyltransferase activity (GO:0016409),0.25973178518220624,0.63738601406682,0.8975903614457831,0.9926643823294489,1.0,7/28,18.50%,ZDHHC11;ZDHHC23;ZDHHC5;ZDHHC15;GLUL;GOLGA7;ZDHHC7
prerank,G protein-coupled photoreceptor activity (GO:0008020),-0.26272333980576,-0.6350363580968941,0.885286783042394,0.9976107615346965,1.0,8/12,51.45%,ELOVL4;GPR88;RRH;GPR52;OPN5;OPN1SW;GNAT2;OPN4
prerank,DNA polymerase binding (GO:0070182),0.27870644853387677,0.6344160163610233,0.8625204582651391,0.9928558035585231,1.0,5/18,18.94%,SMG6;SMARCA4;POLG2;ACD;LONP1
prerank,calcium-dependent phospholipase A2 activity (GO:0047498),0.2850372562632657,0.6301825382693241,0.8754208754208754,0.9941828215444556,1.0,2/15,15.54%,PLA2G4F;PLA2G4A
prerank,motor activity (GO:0003774),0.22898632771057312,0.628298242216194,0.9393548387096774,0.9933806368206306,1.0,11/60,14.10%,KIF13A;DYNC1I1;KIF1B;DNAH8;KIF1C;KLC1;KIF27;KIF2C;KIF7;KIF9;APPBP2
prerank,store-operated calcium channel activity (GO:0015279),-0.272975702369277,-0.6269999791697831,0.9180327868852459,0.9982570231326976,1.0,4/10,17.62%,TRPC3;TRPC4;TRPC6;ORAI2
prerank,phosphatidylinositol kinase activity (GO:0052742),0.2903125412556878,0.6255722325092835,0.890728476821192,0.9932755886287868,1.0,5/15,24.45%,ATM;PI4KB;PIK3C2B;PIKFYVE;PIK3R3
prerank,phosphatidylinositol monophosphate phosphatase activity (GO:0052744),-0.24209720914905009,-0.6242266570968744,0.8995215311004785,0.9954531886903318,1.0,8/16,34.06%,INPP5F;MTMR10;MTMR9;MTMR2;MTMR1;MTM1;MTMR4;MTMR7
prerank,regulatory RNA binding (GO:0061980),-0.19288093844009063,-0.622636353396732,0.9894736842105263,0.9918861565248771,1.0,10/38,24.58%,AGO1;YBX1;AGO4;TLR7;TARBP2;ELAVL1;SPOUT1;ZC3H10;RBM10;ZC3H7B
prerank,mRNA 3'-UTR binding (GO:0003730),0.21799109690074603,0.6219060156324813,0.951715374841169,0.9938958317921839,1.0,13/79,14.95%,DDX5;YBX3;AUH;LARP4B;PABPC4;CELF1;PCBP4;SERBP1;RBMS3;SECISBP2L;PUM2;FXR2;PUM1
prerank,SH2 domain binding (GO:0042169),0.2521746392768321,0.6210600907021452,0.9101620029455081,0.9922637756271934,1.0,7/31,16.15%,ABL1;IRS1;AFAP1;SQSTM1;NLK;ARHGAP5;LAX1
prerank,protein phosphatase regulator activity (GO:0019888),0.22709681163742299,0.6166640240641418,0.9460526315789474,0.9933323172799131,1.0,14/53,17.78%,CABIN1;SHOC2;PPP2R2D;BOD1L1;PPP6R2;RCAN1;STYXL1;PPP2R1B;PPP4R1;PPP6R3;PPME1;PPP4R2;RCAN3;PPP2R5C
prerank,NADPH binding (GO:0070402),-0.24994083887461943,-0.6153349810877802,0.9118329466357309,0.9917508224774821,1.0,3/13,14.21%,KCNAB1;QDPR;CRYZ
prerank,"hydrolase activity, hydrolyzing N-glycosyl compounds (GO:0016799)",-0.23283410856257447,-0.6145736248463771,0.9371980676328503,0.9877435023590004,1.0,3/16,12.31%,RPS3;CD38;MACROD1
prerank,phosphatidylinositol-3-phosphatase activity (GO:0004438),0.2797492668436378,0.6139563999273762,0.8836805555555556,0.993078314594403,1.0,3/14,15.53%,MTMR12;MTMR11;SYNJ1
prerank,acetylcholine-gated cation-selective channel activity (GO:0022848),0.2952927065189797,0.6116170800108215,0.9013605442176871,0.9925331157180095,1.0,4/11,28.41%,CHRNA4;CHRNB1;CHRNB2;CHRNA3
prerank,nucleotidyltransferase activity (GO:0016779),0.26335868399532936,0.6059872287226168,0.8817034700315457,0.994279687316647,1.0,3/19,13.24%,PAPSS2;MOCS3;REV1
prerank,semaphorin receptor activity (GO:0017154),0.29400690814048247,0.603960523313991,0.9157706093189965,0.9935037408250716,1.0,4/11,20.71%,PLXNA2;NRP1;PLXNA3;PLXNA1
prerank,ribonuclease P RNA binding (GO:0033204),0.29600592675760035,0.5979773237489523,0.9041591320072333,0.9954095938819173,1.0,1/10,5.55%,RPP38
prerank,kinesin binding (GO:0019894),0.24070796784148116,0.5934027313476005,0.9361370716510904,0.9963820055565604,1.0,8/27,22.38%,ARHGEF10;KIF1B;MAPK8IP3;IFT88;SPAG9;PLEKHM2;CROCC;NEK6
prerank,ATPase regulator activity (GO:0060590),0.2300859542305847,0.5918228157999136,0.9452054794520548,0.9950262202701278,1.0,4/38,12.29%,ATP1B1;TOR1AIP1;DNAJB6;DNAJC19
prerank,chemokine receptor activity (GO:0004950),-0.20348263096316221,-0.5889190450290905,0.9575070821529745,0.9968155098137566,1.0,1/24,1.69%,CCR9
prerank,5'-3' exonuclease activity (GO:0008409),0.2744251060520101,0.586093541301962,0.9247491638795987,0.996398763613789,1.0,1/14,3.98%,DXO
prerank,single-stranded DNA helicase activity (GO:0017116),0.25586968777036767,0.5847375574759675,0.9266347687400319,0.9950307179265402,1.0,7/19,29.76%,MCM7;RFC5;DHX9;MCM6;MCM2;POLQ;DNA2
prerank,alpha-tubulin binding (GO:0043014),0.23188768605551688,0.5801786031983768,0.9484848484848485,0.9955128937067383,1.0,5/31,11.77%,TBCE;WASHC1;ARL8A;BEX4;SETD2
prerank,hormone activity (GO:0005179),0.21102602489813468,0.577666059046996,0.9760319573901465,0.9946021462673801,1.0,3/54,5.10%,INHBA;C1QTNF12;ERFE
prerank,purine ribonucleotide transmembrane transporter activity (GO:0005346),-0.24600435722472003,-0.5768438555865921,0.94,0.9981557930241658,1.0,5/11,26.03%,LRRC8A;SLC35B3;SLC25A24;SLC25A42;SLC17A9
prerank,ubiquitination-like modification-dependent protein binding (GO:0140035),-0.24645735784719103,-0.576019645615446,0.9402298850574713,0.9940452299357574,1.0,2/10,10.30%,FAN1;ANKRD13A
prerank,adenine nucleotide transmembrane transporter activity (GO:0000295),-0.23888476570178296,-0.5743490322782987,0.9451371571072319,0.990276009165158,1.0,5/12,26.03%,LRRC8A;SLC35B3;SLC25A24;SLC25A42;SLC17A9
prerank,miRNA binding (GO:0035198),-0.18433159190908216,-0.5629126260176742,0.98989898989899,0.9906786483156663,1.0,9/30,27.64%,AGO1;YBX1;AGO4;ELAVL1;SPOUT1;ZC3H10;RBM10;ZC3H7B;HNRNPA1
prerank,ubiquitin-specific protease binding (GO:1990381),0.24991908345779618,0.5618434908344279,0.9437299035369775,1.0,1.0,7/19,32.73%,VCP;LCOR;SUMO1;RAD23A;DERL2;SYVN1;RHBDD2
prerank,tRNA methyltransferase activity (GO:0008175),0.2501626281170797,0.5582701185628836,0.9291736930860034,1.0,1.0,5/16,26.37%,TRMT13;TRDMT1;ALKBH8;TRMT12;TARBP1
prerank,MAP kinase kinase activity (GO:0004708),-0.2179101995664616,-0.5567998290998867,0.9646464646464646,0.9884798638684062,1.0,2/15,8.91%,MAP2K6;LRRK2
prerank,telomerase RNA binding (GO:0070034),-0.19467933959299097,-0.5532647454067319,0.9818652849740933,0.9852990891552725,1.0,10/22,33.72%,SNRPB;TENT4B;DCP2;HNRNPU;EXOSC10;SMG7;SMG5;NOP10;DKC1;NHP2
prerank,nuclear localization sequence binding (GO:0008139),0.23987407466247546,0.5465162739265873,0.9406099518459069,1.0,1.0,3/18,15.05%,KPNA1;TNPO2;KPNA4
prerank,neuropeptide receptor binding (GO:0071855),0.25357860371672514,0.5463837077656997,0.9389830508474576,1.0,1.0,14/14,74.66%,SHANK1;NMU;NTS;UCN3;APELA;AGRP;QRFP;GHRH;NPPA;UCN2;GAL;PPY;APLN;NPY
prerank,microtubule minus-end binding (GO:0051011),-0.22115955776467594,-0.5454063015642078,0.9675810473815462,0.9835075109605907,1.0,6/13,30.42%,MACF1;CAMSAP2;HAUS4;TUBGCP3;CAMSAP1;TUBGCP2
prerank,histone-lysine N-methyltransferase activity (GO:0018024),0.20513650469699674,0.5382971201753072,0.9785809906291834,1.0,1.0,14/44,25.39%,SMYD2;SETD5;SETD2;EHMT2;EHMT1;KMT2C;KMT2D;ASH2L;SETD1B;KMT2A;EED;EZH2;KMT5A;WDR5
prerank,fibroblast growth factor receptor binding (GO:0005104),0.23365142277867154,0.5366991062547831,0.9610591900311527,1.0,1.0,4/21,15.66%,FGF22;FGF2;KLB;FGF18
prerank,pyridoxal phosphate binding (GO:0030170),0.23241346280351644,0.535220444659795,0.9636650868878357,1.0,1.0,4/20,21.26%,PYGB;PNPO;OAT;ACCS
prerank,acyl-CoA hydrolase activity (GO:0047617),0.23494073007215555,0.5289491823878508,0.9651741293532339,1.0,1.0,5/17,25.37%,ACOT8;ACOT13;ACOT12;ACOT9;ACOT1
prerank,RNA stem-loop binding (GO:0035613),0.24987408704187364,0.5263468285188593,0.9550359712230215,0.9990826823930518,1.0,5/12,27.35%,DHX9;RC3H2;CSDE1;FMR1;ZC3H12A
prerank,acetylgalactosaminyltransferase activity (GO:0008376),0.22027584934643687,0.5258822587143626,0.9702660406885759,0.9970529191505704,1.0,2/26,8.63%,B3GNT2;B3GNT6
prerank,endoribonuclease activity (GO:0004521),0.20934185668564848,0.5241243684209997,0.9790732436472347,0.9955663875270867,1.0,6/32,18.67%,SMG6;ZC3H12D;LACTB2;ERN2;PIWIL4;NYNRIN
prerank,neuropeptide binding (GO:0042923),0.22515927766379087,0.520484987996524,0.962843295638126,0.9946997738311669,1.0,3/18,21.03%,SSTR3;OPRL1;OPRM1
prerank,snRNA binding (GO:0017069),0.19822600312668873,0.5200610614552722,0.9877216916780355,0.9926352674916696,1.0,19/42,32.51%,SNRPB2;LSM2;SNRPD3;SNRNP70;MEPCE;RNPC3;CCNT1;HEXIM2;NCBP2;DDX21;TOE1;COIL;LSM8;PRPF31;LSM4;SF3B3;LSM11;SNRNP35;EIF5A
prerank,ribonuclease P activity (GO:0004526),0.25026233412064885,0.5128968416504267,0.9553571428571429,0.9928780768341828,1.0,1/11,5.55%,RPP38
prerank,carbohydrate kinase activity (GO:0019200),0.23489042345716007,0.489808600550068,0.9758620689655172,0.9975266932228117,1.0,2/11,10.23%,GALK2;GNE
prerank,"exodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016895)",0.2427801334982384,0.4867556896282387,0.9712746858168761,0.9961062698882651,1.0,4/10,26.40%,EXD2;TATDN1;APEX1;EXO1
prerank,1-phosphatidylinositol-3-kinase activity (GO:0016303),0.24159871421055107,0.4867120493804173,0.957968476357268,0.9939376359115855,1.0,2/10,15.29%,ATM;PIK3C2B
prerank,superoxide-generating NAD(P)H oxidase activity (GO:0016175),0.23715808475345754,0.4840180056939293,0.9699115044247788,0.9925070394555975,1.0,2/10,12.93%,NOX1;DUOX1
prerank,S-adenosylmethionine-dependent methyltransferase activity (GO:0008757),0.1850764407756072,0.47900439730584055,0.994535519125683,0.991539510020986,1.0,12/40,26.82%,CARNMT1;GNMT;METTL4;ARMT1;NNMT;PRMT8;MEPCE;GAMT;METTL18;DPH5;TARBP1;PCMTD2
prerank,antiporter activity (GO:0015297),-0.16416049031343616,-0.4514762229397555,0.9947368421052631,0.9992586400772209,1.0,12/20,45.40%,SLC35D1;SLC25A11;SLC25A30;SLC35E2A;SLC35E2B;SLC35D2;SLC35E4;SLC35C1;SLC35D3;TMEM241;SLC25A10;SLC35C2
prerank,tRNA-specific ribonuclease activity (GO:0004549),0.20597411817046055,0.4436219359344724,0.9876760563380281,0.9959520354380594,1.0,1/14,5.55%,RPP38
prerank,transaminase activity (GO:0008483),0.20889335330363876,0.4332091387127341,0.9930313588850174,0.9953158089639346,1.0,3/11,19.90%,BCAT2;OAT;GOT1
prerank,neuropeptide hormone activity (GO:0005184),-0.14541457286432163,-0.4242649764546236,0.9940828402366864,0.9972541638735626,1.0,22/22,85.48%,PENK;NPY;CCK;NMB;PNOC;PPY;GAL;CALCB;UCN;SPX;NPFF;NPPA;GHRH;QRFP;AGRP;CORT;OXT;HCRT;GRP;CRH;ADCYAP1;VIP
prerank,"oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor (GO:0016655)",0.1969400897889203,0.4070200160073466,0.9813432835820896,0.996094125040368,1.0,2/12,16.91%,AIFM2;CBR4
